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ABSTRACT
Sleep fragmentation is the term used to describe brief awakenings or
microarousals from sleep which are less than 15 seconds long and often
occur without the awareness of the sleeping subject. Arousals is the
collective term for awakenings >15 seconds and microarousals < 15
seconds. Patients with sleep apnoea/ hypopnoea syndrome (SAHS) have
recurrent upper airway obstructions during sleep usually terminated by
arousals and decreases in oxygen saturation. They suffer from impaired
daytime function which correlates weakly with their nocturnal hypoxemia and
sleep fragmentation. These are interrelated making it difficult to distinguish
which is the cause of daytime dysfunction in SAHS patients. This thesis
examines the impact of sleep fragmentation alone on daytime function by
inducing sleep fragmentation in normal subjects and studying their
subsequent daytime function.
A problem associated with studying sleep fragmentation is its poor
definition. Current arousal definitions use a combination of a greater than 1
second increase in EEG frequency with or without increased EMG activity
depending on sleep stage. This can lead to difficulties in comparing results
between studies. Although the American Sleep Disorders Association
(ASDA) has published guidelines on visual scoring of arousals they have not
been validated or compared with other arousal definitions currently in use.
Therefore 3 different arousal definitions and 1 definition of awakening were
compared in SAHS patients. The definitions were (1) ASDA (3 seconds), (2)
ASDA modified to 1.5 seconds, (3) Cheshire 1.5 second. The awakening
was defined as a Rechtschaffen and Kales' stage shift to wakefulness. There
were significantly more arousals of any kind than awakenings, and
significantly more 1.5 second arousals by either definition than ASDA
arousals. However not all apnoeas and hypopnoeas were terminated by
visible EEG arousals with at best, 83% of respiratory events being
terminated by 1.5 second ASDA arousals. There were weak but significant
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relationships between microarousals scored by any definition and daytime
sleepiness on the multiple sleep latency test (MSLT).
The first sleep fragmentation protocol examined the effects of one
night of induced visible EEG arousals on the daytime function of normal
subjects. The subjects were objectively sleepier during the day after
fragmentation as measured by both the MSLT and the maintenance of
wakefulness test (MWT). Subjects had altered mood on the UWIST mood
adjective checklist following sleep fragmentation; energetic arousal was
diminished all day except at 12.00, hedonic tone was decreased at 10.00,
and tense arousal was increased at 08.00 and 10.00. Subjects had impaired
performance on 2 tests of cognitive function; Trailmaking B, a test of mental
flexibility, and on PASAT 4 seconds, a test of sustained attention. These
deficits were similar to those seen in SAHS patients prior to CPAP therapy.
There are subgroups of patients with sleep apnoea whose apnoeas
and hypopnoeas occur when they are lying supine or when they are in REM
sleep. This allows them to obtain periods of uninterrupted sleep which may
be sufficient to overcome any daytime dysfunction that may have occurred
due to their REM or posture related sleep apnoea. Therefore 2 fragmentation
paradigms were compared; regular fragmentation every 90 seconds of sleep,
and clustered fragmentation every 30 seconds for 30 minutes every 90
minutes. There was no difference in arousal frequencies between study
nights. There were no differences in daytime function despite significantly
less stage 2 and more slow wave sleep on the clustered fragmentation night.
This suggests that deficits in daytime function are dependent on sleep
fragmentation and not stage 2 or slow wave sleep.
Not all apnoeas and hypopnoeas are terminated by visible EEG
arousals but are terminated by transient increases in blood pressure. The
impact of these transient increases in blood pressure on daytime function are
unknown. Therefore daytime function was compared after an undisturbed
night's sleep and one night of sleep fragmentation to cause blood pressure
elevations alone without coincident visible EEG arousals. There was
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significantly less slow wave sleep on the fragmented study night but there
was no difference in visible EEG arousals between study nights. Non-visible
sleep fragmentation made subjects sleepier during the day on the MSLT and
MWT, and decreased hedonic tone upon awakening. There was no effect on
cognitive function.
Finally changes in EEG frequencies during visible EEG arousals were
examined using Fast Fourier Transformation (FFT). There were significant
increases in all physiological frequencies of human sleep within 5 seconds of
the start of an arousal. During the non-visible fragmentation night alpha EEG
power was determined with FFT. There was a significant increase in peak
alpha power within 5 seconds of a tone whether that tone produced a visible
EEG arousal or not. This suggests that computerised analysis of the EEG
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Sleep apnoea/ hypopnoea syndrome (SAHS); background and treatment.
1.1 Background
The sleep Apnoea/Hypopnoea syndrome (SAHS) is a relatively
common condition in the general population (Young et al 1993) whereby the
sufferer's upper airway is repetitively completely (apnoea) or partially
(hypopnoea) sucked closed during sleep. Patients suffer from SAHS for a
variety of reasons, outlined in more detail in the following introduction. When
the SAHS patient falls asleep combinations of factors lead to their upper
airway gradually becoming obstructed. During an apnoea the patient keeps
trying to breathe against the obstructed airway but has to undergo some
degree of arousal from sleep in order to clear the obstruction. Once the
upper airway is open, in the more severe cases, the patient will fall straight
back to sleep only for the cycle to repeat itself. This tends to result in highly
disrupted or fragmented sleep which can leave the patient feeling very
sleepy during the day. In addition these patients may suffer from impaired
daytime mood and performance. The focus of this introduction is to describe
SAHS and the factors that contribute to it, to outline previous research on
sleep apnoea and daytime function, and to describe previous research on
sleep disruption in normal subjects.
1.2 Uncovering Sleep Apnoea
Apnoea literally means absence of breath during sleep. It was first
described polygraphically by Gastaut et al (1965, 1966), and independently
by Jung et al (1965), in patients suffering from the Pickwickian syndrome. It
was characterised as repetitive upper airway obstructions during sleep
terminated by electroencephalograph (EEG) defined arousals from sleep and
associated with decreases in arterial oxygen saturation. These patients also
suffered from excessive somnolence. Although this led to better
l
understanding of the pathophysiology of Pickwickian syndrome it also
provoked interest in the study of breathing during sleep alone without
associated cardiorespiratory problems. A symposium on sleep related
respiratory problems in Europe drawing together the fields of neurology and
respiratory medicine (Sadoul and Lugaresi 1972) served to recognise sleep
apnoea as a primary disorder not necessarily associated with obesity or
cardiorespiratory problems, both of which are characteristics of the
Pickwickian syndrome.
Gastaut et al (1965, 1966) described 3 types of apnoea as episodes
of complete cessation of airflow for more than 10 seconds associated with;
(1) cessation of respiratory effort (central), (2) continued respiratory effort
(obstructive), and (3) initial cessation of respiratory effort which resumes
midway through the event (mixed). True central sleep apnoea is rare and will
not be dealt with in this thesis. In an early published series of 62 patients
with sleep apnoea, Guilleminault et al (1976) found that most had obstructive
or mixed apnoeas during sleep.
1.3 Obstructive Apnoea- Sequence of Events
During sleep muscle tone decreases throughout the body which, as it
includes the upper airway dilating muscles, invariably results in narrowing of
the upper airway. In patients with disorders of breathing during sleep this
loss of muscle tone in the upper airway dilating muscles leads to narrowing
of the upper airway. This may result in increased upper airway resistance,
snoring or, in patients with sleep apnoea, the generation of increasingly
negative intraluminal pressures in the upper airway so that it occludes.
During the resulting apnoea increasingly negative intrathoracic pressure is
generated with each occluded inspiratory effort until a critical level is reached
(Gleeson et al 1990) and the patient arouses from sleep and clears the
upper airway obstruction. The patient resumes breathing, returns to sleep
and in severe cases the cycle begins again instantly. Most apnoeas and
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hypopnoeas terminate in visible EEG arousals from sleep. In addition
apnoeas and hypopnoeas terminate in transient increases in arterial blood
pressure (Shepard 1986) regardless of whether there is an EEG arousal or
not. This is reflected in the finding of Rees et al (1995) that even if
respiratory events do not terminate in a visible EEG arousal there are
increases in computer detectable EEG frequency. Upper airway obstructions
may be accompanied by decreases in arterial oxygen saturation in older or
more overweight patients which, due to a combination of delays, both
physiological and within the technique of measuring oxygen saturation, reach
their nadir after breathing has resumed.
1.4 Symptoms of Sleep Apnoea
The most common symptoms of sleep apnoea include snoring,
uncontrollable daytime sleepiness, nocturnal choking attacks, restless and/
or unrefreshing sleep, personality changes, poor concentration and memory
and decreased sex drive (Guilleminault et al 1976, Whyte et al 1989).
Patients with sleep apnoea cannot be diagnosed on their symptoms but
need to have objective evidence from overnight monitoring. Hillerdal et al
(1991) demonstrated that heavy snorers and patients with SAHS could not
be separated on the basis of their symptoms alone. Amongst these
symptoms this thesis will focus on the daytime sleepiness, impaired mood
and cognitive function that are found in SAHS patients. The relative
contributions of nocturnal events to these impairments are discussed in
greater detail in chapter 2 dealing with SAHS and daytime function.
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1.5 Defining Sleep Apnoea
The term sleep apnoea covers a broad range of disease. The
relationships between nocturnal indicators of SAHS i.e. number of apnoeas
and hypopnoeas, and daytime sleepiness are poor (section 2.7) and
therefore combining patient symptoms and objective evidence from nocturnal
monitoring to define the condition is important in the determination of who
receives treatment.
Early definitions of sleep apnoea included 30 apnoeas in 7 hours of
sleep (Guilleminault et al. 1976), 5 apnoeas per hour of sleep (Guilleminault
et al 1978) and 10 apnoeas per hour of sleep (Lavie 1983). Apnoeas were
defined as a minimum of 10 seconds in duration. These definitions were
largely arbitrary and as most patients referred to sleep apnoea clinics at that
time had hundreds of apnoeas in any night's sleep, were not often
implemented as exclusion criteria for treatment (Guilleminault et al 1976).
As awareness of the disorder and the numbers of patients referred to
sleep centres who had symptoms of sleep apnoea, but milder forms of the
syndrome, increased, (Whyte et al 1989) definition of sleep apnoea became
more crucial. Lugaresi et al (1983) recognised the need for describing the
less severe forms of sleep apnoea. They suggested that trivial snoring was
the beginning point and severe sleep apnoea the end point along a
continuum of disease progression. They divided this continuum into 4 stages
based on objective monitoring of respiration during sleep and daytime
sleepiness. The stages were: preclinical; with sporadic apnoeas, initial; when
apnoeas occurred during stage 1, 2 and REM sleep, overt; apnoeas
throughout all stages of sleep, and complicated; when alveolar
hypoventilation persists during wakefulness. Interestingly they also divided
patients into 4 stages of daytime somnolence, however the nocturnal and
daytime observations did not match.
Gould et al (1988) recognised that some patients with clinical features
of sleep apnoea did not have apnoeas but had recurrent nocturnal
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hypoventilation with arousal. These events were termed hypopnoeas and a
definition of greater than 50% decrease in thoracoabdominal movement for
at least 10 seconds was validated in a series of patients. This led to a
definition of the sleep apnoea/ hypopnoea syndrome (SAHS) as more than
15 apnoeas + hypopnoeas per hour of sleep (AHI) associated with 2 major
symptoms out of those outlined previously.
The above definition of hypopnoea is not universal with some
laboratories requiring a 50% decrease in oronasal airflow rather than
thoracoabdominal movement. Many laboratories require a 4% decrease in
arterial oxygen saturation associated with either of the above. The above
definitions are based on polysomnography evaluation of sleep and breathing
and although sleep apnoea can be diagnosed using limited sleep studies
which concentrate on respiratory and/ or oxygen saturation signals, their
reliability in accurate diagnosis of milder forms of sleep apnoea remains
questionable (Douglas et al 1992, Gugger et al 1995).
1.6 Epidemiology of SAHS
Sleep apnoea syndrome is only 30 years old as a medical disorder.
Since the first description by Gastaut et al (1965) clinicians dealing with this
condition have reported exponentially increasing numbers of patients being
referred for treatment (Whyte et al 1989). However epidemiological studies
have only recently begun to estimate the true prevalence of this disorder in
the general population. Indeed the UK has lagged behind the USA and
Australia in the recognition and diagnosis of sleep apnoea (Shapiro et al
1981) which has led to the early suggestion that there may be fewer sleep
apnoea patients in this country. Data from Stradling and Crosby (1991a)
however suggests that this is not the case.
There are methodological difficulties in performing such
epidemiological studies. Definitions of what constitutes clinically significant
sleep apnoea have moved forward considerably from suggestions of 5
5
apnoeas per hour of sleep (Guilleminault 1976). The significance of partial
breathing pauses (hypopnoeas) (Gould et al 1988) and the subsequent
elucidation of minimum criteria for diagnosis of SAHS (AHI>15 with 2 major
symptoms) has been somewhat superseded by the findings that patients
with milder sleep apnoea can benefit from treatment (Engleman et al 1997).
Some laboratories use oximetry to diagnose sleep apnoea (Stradling and
Crosby 1991a), however this technique has been reported to miss some
33% of patients with significant SAHS (Douglas et al 1992). In addition there
is the argument that patients only have sleep apnoea when they suffer from
symptoms, in addition to having a positive diagnosis on objective nocturnal
measures of oximetry, breathing pattern and/ or sleep (Young et al 1993).
This should be interpreted with caution as patients may not have an insight
into their "symptoms". This applies in particular, to two of the major
symptoms of sleep apnoea, snoring and daytime sleepiness. Snoring is often
reported by the bedpartner, as the snorer is unaware because they are
asleep, and SAHS patients may deny daytime sleepiness as they have lost
their frame of reference (Dement et al 1978). Studies can also be biased by
selection procedures. Patients consenting for polysomnography in studies of
this nature may do so because they suspect that they have a sleep disorder.
Early epidemiological studies in Italy (Franceschi et al 1982) and
Israel (Lavie 1983) found that 1.1% of hospital inpatients, and 1.0% of
industrial workers had sleep apnoea. These percentages may have been
underestimated due to the relatively strict diagnostic criteria used in these
studies of greater than 10 apnoeas per hour of sleep. In the Israeli study
Lavie points out that results may have been biased by the large percentage
of subjects with EDS who consented to polysomnography (26% of subjects
who had polysomnography had EDS) compared with 8% of the total sample
suffering from EDS. Both these studies included a wide age range and
subsequent studies have focused on middle aged subjects as most patients
referred to sleep clinics with sleep apnoea are in this age group.
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Cirignotta et al (1989) found that 3.3% of their male sample (aged 30
to 69) had an apnoea index greater than 10 per hour of sleep, but concluded
that only 0.5% had symptomatic apnoea requiring treatment. Stradling and
Crosby (1991a) found a similar number of subjects with severe symptomatic
sleep apnoea (0.3%). This study circumvented the problem of self interest in
its selection process for polysomnography by performing home oximetry on
900 middle aged men. They found that 46 (5%) subjects had 4% oxygen
desaturation dip rates >5/hour, and of these, 3 had severe symptomatic
sleep apnoea and a further 18 had sleep apnoea when supine only, giving a
prevalence rate of 2%. This may be an underestimation as polysomnography
failed technically in 15 subjects and oximetry may underdiagnose patients
with sleep apnoea (Douglas et al 1992). In America, Young et al (1993)
found that 4% of men and 2% of women had AHI > 5 + daytime sleepiness
but that 24% of men and 9% of women had AHI > 5 alone. The high ratio of
men: women (2:1) with sleep disordered breathing in this study is similar to
that found by Jennum and Sjol (1992) in Denmark. This is similar to
Bearpark et al (1995) who reported a high prevalence of sleep apnoea in
Australia. Twenty four percent of middle aged men had respiratory
disturbance indices (RDI; equivalent to AHI) > 5, however only 3% of
subjects had RDI>5 and coexisting daytime sleepiness.
In summary these studies show that severe symptomatic sleep
apnoea may have a prevalence of approximately 3/ 1000 middle aged men,
but that milder forms of the syndrome are relatively common (3 to 4/100
middle aged men).
These findings in women (Young et al 1993, Jennum and Sjol 1992)
are of particular interest as this is a considerably higher proportion of women
in the population with sleep apnoea than has been seen in sleep apnoea
clinics where the ratios of men: women was approximately 8:1 (Whyte et al
1989). It is unclear why a greater proportion of men than women are referred
for evaluation in sleep apnoea clinics. There is however some evidence that
women present with different symptoms at the clinic more indicative of
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insomnia (Ambrogetti et al 1991) and that they underreport classic sleep
apnoea symptoms such as snoring, nocturnal gasping and witnessed
apnoea (Redline et al 1994).
1.7 Mortality in Sleep Apnoea
Untreated sleep apnoea is associated with increased mortality and
treatment with tracheostomy improves survival. However the data for survival
after treatment with uvulopalatopharyngoplasty (UPPP) or continuous
positive airway pressure (CPAP) (see section 1.12, 1.13) are ambiguous.
Partinen et al (1988) found that out of 198 patients who were followed up
after 5 years there were 14 deaths. These deaths all occurred in the patients
who had been conservatively treated, with encouragement to lose weight, as
opposed to those who had had a tracheostomy. He et al (1988) found that
mortality was higher in untreated patients with an apnoea index greater than
20 compared with those less than 20. This was true whether patients were
older or younger than 50. In the treated patients significantly more patients
who had had UPPP died (8 deaths) than those who had had CPAP or a
tracheostomy (0 deaths). Keenan et al (1994) however found no difference in
long term survival over 6 years between CPAP and UPPP treated SAHS
patients. These latter 2 studies had low numbers of deaths for reliable
comparison between UPPP and CPAP. Performing long term prospective
studies assessing CPAP or UPPP for reducing mortality in SAHS is ethically
impossible as patients with SAHS cannot be diagnosed and left untreated.
1.8 Mild SAHS, Snoring, Increased Upper Airway Resistance
Patients with mild sleep apnoea may only have respiratory events
during REM sleep or when they are lying supine. Apnoeas during REM sleep
were originally dismissed by Guilleminault et al (1976) as non-pathologic due
to the inherent respiratory instability found in REM sleep (Douglas 1994). In
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addition REM sleep occurs every 90 minutes during nocturnal sleep and
therefore patients with REM-sleep apnoea may have time in between REM
periods where they have relatively uninterrupted sleep. This sleep will include
slow wave sleep (SWS) which has been suggested as the sleep required for
adequate cerebral functioning (Home 1988). In postural related sleep
apnoea respiratory events may occur during time spent asleep in the supine
position. If the patient alternates between body positions there will be periods
during the night when they obtain uninterrupted sleep. It is unclear whether
these periods of uninterrupted sleep are sufficient to allow normal daytime
functioning. The question of how much sleep and of what type is required to
be restorative is dealt with in the section on sleep deprivation and disruption
(section 2.11).
In recent years the rigid definitions of SAHS have become less fixed
with the recognition that some patients with the clinical indications of sleep
apnoea nonetheless have AHI <15 (Young et al 1993). Engleman et al
(1997) found that patients with mild sleep apnoea (AHI; 5 to 15 per hour of
sleep) can benefit from CPAP therapy, the treatment of choice for sleep
apnoea. It has also emerged that patients may become symptomatic for
sleep apnoea when they do not have even mild sleep apnoea, i.e. AHI< 5
per hour slept, but suffer from heavy snoring or even increases in upper
airway resistance (Guilleminault et al 1991, Guilleminault et al 1993). These
findings lend support to the theory of Lugaresi et al (1983) that snoring is the
initial phase and severe sleep apnoea the end phase of a continuum of
disease which has common pathophysiology. Increased upper airway
resistance may occur prior to the development of snoring. Collectively
increased upper airway resistance (UAR), snoring and sleep apnoea
syndromes of varying severities have become known as sleep disordered
breathing (SDB).
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1.9 Risk Factors for SAHS
The obese middle aged man has long been the classical image of the
sleep apnoea patient and in early clinical reports this description fitted a
large number of the patients (Guilleminault et al 1976). Indeed in all of the
above epidemiological studies, apart from Lavie (1983), obesity was
significantly associated with the incidence of sleep apnoea. Although sleep
apnoea is common in middle age, evidence on the relationship between age
and the incidence of sleep apnoea is inconclusive. Bearpark et al (1995) and
Young et al (1993) did not find any significant relationship between age and
SDB whereas Jennum and Sjol (1992) and Stradling and Crosby (1991a)
did. In a similar fashion Jennum and Sjol (1992) found significant
contributions of both smoking and alcohol intake to the incidence of SDB but
Bearpark et al (1995) and Lavie (1983) did not. Stradling and Crosby (1991a)
found that alcohol intake but not smoking was a small (1%), but significant,
independent predictor of the 4% oxygen desaturation index.
1.10 Neck Circumference and the Upper Airway
The main risk factors for SAHS of male sex and obesity may be
linked. Men generally deposit adipose tissue centrally around the trunk and
abdomen whereas women deposit it around the periphery (Edwards 1951).
Vague (1956) termed excess fat deposition in these areas android and
gynoid obesity respectively and suggested that the region over the first three
cervical vertebrae was the area where at equal body weights men have more
fat than women. A large proportion of women with SDB are postmenopausal
(Redline et al 1994) which may be related to their increased central fat
deposition (Edwards 1951).
It can be argued that measuring neck circumference would be a good
indicator of fat deposition around the first 3 cervical vertebrae. Studies in
normal subjects suggest that for equal body mass indices (BMI; kg/m2) men
and women have significantly different neck circumferences (Martin et al
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1994) with the regression lines for each relationship approximately parallel.
Stradling and Crosby (1991a) found that neck circumference was the best
predictor for the incidence of sleep apnoea (r2=7.9%) in the epidemiological
study described in section 1.6. In SAHS patients, Katz et al (1990) found that
external neck circumference was a better predictor for severity of sleep
apnoea than BMI or age, and Davies et al (1992) found that neck
circumference was the single best predictor for Sa02 dip rate. Neck
circumference accounted for 29% (Katz et al 1990) and 35% (Davies et al
1992) of the variance in severity of disease.
Eller Shelton et al (1993), using magnetic resonance imaging (MRI),
measured fat deposition in the neck. They found that SAHS patients had
increased volume of adipose tissue adjacent to the upper airway compared
to normals and that this correlated significantly with AHI. Although the
authors did not control for BMI, there was no relationship between BMI and
adipose tissue volume suggesting that SAHS patients have an increased
tendency to deposit fat in the neck regardless of obesity. This fat deposition
in SAHS patients may increase mass loading of the upper airway which in
turn may lead to increased upper airway resistance (Koenig and Thach
1988) and a greater tendency to occlusion. However the link between obesity
and sleep apnoea cannot solely be caused by increased neck fat deposition
leading to increased mass loading of the upper airway as Grunstein et al
(1993) found that waist circumference was a better predictor of sleep apnoea
severity than either neck circumference or BMI.
The upper airway of SAHS patients is already compromised even
before any potential effect of mass loading around it can be taken into
account. Studies measuring upper airway dimensions using acoustic
reflection (Bradley et al 1986, Martin et al 1995), MRI (Rodenstein et al 1990,
Schwab et al 1993) and cephalometry (Lowe et al 1986, Jamieson et al
1986, Yildirim et al 1991) have shown that SAHS patients have smaller
internal upper airways than normal subjects while awake. In addition the
upper airway in sleep apnoea patients appears to be 'floppier' than normal
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subjects. Suratt et al (1985) found that SAHS patients' upper airways were
more collapsible compared to normals, Brown et al (1985) that they were
more compliant, and Brown et al (1987) that with the application of positive
pressure SAHS patients had more distensible upper airways than normal
subjects. Recent evidence suggests that during wakefulness SAHS patients
defend their upper airway and that this loss of defense during sleep may
contribute to upper airway collapse/ occlusion. Mezzanotte et al (1992) found
that genioglossal EMG tone in SAHS patients is increased compared to
normals, and we (Martin et al 1995) found that SAHS patients have a smaller
decrease in the upper airway dimensions upon lying supine compared to
snorers or BMI matched control subjects.
In addition to the upper airway of SAHS patients being smaller than
non-SAHS patients and normals there is also evidence that SAHS patients
have a differently shaped upper airway. Rodenstein et al (1990), and
Schwab et al (1993) using MRI suggested that SAHS patients had upper
airways with anterior- posterior alignment compared to normals whose
airways were aligned in a lateral fashion.
1.11 Genetic Predisposition to SAHS
The altered bony structures in the upper airways of SAHS patients
may have a genetic component. Strohl et al (1978) within one family noted
the presence of sleep apnoea in more than one family member. The
predominant risk factor for this family was obesity. Obesity itself runs in
families (Stunkard et al 1986) which makes it difficult to interpret whether
SAHS is truly a heritable disease. The finding in sleep apnoea clinics that not
all patients with SAHS are obese suggests that there are other heritable risk
factors for the presence of sleep apnoea. There are many genetic disorders
that are associated with SAHS most notably Down's syndrome and Prader-
Willi syndrome in both of which obesity is a common problem and may
exacerbate their predisposition to SAHS.
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Pillar and Lavie (1995) found that 47% of the offspring of SAHS
patients had AHI > 5 and 13% had AHI>20. Redline et al (1995) found that
13% of relatives of SAHS patients, compared to 6% of neighbourhood
control subjects had sleep apnoea (AHI> 15 + one major symptom). In this
study however relatives were significantly older than controls and 83% of the
index SAHS patients were obese, both of which may have predisposed the
relatives towards having a greater incidence of sleep apnoea compared to
control subjects.
Mathur and Douglas (1995a) performed a similar case control study
but only used index SAHS patients with BMI<30 to factor out the familial
effects of obesity. Relatives were matched for age, sex, height and weight
with control subjects drawn from a GP register. They found that relatives had
increased AHI, arousal indices and 2% and 3% desaturation indices, and
more relatives had symptoms of sleep apnoea than controls. In addition
relatives had altered craniofacial morphology similar to that found in SAHS
patients (Lowe et al 1986, Jamieson 1986) compared to controls. This
suggests that craniofacial abnormality may mediate the inheritance of SAHS
in non-obese patients.
1.12 Treatment of Sleep Apnoea/ Hypopnoea Syndrome
Common treatments of sleep apnoea fall into four categories;
conservative, surgical, mechanical devices, or continuous positive arway
pressure (CPAP). Conservative therapy consists mainly of encouraging
patients to lose weight, due to the relationship between body mass index
(kg/m2) and severity of sleep apnoea as measured by the apnoea +
hypopnoea index, and avoiding evening alcohol (Engleman et al 1993).
Surgical treatments include tonsillectomy (mainly used in children),
craniofacial surgery for correction of craniofacial abnormalities (Riley et al
1990) which can occur in SAHS patients (Jamieson et al 1986), and
tracheostomy (Guilleminault 1976), which was the only treatment for sleep
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apnoea until 1981. A further surgical treatment, uvulopalatopharyngoplasty
(UPPP), was introduced for sleep apnoea by Fujita et al (1981) which
involves the surgical removal of the uvula and part or all of the soft palate.
There is burgeoning interest in mechanical devices for the treatment of sleep
apnoea (Lowe 1994) which fall into 2 categories; (1) simple non-prescription
devices for snoring which act by keeping the mouth closed and preventing
mouth breathing (e.g. snoreguard) or increasing the nasal airspace to reduce
nasal resistance (e.g.nosovent), (2) appliances which act by gradual
advancement of the mandible to increase upper airway area which is smaller
in patients with sleep apnoea (Yildirim et al 1991, Martin et al 1995). These
latter devices are complex appliances currently under assessment for
treatment of sleep apnoea (Lowe 1996).
Around the same time as Fujita et al (1981) described UPPP
treatment for SAHS, Sullivan et al (1981) described continuous postive
airway pressure therapy (CPAP) for sleep apnoea. This acts as a pneumatic
splint holding the upper airway open. The CPAP machine pumps air at
positive pressure into the upper airway via a mask held in place over the
patient's nose with straps fitted over the back of the head. The pressure
required by the CPAP machine to hold the upper airway open during sleep
and prevent apnoeas and hypopnoeas occurring can be titrated in the sleep
laboratory on an individual basis. The patient then takes the machine home
with instructions to use it every night while sleeping.
1.13 Efficacy of Treatment
The goals of treatment for sleep apnoea are to produce a resolution of
symptoms, notably snoring and daytime sleepiness, via minimising or
eliminating apnoeas and hypopnoeas. Conservative therapy may be
indicated for young patients for whom the intrusive nature of CPAP or its
requirement as a therapy for life may discourage them from using it, or for
those with milder sleep apnoea whose symptoms are not severe enough for
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them to tolerate CPAP. However Partinen et al (1988) found that patients
treated conservatively had almost a 5 times greater chance of vascular
mortality than those treated with a tracheostomy. In addition Engleman et al
(1993) found that conservative treatment did not improve daytime sleepiness
in patients with sleep apnoea. Simple non-prescription devices for snoring
may be attractive for some individuals due to their relative non intrusiveness
compared to CPAP, however there is a lack of placebo controlled trials of
their effectiveness in reducing apnoea + hypopnoea index or resolving
symptoms (Lowe et al 1994). There is also a cost consideration in the U.K.
as these devices are not generally available through the NHS.
CPAP is now accepted as the therapy of choice for sleep apnoea due
to problems with UPPP. He et al (1988) found that the cumulative probability
of survival after UPPP over 7 years was similar to that of untreated SAHS
patients. Polo et al (1989) found that UPPP, while reducing apnoeas,
actually led to an increase in hypopnoeas which may themselves be
pathological (Gould et al 1988). Sangal et al (1992b) found that there was no
significant reduction in respiratory events in 11 patients followed up within 1
to 6 months after UPPP. These results may be due to UPPP only dealing
with upper airway obstruction in the nasopharynx, which does not include
those patients who obstruct retroglossally or those who have upper airway
obstruction in both areas of the upper airway (Chaban et al 1988, Shepard et
al 1990). In addition patients who require further treatment for their sleep
apnoea after UPPP may find use of CPAP difficult due to problems with
mouth leak at higher CPAP pressures (Polo et al 1994).
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1.14 Concluding Remarks
The aim of this chapter has been to give background information on
the sleep apnoea/ hypopnoea syndrome. It has dealt with the recognition
and definition of the syndrome, and its prevalence in the population. There
are various risk factors leading to SAHS, including its heritability and how
male sex and obesity affects it with increased neck circumference. The
treatment of choice for sleep apnoea is CPAP therapy but there is
controversy about whether it actually improves mortality in SAHS. The




Daytime function in patients with sleep apnoea hypopnoea sydrome and
during sleep intervention studies in normal subjects.
2.1 DAYTIME FUNCTION
The rationale behind this thesis is the fact that patients with sleep
apnoea/ hypopnoea syndrome suffer from impaired daytime function. They
are pathologically sleepy during the day (Roth et al 1980) and have
decrements in their neuropsychologic function compared to control subjects
(Greenberg et al 1987). More recently Engleman et al (1994a) demonstrated
that some of these decrements are reversible with CPAP therapy. This
following chapter will focus on previous research in this area. This includes
describing the methods available for measuring daytime function, sleep
intervention studies in normal subjects (sleep deprivation, restriction and
disruption), and studies of daytime function in patients with sleep apnea. This
chapter will also focus on the relationships between nocturnal sleep and
breathing variables and daytime impairments and on the resolution of SAHS
patients' impairments with CPAP therapy.
2.2 Measuring Daytime Sleepiness
Sleepiness can either be measured subjectively, with questionnaires
or objectively using sleep EEG. The most commonly used tests for daytime
sleepiness in patients with sleep apnoea are:
Subjective
Stanford Sleepiness Scale (SSS) (Hoddes et al 1973).
This is a Likert type scale where a patient rates their sleepiness at that
moment on a seven point scale, 1 being wide awake, and 7 being practically
asleep.
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Epworth Sleepiness Scale (ESS) (Johns 1991)
The scale consists of asking the patient whether they would never (0), have
a slight chance (1), moderate chance (2), or high chance (3) of dozing in 8
daily situations. Patients are asked to answer the questions with reference to
their "life in recent times" (see Appendix 1). The maximum of 24 indicates
excessive sleepiness. This scale involves reflection over past experience
rather than the instantaneous assessment of the SSS.
Objective
Multiple Sleep Latency Test (MSLT) (Dement et al 1978)
Subjects are asked to lie down in bed in a dark room and try to sleep for 20
minutes, 4 or 5 times during the day, at 2 hourly intervals. Sleep is monitored
with polygraphically recorded EEG in 30 second epochs. Sleep onset is
determined as the time to the first epoch of any stage of sleep including
stage 1 (Thorpy 1992). An epoch is scored asleep if at least 50% of that
epoch is indicative of any sleep stage. The sleep onset latency was originally
the time to 3 consecutive epochs of stage 1 sleep or the first epoch of any
other sleep stage (Carskaddon et al 1986) but was changed as some sleep
apnoea patients have apnoeas as soon as they fall asleep and then arouse
themselves and therefore never get 3 consecutive epochs of stage 1 sleep.
The mean sleep onset latency is calculated as the mean of the individual
sleep onset latencies from the 4 or 5 naps. Normal daytime sleepiness
consists of a mean sleep onset latency of between 10 and 20 minutes.
Pathological daytime sleepiness is less than 5 minutes with the grey area of
undefined sleepiness between 5 to 10 minutes (Thorpy 1992).
Maintenance of Wakefulness Test (MWT) (Mitler et al 1982)
(Repeated Test of Sustained Wakefulness)
Subjects are asked to sit upright in a bed or an armchair, in a dimly lit room
and are asked to try to remain awake for 40 minutes, 4 times during the day,
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again at 2 hourly intervals. They are not allowed to read, sing, exercise their
limbs or do anything physical which may help them stay awake. Again sleep
is monitored with polygraphically recorded EEG and the sleep onset latency
is the time to the first epoch of any sleep stage. This test was originally
described by Mitler et al (1982) with 20 minute naps, and by Hartse et al
(1982) with 30 minute naps. This was extended to 40 minutes by Poceta et
al (1990a, 1990b) to minimise ceiling effects. Again mean sleep onset
latency is calculated from the individual sleep onset latencies over the 4
naps.
The effect of instructing subjects to remain awake and to sit upright
rather than lie down increases the sleep onset latency on the MWT
compared to the MSLT in normals (Hartse et al 1982). In patients referred to
a sleep clinic for their daytime sleepiness instructing them to remain awake
increases their sleep onset latency from 8.4 minutes on the MSLT to 26.5
minutes on the MWT. The MWT has not been used nearly as extensively as
the MSLT and therefore validated data as to what constitutes normal or
pathological sleep onset latencies on this test are not available yet.
2.3 Measuring Mood
Patients with sleep apnoea may suffer from alterations in personality,
notably increased irritability (Whyte et al 1989). There is controversy over
whether sleep apnoea alone can lead to clinical depression (see section
2.14) however it is clear that SAHS patients can have clinically significant
scores on questionnaires which are used in clinical settings to aid diagnosis
of anxiety and depression (Cheshire et al 1992). In the series of studies
presented in this thesis sleep fragmentation is being modeled in normal
subjects in whom it is difficult to mimic the chronicity of sleep apnoea and its
subsequent effect on mood and personality. Therefore instantaneous
measurements of mood as described by Matthews et al (1990) were used.
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Thayer (1989) postulated that arousal, that is wakefulness as
opposed to arousal from sleep, was a basic component of mood which could
not be described in a single way but involved interaction between more than
one process. This led to the idea of 2 different ways of describing arousal;
energetic arousal and tense arousal which varied in orthogonal directions to
one another to produce well documented mood states; e.g. tense-tiredness
(high tense arousal, low energetic arousal), and calm-energy (low tense
arousal, high energetic arousal). Matthews et al (1990) refined
measurements of mood to produce the UWIST (University of Wales Institute
of Science and Technology) mood adjective checklist (UMACL) using factor
analysis of items from various mood scales. In addition to the original
energetic arousal and tense arousal dimensions of mood, which were not
interrelated, they added a pleasure- displeasure dimension termed hedonic
tone, which had moderate relationships to both arousal dimensions.
Thayer (1989) suggested that arousal as a component of mood has
its basis in biological systems, with energetic arousal mediated by the
reticular activating system, which also mediates arousal stimuli from the
brainstem to the cortex during sleep, and tense arousal by the autonomic
nervous system. Studies by Gold et al (1995), Hepburn et al (1995) and
Hepburn et al (1996) tested this hypothesis using acute insulin induced
hypoglycaemia as a biological stressor. These studies showed that hedonic
tone and tense arousal alterations in mood closely followed the autonomic
activation seen in response to hypoglycaemia whereas energetic arousal
changes mirrored the changes in cerebral function seen in response to
hypoglycaemia.
In a similar fashion the sleep fragmentation protocols presented in this
thesis in chapters 5 and 6 could be described as interventions aimed at the
reticular activating system and the autonomic nervous system respectively.
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2.4.1 Daytime Sleepiness in Sleep Apnoea; Subjective
Hypersomnolence has long been associated with sleep apnoea. In the
categorisation of Pickwickian syndrome the concurrence of daytime
sleepiness and nocturnal apnoea was noted (Gastaut et al 1965).
Quantitative assessment of this problem has traditionally been difficult due to
the apparent lack of insight that the sleep apnoea patient has into their own
sleepiness (Dement et al 1978), and the patients' fears that admissions of
sleepiness, particularly related to driving, may jeopardise their job. Although
there is a significant relationship between polygraphic sleep onset and
Stanford Sleepiness Scale (SSS) score (Hoddes et al 1973) in normal
subjects, this relationship is uncoupled in SAHS patients (Dement 1978).
Roth et al (1980) found that SAHS patients rated themselves as alert as
normal subjects on the SSS and anecdotally reported that some patients
rated themselves as being fully alert whilst to the observer they were
practically asleep. These poor results may be due to the nature of the SSS
which is instantaneous and does not allow for sleepiness in different daily
situations. Patients with sleep apnoea often report that if they are performing
a stimulating task then their sleepiness can be overcome but it is when they
are in a monotonous or relaxing situation that their sleepiness may be
overwhelming. In addition patients with sleep apnoea, who may have been
suffering from excessive sleepiness for a prolonged time may have adjusted
their frame of reference so that they cannot accurately rate their own
sleepiness.
The development of the Epworth Sleepiness Scale (ESS) (Johns
1991, 1992, 1993) has addressed these problems by asking questions that
are specifically related to sleepiness and require discrete answers about the
patient's recent experience (Appendix 1). Johns (1991) found that patients
with sleep disorders that included daytime sleepiness as a symptom scored
significantly higher than normal subjects. There were significant relationships
between respiratory disturbance index (RDI) and ESS in SAHS patients, and
ESS and objective daytime sleepiness as measured by the multiple sleep
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latency test (MSLT) in a group of patients diagnosed with sleep disorders. In
a second study Johns (1992) found that there was no difference between
two ESS scores of 87 medical students 5 months apart, confirming test-
retest reliability. Also ESS improved with CPAP therapy in 54 SAHS patients
to within the range scored by normal subjects (Johns 1992). This was
confirmed by Hardinge et al (1995) in a recent report. Using factor analysis
Johns (1992) found that one factor, sleepiness, accounted for most of the
variance in ESS and that each question was internally consistent for that
factor. Furthermore Johns (1993) found that the ESS could distinguish
between snorers and patients with mild, moderate or severe sleep apnoea.
However the problem of the unreliability of subjective assessment of
sleepiness in sleepy patients remains. Kingshott et al (1995) investigated
whether partner assessments of SAHS patients' ESS were more reliable
than the SAHS patients own assessments. They found that partner ESS
varied randomly with no overall consistent difference to patient ESS. They
also found that there were no relationships between either patient or partner
assessments of ESS and AHI, in contrast to Johns (1992, 1993). Therefore
the ESS is an improvement on the SSS but is still imperfect.
2.4.2 Daytime Sleepiness in Sleep Apnoea; Objective
This problem of subjective assessment of sleepiness can be
addressed by using objective tests of daytime sleepiness which
polygraphically document the onset of sleep in a series of naps during the
day. Those most commonly used are the MSLT (Carskaddon 1986, Thorpy
et al 1992), and to a lesser extent the MWT (Poceta et al 1992). Although
they are time consuming and expensive to perform they are useful in
diagnosis of daytime somnolence, especially in narcolepsy, and in assessing
patient response to treatment. In patients with SAHS this is of particular
importance as daytime sleepiness is a presenting symptom of the syndrome
and the incidence of road traffic accidents is significantly higher in these
patients (Findley et al 1988).
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Dement et al (1978) and Roth et al (1980) found that sleep apnoea
patients were objectively sleepier than normal subjects on the MSLT. It is
less clear however what causes daytime sleepiness in SAHS patients,
whether it is nocturnal hypoxemia or the frequency of arousals from sleep
suffered by SAHS patients. This is discussed in greater detail in section 2.7
however prior to this methods of measurement of arousals and their
relevance in SDB shall be discussed.
2.5.1 Measuring Arousals (Sleep Fragmentation); Visual
Sleep fragmentation is the term used to describe the interruption of
sleep with short (less than 15 seconds) increases in EEG frequency either
occurring spontaneously or in response to respiratory events or tones. These
short events are known as microarousals. Although there is general
agreement that they exist and have important influences on sleep itself and
daytime function there is not universal agreement on how they should be
defined and scored (ASDA 1992, Cheshire 1992).
Initial guidelines from Rechtschaffen and Kales (1968) on measuring
sleep disturbance deal only with scoring movement arousals which were
equated with a stage shift to a lighter sleep stage or a stage shift to
wakefulness. This has a minimum duration criterion of 15 seconds which is
often too long to pick up the recurrent microarousals that often terminate
apnoeas or hypopnoeas. In 1978 Phillipson and Sullivan drew the attention
of sleep physiologists to the phenomenon that arousals (microarousals or
>15 sec arousals) occur in response to apnoeas and hypopnoeas. Roth et al
(1980) used increases in chin or leg EMG to score arousals subsequent to
apnoeas or hypopnoeas. Zwillich et al (1981) looked for 5 second bursts of
alpha rhythm on the EEG associated with an increase in EMG activity. Gould
et al (1988) reduced the duration further to a 1.5 second increase in EMG
activity accompanied by any increase in EEG frequency. This definition was
altered by Cheshire et al (1992) to a return to alpha ortheta on the EEG for
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1.5 seconds accompanied by any increase in EMG activity, which improved
the relationship between microarousal frequency and AHI. The American
Sleep Disorders Association guidelines on the scoring of arousals (1992)
suggest a 3 second increase in EEG frequency accompanied by a 3 second
increase in EMG activity during REM sleep only. The increase in EMG
activity in REM sleep is included in definitions because transient alpha
intrusion into REM sleep is common and may not constitute an arousal.
Although all the above studies have aspects of their definitions in
common and all use the sleep EEG, there has been no systematic
comparison, and more importantly validation, of the definitions available in
SAHS patients. In addition defining what constitutes a "normal" arousal
frequency is contentious.
Mathur and Douglas (1995b) compared R&K awakenings with 3
microarousal definitions in normal subjects recruited from a general practice
who had one night of polysomnography. The microarousal definitions used
were from ASDA (1992), Cheshire (1992) and a modified ASDA definition to
a shorter duration of 1.5 seconds. The modified ASDA scored the greatest
number of microarousals, however, all definitions demonstrated that the
upper limit of arousal frequency in these normal subjects was high (from 55
to 67 per hour of sleep). Either this is a true finding or the semi- invasive
nature of polysomnography itself may be responsible for this high arousal
frequency on the first night of polysomnography in these normals. Applying
these data to SAHS patients suggests that microarousal scoring may be
inaccurate due to polysomnography causing spontaneous microarousals.
However these patients are sleepy anyway and thus may have fewer
spontaneous microarousals caused by the polysomnography than a normal
subject.
All these definitions rely on the accuracy and consistency of the
human eye and there is currently no data on within or between rater reliability
of arousal scoring by any definition.
24
2.5.2 Measuring Sleep Fragmentation; Non-Visual
Visual methods of arousal scoring are monotonous and time
consuming and automation of the process is of clinical and research interest.
Fast Fourier Transformation (FFT) is a widely used technique to generate
frequency spectra from the sleeping EEG (Hjorth 1970, Necklemann and
Ursin 1993, Oglivie et al 1991). It functions on the premise that the EEG can
be described by a series of sine waves of different frequencies and that as
EEG frequency decreases EEG amplitude increases. Resolution of the FFT
depends on the duration of the window within which separate calculations of
EEG power are made, power being the square of the EEG amplitude. It is
possible to use a zero cross method to produce frequency spectra however
this may lose some of the heterogeneity of the EEG.
Rees et al (1995) used FFT to produce EEG spectra in patients with
sleep apnoea on a timescale short enough to distinguish between the
beginning and the end of respiratory events. They found that median EEG
frequency increased in the second half of an apnoea or hypopnoea
compared to the first half and that EEG frequency increased at the end of a
respiratory event regardless of whether there was a visible EEG arousal or
not. They also found that EEG frequencies during visible EEG arousals at
the end of respiratory events did not differ from frequencies at the end of
events that did not terminate in visible EEG microarousals. In this study FFT
was sensitive enough to isolate changes in the EEG which the human eye
could not score as a microarousal.
Roberts and Tarassenko (1992) have applied fuzzy logic to the EEG
by using an artificial neural network to analyse sleeping EEG. Davies et al
(1993) fragmented normal subjects' sleep with tones to produce definite
microarousals. Tones were also given which did not produce any visible
change on the EEG. Artificial neural network analysis of the EEG by the
Roberts technique found changes in the EEG in response to tones even
when there was no visible EEG arousal.
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Drinnan et al (1996) selected 4 microarousals at the end of respiratory
events in 30 subjects with varying severities of sleep apnoea. Raw EEG data
were passed through 3 automated EEG analyses which included zerocross
and FFT methods. A point 8 seconds prior to the start of the arousal was
compared to one 8 seconds after the start of the arousal. They found
significant increases in EEG frequency during arousals at the termination of
respiratory events demonstrating that automated EEG analysis can detect
visible EEG arousals in response to respiratory events.
The above 3 studies all require the user to give the computer time
markers to direct the various analyses in their search for increases in EEG
frequency/ activity. The next step with non-visual methods of EEG analysis is
to automate this process. Average increases in EEG frequency/ activity could
be used as a threshold above which microarousals may be detected
automatically and consequently validated against manual arousal scoring.
However manual scoring of the EEG for visible microarousals may not be the
best starting point for validating automatic arousal selectors for use in
patients with sleep apnoea. Rees et al (1995) compared apnoeas that did
terminate in visible microarousals with those that did not and found no
difference between them in the chemical and mechanical changes that
occurred either during the apnoea or at apnoea termination. The limiting
factor is that EEG only records from the cortex and many apnoeas may well
be resolved with brainstem arousal only.
An alternative is to use non-EEG methods of arousal determination.
Acoustic stimulation that does not produce visible EEG arousals can cause
transient blood pressure elevations (Davies et al 1993). However beat to
beat blood pressure can only be monitored using an arterial catheter or by
digital infrared plethysmography (Finapres) (Parati et al 1989) both of which
are cumbersome and require good subject cooperation. Pulse transit time
(PTT), the time interval between the ECG R wave and the arrival of the pulse
at and extremity, usually the finger, is approximately inversely proportional to
blood pressure (Geddes et al 1981).
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Brock et al (1993) and Pitson et al (1994, 1995) have performed
studies validating PTT as a more portable and reliable measure of changes
in autonomic activity during sleep. PTT is measured as the time it takes for
the pulse wave to travel from the aortic valve to a peripheral site. For ease of
measurement this is usually the finger. PTT is approximately inversely
proportional to blood pressure; as blood pressure increases the arterial walls
become stiffer and the pulse wave can propagate faster, therefore PTT is
shorter, and as blood pressure falls, arterial wall stiffness drops causing
slowing of propagation of the pulse wave and a subsequent lengthening of
PTT (Geddes et al 1981). Brock et al (1993) compared the blood pressure
oscillations measured with the Finapres and swings in PTT that occur while
awake during quiet breathing with a variety of inspiratory loads. There were
similar arterial blood pressure oscillations and PTT swings in response to the
same inspiratory load. In a subsequent study (Pitson et al 1995) PTT
correlated well with inspiratory effort measured with oesophageal pressure in
sleeping SAFIS patients. In addition to this Pitson et al (1994) demonstrated
that there were significant changes in PTT in normal sleeping subjects in
response to tones regardless of whether they caused visible EEG arousals
or not. These results suggest that PTT may be useful in screening for sleep
apnoea. Its advantages are that it is not cumbersome like the Finapres and it
is well tolerated by human subjects requiring only ECG monitoring and a
finger oxygen saturation probe. It does not however give beat to beat
information like the Finapres and it varies with the respiratory cycle. Its merits
for use in the experiments in this thesis are discussed in chapter 3.
In normal subjects inspiratory effort prior to arousal is similar in
individuals regardless of whether the stimulus to arousal is hypoxia,
hypercapnia or increased ventilatory load (Gleeson et al 1990). Therefore
PTT as an indicator of inspiratory effort may be useful in monitoring
autonomic arousal in patients with sleep apnoea.
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2.6 Arousals in Sleep Disordered Breathing
The original characterisation of sleep apnoea by Gastaut et al (1966)
includes clear descriptions of EEG arousals that occur at the end of
apnoeas but also includes a description of apnoeas that do not terminate in
visible EEG arousals, the importance of which has only recently been re-
identified as described above (Davies et al 1993, Basner et al 1995, Rees et
al 1995). It is these EEG and non-EEG arousal phenomena, and their
relative impacts on daytime function which are the focus for this thesis.
Gastaut et al (1966) suggested 2 mechanisms for the severe daytime
somnolence found in their 2 Pickwickian patients who had obvious sleep
apnoea; a narcolepsy syndrome where obesity and somnolence are linked
by a central defect in the brainstem, or that insufficient sleep at night causes
the daytime somnolence. The initial theory is incorrect due to the fact that
patients with sleep apnoea do not have to be obese (Mathur and Douglas
1995a). The latter theory is logical as feeling sleepy during the day following
a shortened nocturnal sleep is a common experience. Evidence from sleep
deprivation/ restriction studies has documented this objectively in normal
subjects (se section 2.11).
Initial studies on daytime sleepiness in patients with sleep apnoea by
Dement et al (1978) and Roth et al (1980) suggested that rather than
quantity of sleep it was the quality or continuity of sleep, assessed by the
number of arousals associated with apnoeas, that determined daytime
sleepiness. The relationships between severity of sleep apnoea and
consequent sleep fragmentation, and daytime sleepiness (as discussed in
greater detail in section 2.7) are weak and do not fully explain the daytime
sleepiness found in sleep apnoea patients.
Although the correlations between sleep fragmentation and daytime
sleepiness are relatively weak (Roehrs 1989) or non-existent (Cheshire et al
1992) the relevance of sleep fragmentation as an additional variable to score
in an overnight sleep study has increased somewhat in recent years. This is
largely due to the referral of patients to sleep apnoea clinics who do not have
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a concrete explanation for their symptom of daytime sleepiness, (AHI > 5/
hour of sleep, narcolepsy or periodic leg movement syndrome). The only
problem that may show up on the polysomnography is an elevated
microarousal index. Recent data from Mathur and Douglas (1995b) found
high microarousal indices in normal subjects on a single night of
polysomnography. Control subjects recruited from the general population
had mean arousal frequency of 21, (95 th percentile; 56) per hour of sleep,
and thus what constitutes a normal arousal index is unclear. Collard et al
(1996) found contrasting results, that normal subjects had a mean arousal
index of 13 (95th percentile; 24) per hour of sleep. This lower figure may
have been due to 2 reasons; the subjects in this study were younger than
those of Mathur and Douglas (1995b) who found that arousal index
increased with age, and the arousal definition of Collard et al (1996) did not
score events which showed a return to theta rhythm on the EEG.
Guilleminault et al (1991) noted that patients who did not have sleep
apnoea per se but who suffered from daytime sleepiness had snoring
associated microarousals and in a further study had increases in upper
airway resistance associated with microarousals (Guilleminault et al 1993).
Upon treatment with CPAP therapy in both studies the number of
microarousals decreased coincident with an improvement in daytime
sleepiness.
Thus microarousals, with snoring or increased upper airway
resistance, can cause daytime sleepiness in certain patients. The converse
of this, that subjects with high arousal indices will suffer from daytime
sleepiness, (Mathur and Douglas 1995b) does not seem to be true. The
mechanism(s) whereby similar microarousal indices, or AHI, will lead to
daytime sleepiness, either subjective or objective, in one person and not
another are not understood.
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2.7 Daytime Sleepiness; Correlation with Nocturnal Variables
Apnoeas and hypopnoeas terminate in dips in oxygen saturation and
brief arousals from sleep and therefore research has focused on
investigating the relationships between indices of nocturnal hypoxemia and
sleep fragmentation, and daytime sleepiness. Unfortunately the methods for
quantification of the two parameters are not standardised in the literature
although many authors use the number of 4% desaturations per hour for
nocturnal hypoxemia (Stradling and Crosby 1991a, Douglas et al 1992) and
some combination of 3 seconds or less increase in EEG frequency and/or
EMG tone for sleep fragmentation (Cheshire et al 1992, ASDA 1992).
Orr et al (1979) compared 4 sleepy and 4 non-sleepy subjects with
equal severity of upper airway obstruction and found that the sleepy subjects
had lower Pa02 during sleep and upon awakening. They concluded that
hypoxemia may cause daytime sleepiness in the sleep apnoea syndrome.
However sleep was not scored and daytime sleepiness was assessed
subjectively which is unreliable in the hypersomnolent patient (Dement et al
1978, Roth et al 1980).
Roth (1980), in 10 apneic subjects, only found one weak relationship
between daytime sleepiness and nocturnal variables; between objective
daytime sleepiness and the number of brief arousals associated with
respiratory events. These were scored as respiratory events accompanied by
increases in chin EMG or leg movements and did not include any EEG
criteria. Stepanski et al (Sleep 1984) found that in a group of 55 subjects
which included 15 with insomnia, 15 with periodic leg movement syndrome
(PLMS), 15 with sleep apnoea and 10 normals, arousals explained 25% of
the variance in objective daytime sleepiness measured by the MSLT. In the
sleep apnoea patients alone there was no relationship between daytime
sleepiness and arousals, results similar to Cheshire et al (1992). Stepanski
et al (1984) attribute this to the small variability of daytime sleepiness within
each group of subjects. Interestingly they found that longer total sleep time
was significantly correlated with increased daytime sleepiness. They explain
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this by suggesting that there is a minmum duration of sleep required for
sleep to be restorative, an idea which Downey and Bonnet (1987) have also
explored. This interruption of sleep may increase the drive to sleep and any
extra sleep the subjects have will in turn be interrupted and thus not be
restorative. Alternatively it may be a consequence of scoring sleep in 30
second epochs which will show no loss of total sleep even if the subject has
had many brief (less than 15 second) arousals. The method of scoring of
arousals in this study would go some way to dealing with this as the authors
scored arousals according to 6 different categories from as subtle as less
than 5 second increases in EEG frequency through to stage shifts and
awakenings from sleep. There were however small numbers of subjects in
these studies which may account for the poor relationships between various
measures of sleep fragmentation and daytime sleepiness
Guilleminault et al (1988) found that, out of nocturnal variables
including apnoea + hypopnoea index, nocturnal hypoxemia and sleep
staging, only duration of stage 1 and slow wave sleep correlated significantly
with daytime sleepiness measured by the MSLT. They did not measure
microarousals but used stage 1 sleep duration as an indicator of sleep
fragmentation. There is something of a methodological problem here as
Rechtschaffen and Kales guidelines for sleep staging suggest that stage 1
has to be scored prior to scoring stage 2 sleep. In cases of severe sleep
apnoea patients may often go straight into stage 2 sleep after awakenings
due to apnoeas or hypopnoeas. The amount of stage 1 sleep that is scored
depends on how strictly the particular sleep laboratory interprets the scoring
guidelines. Microarousal scoring improves on this as it is event based and
only requires 10 seconds of prior sleep as an interval between events (ASDA
1992, Cheshire et al 1992).
Bedard et al (1991a) found that in 20 SAHS patients only nocturnal
hypoxemia correlated with MSLT. They did not score microarousals and they
may have biased their patient sample by selecting only those with a minmum
nocturnal 02 less than 80%. Roehrs et al (1989) in 466 patients, found that
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both 3 second arousals associated with respiratory events and nocturnal
hypoxemia were correlated with daytime sleepiness on the MSLT. These two
variables were significantly interrelated and in multiple regression analysis
microarousals came out as the single best predictor of daytime sleepiness.
Cheshire et al (1992) unlike any of the previous studies, did not find any
relationship between daytime sleepiness and nocturnal variables. This may
have been due to the relatively low number of subjects; n=29 compared to
n=466 (Roehrs et al 1989).
Using nocturnal hypoxemia as a predictor for daytime sleepiness in
SAHS patients should be done with caution due to the significant
relationships between age and obesity, and hypoxemia. Although SAHS
patients tend to be middle aged and obese, awareness of the syndrome is
increasing in the U.K. and with it referrals to sleep laboratories of younger,
less obese patients who may have just as severe sleep apnoea as an older
more obese patient but who do not have intermittent nocturnal hypoxemia.
The findings in the above studies that nocturnal variables such as
sleep quality and nocturnal hypoxemia correlate with the MSLT suggests that
the MSLT goes some way towards improving on the SSS in the assessment
of daytime sleepiness. However Mitler (1993) has suggested that there may
be a floor effect in excessively sleepy SAHS patients. In addition some
normal subjects and SAHS patients may be particularly good at falling asleep
on demand; the normal subjects because they may be 'sleepy' individuals
(Harrison and Home 1996a), and the SAHS patients because being
excessively sleepy they may nap whenever they can get the opportunity.
Mitler et al (1982) also suggested that testing the patients' ability to remain
awake more closely approximates to their real life situations, and that
successful treatment for a sleep disorder comprises alleviating this struggle
to stay awake. For these reasons Mitler et al (1982) and Hartse et al (1982)
introduced the MWT. Poceta et al (1992) used the MWT with 40 minute naps
to test daytime sleepiness in patients with SAHS. Mean sleep onset latency
was 26 minutes, considerably higher than that seen on the MSLT in SAHS
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patients, which is often less than 10 minutes (Roehrs et al 1989, Cheshire et
al 1992). In addition they found that the strongest nocturnal correlates of
sleep onset latency on the MWT were respiratory associated arousals,
apnoea + hypopnoea index and nocturnal hypoxemia. The major criticism of
the MWT is that subject motivation is uncertain, and as this test is tedious,
this may add significantly to its variability. This may explain why Sangal et al
(1992a) found that 15% of SAHS patients had above average sleep latencies
on the MSLT but were below average on the MWT. It is interesting to note
that the amount of variance in daytime sleepiness explained by nocturnal
variables (13%) is similar whether sleepiness is measured by the MSLT
(Roehrs et al 1989) or the MWT (Poceta et al 1992).
In summary sleep fragmentation is the more reliable predictor of
daytime sleepiness in SAHS patients whether it is measured by the MSLT or
the MWT. However at best only 13% of the variance in daytime sleepiness is
explained by sleep fragmentation.
2.8 Performance Measures; Driving
A potentially fatal consequence of daytime sleepiness is sleepiness
whilst driving. Home and Reyner (1995) found that sleep related vehicle
accidents accounted for between 16 and 20% of accidents on major roads
and motorways in England. Circadian rhythm influenced accident numbers
with three peaks in the number of accidents related to time of day; 2 to 3 am,
6 to 7 am, and 4 to 5 pm. Leger (1994) estimated that in the U.S. the cost of
sleep related vehicle accidents was somewhere between $29 and $38 billion
in one year (1988). It is unclear what the relative contribution of sleep
apnoea and its consequent daytime sleepiness is to these estimates. George
et al (1987) found that SAHS patients had more than twice the number of
vehicle accidents than controls. Findley et al (1988) found that 29 SAHS
patients had a seven fold greater record of automobile accidents than did 35
control subjects, and had 2.6 times the rate of accidents than all licensed
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drivers in one U.S. state. In a further study Findley et al (1989) found that
patients with sleep apnoea performed significantly worse than control
subjects on 2 driving simulators, consisting of a simulator car with road films,
and a computer programme of a monotonous highway drive (Steer Clear).
However Stoohs et al (1994) found a non significant increase (p=0.14) in the
rate of accidents for comercial long haul truck drivers with sleep disordered
breathing (SDB) compared to those without, although those with SDB were
more obese than those without. There was no relationship between severity
of SDB and accident rate in this sample. This is similar to a preliminary
report by Flemmons et al (1993) who did not find any relationship between
the number of objects hit on the Steer Clear programme (Findley et al 1989)
and AHI or arousal frequency. Results from driving simulators should be
interpreted with caution as few can truly mimic day to day driving.
2.9 Cognitive Function
Further evidence of the effects of sleep apnoea on performance come
from cognitive function testing. The literature in this area focuses on whether
potential cognitive deficits in SAHS patients are due to functional cerebral
impairment caused by nocturnal hypoxemia or are secondary to the daytime
sleepiness suffered by these patients.
Hypoxemia itself impairs cognitive function as demonstrated by
altitude simulation studies (Gibson et al 1981). Attention has focused on
patients with COPD, who suffer from chronic hypoxemia. These patients
have deficits in cognitive function (Fix et al. 1982, Grant et al 1982), which
get progressively worse with increasing severity of hypoxemia (Grant et al
1987). These patients should not be used as a model for the effects of
hypoxemia alone on daytime function because they also have disrupted
sleep (Calverley et al 1982) which itself can impair cognitive function (see
section 2.11.3). In addition it is difficult to extrapolate results from studies on
patients with COPD to patients with SAHS, because COPD patients are also
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hypoxic during the day which may add to their cognitive impairment.
Neuropsychological function in SAHS and COPD patients has been
compared by Roehrs et al (1995). They found that performances were
similar in both groups and were non-specific to tests related to sleepiness or
hypoxemia, apart from 2 tests, where SAHS patients performed more poorly
on a test related to sleepiness and COPD patients on a test related to
hypoxemia.
Prior to investigating the relationships between performance
measures in SAHS patients and nocturnal sleep and breathing variables it is
important to demonstrate that deficits do exist. Various studies suggest that
cognitive deficits exist in SAHS patients however few demonstrate this
conclusively. Guilleminault et al (1976) noted that patients with sleep apnoea
may suffer from impaired cogntive function in a description of cases of
SAHS. Kales et al (1985) found that SAHS patients had cognitive deficits but
only compared them with standardised scores, i.e. they did not use control
subjects. It is vital in studies of this nature to use carefully matched control
subjects because age and years of education themselves correlate with
cognitive function.
Greenberg et al (1987) studied a wide range of cognitive functions in
SAHS patients, patients with disorders of excessive somnolence (DOES), to
act as sleepy controls, and age and educationally matched healthy controls.
They found that SAHS patients had global neuropsychological impairment
compared with both control groups and they performed significantly worse
than either control group on 7 out of 17 psychometric tests. The authors
point out however that SAHS patients' group mean performance was 1/2 a
standard deviation lower than that of either control group. This may be a
reflection of the 1/2 SD fewer years of education or the lower premorbid IQ
intelligence (vocabulary) measures found in the SAHS patients. Furthermore
objective daytime sleepiness was only measured in 2/14 SAHS patients and
7/10 DOES patients.
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Neagale et al (1995) studied frontal lobe functions in 17 SAHS
patients and 17 age and educationally matched controls and found that
patients had significantly impaired performance on 11 out of 25 outcome
measures. The patient sample was subsequently divided into moderately
and severely apneic, and moderately and severely hypoxemic. Severely
apneic patients had poorer performance on one test of frontal lobe function
and severely hypoxemic patients also had poorer performance on one test of
frontal lobe function. Furthermore logistic regression models identified
specific functions, marked by the TOWER-3 (planning ability) and STROOP
(mental flexibility) tests, which are particularly impaired in patients with sleep
apnoea. Interpretation of these results should be done with care as the
authors did not measure sleep fragmentation nor did they include any sleep
EEG data into their logistic regression model.
2.10 Correlation with Nocturnal Variables
Several studies have correlated cognitive function in SAHS patients
with nocturnal variables to investigate the relative contributions of nocturnal
hypoxemia, respiratory and sleep variables to the cognitive impairment
described above. Many of these nocturnal variables are interrelated and it is
important to include them all in an analysis of this kind particularly as young,
non-obese individuals can have a similar AHI to an older more obese
individual but not have their severe nocturnal hypoxemia. In a similar fashion
many outcome measures from the cognitive function tests are interrelated.
Furthermore care must be taken to ensure that statistically significant
correlations do not occur by chance due to the large numbers of nocturnal
and cognitive variables available for a correlation analysis. Statistical
methods that may help to achieve this are principal components analysis
(Child 1990), multivariate analysis of covariance (MANCOVA), and multiple
regression analysis (Bryam and Cramer 1994).
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Greenberg et al (1987) found that psychomotor function, and Bedard
et al (1991b) found that performance and verbal IQ correlated with nocturnal
hypoxemia. Unfortunately there were no indices of sleep fragmentation
measured in these studies. Greenberg et al (1987) did correlate REM and
slow wave sleep, and cognitive function but found no significant
relationships. Bedard et al (1991b) used multiple analysis of covariance to
produce a 'vigilance' factor, consisting of; sleepiness on the MSLT, and
alertness on the four choice reaction time task, to reflect sleep fragmentation
and found that it correlated significantly with attention and memory
impairment. This assumes that sleep fragmentation causes daytime
sleepiness when at best sleep fragmentation only explains 13% of the
variance in daytime sleepiness.
Berry et al (1986) also found that hypoxemia correlated with verbal
and performance IQ, and memory. They did not report any correlations
between cognitive function and sleep variables. Respiratory events, which
correlate more significantly with sleep fragmentation than hypoxemia
(Cheshire et al 1992), were entered into the analysis but did not show any
significant relationships with cognitive function. In this study AHI was
probably underestimated due to the requirement of a 10% desaturation in
addition to a reduction in airflow for the scoring of an hypopnoea.
Cheshire et al (1992) correlated daytime sleepiness, mood and
cognitive function with nocturnal variables including respiratory events, sleep
staging and sleep fragmentation, and nocturnal hypoxemia. They controlled
for age, as cognitrive function is related to age, and for HAD anxiety and
depression as 40% of their patients scored in the significant range for anxiety
or depression on this scale. In a multiple regression analysis AHI was the
strongest predictor of performance with significant additional contributions
from microarousal frequency (sleep fragmentation) and hypoxemia.
These results suggest that microarousals are an important
contributary factor for daytime performance and strengthen the case for their
inclusion in scoring of overnight sleep studies.
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Yesavage et al (1985) and Hayward et al (1992) have performed
studies in the elderly and have found that respiratory disturbance (AHI)
correlates significantly with performance measures. The presence or
absence of relationships between cognitive function and hypoxemia or sleep
variables were not reported in either study which makes it difficult to assess
their relative contributions. This is especially relevant as Hayward et al
(1992) found that respiratory disturbance only accounted for 4% of the
variance in cogntive function. In addition Hayward et al (1992) did not allow
for the effects of age on cognitive function. The stronger relationships
between respiratory disturbance and cognitive function seen by Yesavage et
al (1985) may have been caused by their inclusion of 23 patients who had
been referred to the sleep clinic. This would raise the level of cognitive
impairment in their sample.
Findley et al (1986) approached this problem in a different way by
isolating all other factors apart from hypoxemia. They compared cognitive
function in hypoxemic and non-hypoxemic patients with sleep apnoea and
found that hypoxemic patients had poorer performance on tests of attention,
memory and vigilance. They did not report on whether the patient groups had
similar AHI, which if they were different would have had an impact on their
cognitive function. In addition these hypoxemic patients were also hypoxic
during the day which alone may have added to their impairment.
As a slight digression the mechanism by which hypoxia may affect
cerebral function has been described by Gibson et al (1981). The
autoregulatory changes in cerebral blood flow which occur in response to
hypoxia happen quickly enough to protect the intracellular energy supply
(ATP synthesis) although not quickly enough for adequate neurotransmitter
synthesis. Enzymes involved in neurotransmitter synthesis, in particular
acetylcholine, are particularly sensitive to hypoxia and it is these which may
be compromised by the intermittent hypoxemia seen in some SAHS patients.
Interestingly Meyer et al (1980) demonstrated that brainstem-cerebellar
blood flow was reduced below normal in patients with sleep apnoea when
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awake and that this decreased even further during sleep. The authors
suggested that there may be an impairment in the autoregulatory mechanism
for increasing cerebral blood flow in response to hypoxia in SAHS patients.
In summary it is difficult to separate the relative effects of hypoxemia
and sleep fragmentation on daytime function in SAHS patients using
correlation analysis as they are interrelated.
Sleep deprivation and sleep disruption impair cognitive function also
but only on performance tests that are of little interest to the subject and of
relatively long duration. If the test is of short duration (less than five minutes)
and complex enough subjects can uprate their performance over the course
of that test (see section 2.11). This suggests that the cognitive impairment
suffered by sleep deprived or sleep restricted subjects may be secondary to
their daytime sleepiness. In patients with SAHS peformance is also impaired
on short complex tests, e.g. Trailmaking B. This suggests that shorter
complex tests may be affected by hypoxemia. However the sleep
fragmentation studies (see section 2.11.4) of Bonnet (1987), Philip et al
(1994), and Roehrs et al (1994) used monotonous performance tests. In the
sleep fragmentation studies in this thesis we propose to use both
monotonous and complex tests to cover a broad range of cognitive function.
2.11 INTERVENTION STUDIES IN NORMAL SUBJECTS
2.11.1 Sleep Deprivation
Patients with SAHS are not totally sleep deprived. They may have
longer than average duration of time spent in bed in an attempt to overcome
their daytime sleepiness. Although the focus of this thesis is on sleep
fragmentation sleep deprivation studies can provide guidelines as to the
kinds of performance tests that could be used in testing for daytime
impairment in patients with sleep apnoea or sleep fragmented normal
subjects.
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The first reported sleep deprivation experiment in 1896 (Patrick and
Gilbert) found that reaction time, letter reading and addition tasks were
greatly impaired in 2 subjects. Williams et al (1959) sleep deprived normal
subjects for 3 to 4 days and compared their performance with that of control
subjects. Their performance measures were divided into tasks in which the
subject controlled the pace of the experiment and those in which the
experimenter controlled the pace or speed. On the subject paced tasks the
authors concluded that, although the accuracy of performance was not
affected by sleep deprivation, the speed of the response to a stimulus (e.g.
reaction time to turn off a light that has switched on) was lengthened and that
this corresponds to an increase in the frequency and duration of lapses in
concentration. They defined these lapses as reaction times that are at least
twice as long as the subject's baseline reaction time prior to sleep
deprivation. More recently these lapses have been termed microsleeps
(Home 1988) although Bjerner (1949) introduced the idea of their association
with falling asleep, finding that long reaction times were associated with
decreases in alpha activity on the EEG. Similarly Wilkinson (1965) found that
on a five choice reaction time test the number of gaps in between responses
longer than 1.5 seconds, corresponding to Williams' lapses, was increased
after 30 hours of sleep deprivation. On the experimenter paced tasks
Williams et al (1959) found that subjects had increased number of errors on
communication, learning and vigilance tasks after sleep deprivation.
Wilkinson (1965) also found that the number of errors on the five choice
reaction time test (tapping the wrong light), as a percentage of the total
number of responses made, was also increased after sleep deprivation.
Task duration is important for uncovering decrements in performance
due to sleep deprivation. Williams et al (1959) found that as the duration of
the task increased so the number of errors increased. This interacted with
the duration of sleep deprivation so that subjects made errors earlier on in
the performance of these tasks as their duration of loss of sleep increased.
Wilkinson (1965) showed that after sleep deprivation, in the first five minutes
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of a reaction time test subjects' performance was similar to normal but it
declined sharply as the duration of the test increased up to 30 minutes.
Reaction time and vigilance tests are relatively monotonous.
Wilkinson (1964) made suggestions on the types of tasks which are
susceptible to sleep deprivation by administering tasks of varying complexity
and interest but of uniform duration. It appears that interesting, complex
tasks are least susceptible to sleep deprivation, and that long, monotonous
tasks that do not engage the subject are more likely to be impaired. This
latter point was clearly demonstrated by Wilkinson (1961) by giving subjects
feedback of their performance during the test. Their motivation to perform
well was enhanced by feedback and they showed no deleterious effect of
loss of sleep. Home and Pettitt (1985) took this a step further and offered
subjects cumulative amounts of money to maintain their performance up to
baseline levels on a vigilance test over 72 hours of sleep deprivation. They
found that subjects uprated their performance for 2 days but could not
maintain this for the 3rd day of deprivation. In summary sleep deprivation
impairs normal subjects' performance on tests that are monotonous, of little
interest and of relatively long duration. However normal subjects can uprate
their performance on these tests especially if they are given some incentive
to do so.
2.11.2 Sleep Restriction
It can be argued that patients with sleep apnoea have reduced overall
sleep. The Rechtschaffen and Kales (1968) criteria for sleep staging are
based on averaged 30 second epochs which may not account for regular
brief arousals from sleep caused by apnoeas or hypopnoeas. If the time
spent in wakefulness was calculated on a second by second basis the SAHS
patient may well have severely restricted sleep. Several studies have
investigated the effects of partial sleep deprivation in order to find the
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minimum amount of sleep necessary for maintenance of baseline
performance.
Webb and Agnew (1965) allowed eight subjects 3 hours sleep a night
for 8 consecutive days. They found that there was a significantly greater
percentage of slow wave sleep on restricted nights than on the baseline
nights largely at the expense of stage 2 and REM sleep. The authors
however gave little data from the performance tests. Wilkinson (1969)
restricted subjects sleep for 2 consecutive nights to 7.5, 5 , 3, 2, 1 or 0 hours.
All subjects performed all conditions in randomised order. The days following
sleep restriction subjects had a full day of performance tests simulating a
day's work. Following one night of sleep restriction subjects' performance fell
only if sleep was less than 3 hours, however after the second night of sleep
restriction performance fell if sleep was less than 5 hours. Wilkinson
attributed these findings to there being insufficient time on the second night
of restriction to allow for a rebound of stage 4 sleep and thus on the 5 hour
restriction regime there builds up a stage 4 sleep debt which only impacts on
performance after the second night. There were no electrophysiological
measurements of sleep made in this study and therefore the results should
be interpreted with care.
The above results are somewhat borne out by those of Carskaddon
and Dement (1981). They restricted sleep to 5 hours for 7 days. They found
that there were progressive decreases in objective daytime sleepiness on the
multiple sleep latency test (MSLT) from the second to the 7th day of sleep
restriction. Although slow wave sleep was similar on all restriction nights
compared with baseline there was a trend towards an increase in slow wave
sleep on the first recovery night which indicates some slow wave sleep debt.
This may have accounted for the gradual decline in mean sleep onset
latency over the restriction period. Therefore it appears that performance




In the preceding 2 sections the focus is on the quantity of sleep
required for adequate functioning. The following 2 sections deal with the
effect of sleep quality on daytime function.
There have been many studies on the effects of the sleep disruption
suffered by junior doctors on their performance. Deary and Tait (1987)
showed that a night spent on call (mean sleep time 5 hrs) did not impair their
mood or cognitive function but that a night spent admitting emergency cases,
(mean sleep time 1.5 hrs) impaired mood and short term memory.
Deaconson et al (1988) found no effect of being on call (less than 4 hrs of
continuous sleep in the previous 24 hrs) on cognitive function the following
morning. The sleep data is self reported in both these studies and
additionally the junior doctor's sleeping patterns are not a good model for
sleep disruption, as their disruptions often involve long awakenings where
they have to get out of bed and perform tasks.
Previous studies on sleep disruption have investigated the
relationships between regular sleep disruption and daytime function in
normal subjects. Bonnet (1985) looked at the effects of recurrent sleep
disruption on daytime function. Healthy young subjects had their sleep
disrupted every minute for 2 consecutive nights' sleep resulting in
significantly reduced slow wave and REM sleep. Subjects had to respond
behaviourally to each sleep disruption by subjectively rating their sleepiness
on a scale of 1 to 7 or by pushing a button on awakening. On the day
following disruption subjects were subjectively sleepier and had poorer
performance on a reaction time test and the Wilkinson addition test than
after a baseline night. These impairments were similar in nature to those
suffered by normal subjects after sleep deprivation leading to the suggestion
that these decrements could be due to slow wave sleep deprivation.
A subsequent study therefore looked at the effect of eliminating slow
wave sleep by disrupting sleep whenever stage 3 or 4 appeared and
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comparing performance during the day with that after a series of nights with
a similar number of sleep disruptions but without the elimination of SWS
(Bonnet 1986a). The difference in SWS between conditions did not have any
impact on tests of performance, mood or objective daytime sleepiness
measured on a single morning nap, implying that it is the frequency of sleep
disruption which determines whether sleep is restorative and not the amount
of slow wave sleep.
This leads to the question of how much sleep disruption affects
performance and sleepiness. Badia et al (1985) investigated this by
disrupting the sleep of normal subjects for 4 consecutive nights at an
average rate of either 4 or 8 minutes. There was no difference between
conditions in their relative effects on daytime sleepiness as measured by
naps at 10 am and 2 pm the day after the disruption nights. In addition there
was no difference in daytime sleepiness after sleep disruption of either
frequency compared with a group of controls who had undisturbed sleep.
These results suggest that sleep disruption at these frequencies is not
sufficient to cause increased daytime sleepiness, although the lack of a full
MSLT makes interpretation more difficult.
The same authors (Magee et al 1987) therefore increased the
frequency of sleep disruption. Daytime sleepiness in 3 groups of normal
subjects was compared following (1) an undisturbed night, (2) sleep
disruption every minute, and (3) sleep disruption every 4 minutes. Daytime
sleepiness this time was assessed with a full MSLT. They found that
subjects whose sleep had been disrupted every 1 minute were significantly
sleepier during the day than those whose sleep had been disrupted every 4
minutes or those subjects whose sleep had been undisturbed. There was no
difference between daytime sleepiness in subjects who had had an
undisturbed night's sleep or those whose sleep had been disrupted every 4
minutes. These results suggest that a sleep duration of about 4 minutes is
critical for allowing sleep to be restorative.
44
Bonnet (1986b) also dealt with this idea by comparing daytime
performance in normal subjects after 4 conditions of sleep disruption;
awakening every minute, awakening every 10 minutes, 2.5 hours of sleep
followed by awakening at each sleep onset, and sleep deprivation. Subjects
performed best after the 2.5 hour condition closely followed by that seen
after the 10 minute awakening condition. The worst performance was found
after sleep deprivation. This was similar to that seen after the 1 minute
awakening condition.
Levine et al (1987) used sleep deprivation as a baseline and disrupted
recovery sleep to investigate at what level sleep could be restorative. Normal
subjects were sleep deprived until 8.30am and then their 100 minutes of
recovery sleep was fragmented at a rate of 1/minute, 1/3 minutes, or 1/5
minutes. There were 2 further conditions; 100 minutes of uninterrupted
sleep, or further sleep deprivation for 100 minutes. Mean sleep onset latency
on the MSLT was diminished after the fragmentation conditions compared
with uninterrupted sleep in a dose dependent fashion. These studies (Badia
et al 1985, Magee et al 1987, Bonnet 1986b, Levine et al 1987) suggest that
there may be a critical minimum period of uninterrupted sleep necessary for
sleep to be restorative. The data from these studies suggests that this period
may be near 4 minutes.
2.11.4 Sleep Fragmentation
The studies described previously all require subjects to make
behavioural responses to arousing stimuli thus major degrees of arousal
occurred and this may have severely disrupted their sleep. If sleep disruption
shortens total sleep time compared with an undisturbed night's sleep any
decrements in daytime function may be attributed to this partial sleep
deprivation, however slight. Patients with sleep apnoea most often have brief
arousals (less than 15 seconds) at the end of their apnoeas and hypopnoeas
of which they are unaware. They can have long total sleep times in an effort
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to obtain recuperative sleep (Dement et al 1978). This, along with the above
suggestion that there is minimum duration of sleep required for it to be
restorative, suggests that in patients with sleep apnoea their lack of
continuity of sleep due to brief arousals terminating apnoeas and
hypopnoeas may cause their daytime sleepiness. Studies by Bonnet (1987),
Philip et al (1994) and Roehrs et al (1994) have investigated this by modeling
the effects of sleep fragmentation alone on daytime function.
Bonnet (1987) investigated the effects of more subtle forms of sleep
disruption on morning sleepiness, performance tests and mood. Daytime
function after a baseline night was compared with the impact on daytime
function of 3 different responses to tones; (1) behavioural response to tones
in a similar fashion to the previous study (Bonnet 1985), (2) by asking
subjects to perform a 1/4 body turn in response to tones, (3) requiring an
ongoing EEG change in response to tones. Acceptable EEG changes in
response to tones included a sleep stage change, the appearance of alpha
or any noticeable increase in EEG frequency. The first 2 conditions are again
behavioural responses to arousing stimuli with the movement condition
designed to mimic limb movements found in PLMS, which can cause
daytime sleepiness, and the EEG condition to mimic the sleep fragmentation
found in patients with sleep apnoea. Daytime function was measured in 11
young subjects using tests of daytime sleepiness; on one morning nap,
performance; using a 30 minute addition test, a 30 minute vigilance test and
10 minutes of simple reaction time, and mood; using the Clyde mood scale.
Sleep fragmentation (EEG condition) increased morning sleepiness,
impaired vigilance and made subjects significantly sleepier and unhappier
compared to a baseline night. Similar results were found for the first 2
disruption conditions. Although the EEG condition models sleep
fragmentation there was no information given about duration criteria on the
EEG for an optimum response to tones, and it appears that the total sleep
time on the EEG condition is significantly shorter than on the baseline night
which could perhaps account for the impairments seen in morning
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sleepiness, mood and vigilance. In addition testing baseline daytime function
is not built into the study design as a separate condition but is a night prior to
each 2 night disruption paradigm.
Philip et al (1994) fragmented the sleep of 8 young adults for 1 night
every minute and tested daytime sleepiness using the MSLT, and
performance using tests which covered a range of functions including
vigilance, attention and memory. Daytime function following fragmentation
was compared with a randomised control night. Subjects had 5 training
sessions with the performance tests to eliminate any potential learning
effects. The fragmented study night was extended by the amount of
wakefulness seen during the study night and therefore there was no
difference in total sleep time between fragmentation and baseline nights.
There was significantly more stage 1 sleep and significantly less slow wave
sleep and REM sleep on the fragmented night. Fragmentation decreased
mean sleep onset latency from 15.4 minutes to 8.8 minutes but did not affect
performance tests. The authors found that SWS was significantly related to
daytime sleepiness following study nights although REM and SWS were the
only sleep variables entered into the regression equation. A threshold
arousal response of 3 seconds was aimed for on the fragmentation night but
there was no data on the number of brief arousals that were induced or how
many of these were full awakenings. The percentage of wakefulness was
over 18% indicating a high level of sleep disruption on the fragmentation
night and there was no wake time given for the baseline night making true
comparison of study nights difficult.
Roehrs et al (1994) induced sleep fragmentation with tones on
average every 2 minutes in 36 young subjects for 2 nights. Daytime
sleepiness was measured with the MSLT and performance using a divided
attention test after each fragmentation night. Daytime function was compared
with that following a screening night prior to the fragmentation nights. Total
sleep time was similar on screening and fragmentation nights again due to
extension of study time by the amounts of prior wakefulness on
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fragmentation nights. Sleep onset latency decreased after one night of
fragmentation (14.3 to 9.8 mins) but did not decrease any further after the
second night of fragmentation (9.5 mins). There was no effect of sleep
fragmentation on the one monotonous test of performance studied. There
was a small rebound effect in sleep stages on the second fragmentation
night towards screening night levels. This may either reflect adaptation to the
laboratory or increased drive to sleep due to sleepiness caused by the
previous night's sleep fragmentation. In either case it may account for the
stabilising of daytime sleepiness after the second fragmentation night. The
success rate of the fragmentation procedure was 78% on the first night and
68% on the second night but there were no comparisons of arousal indices
between fragmentation and screening nights. A criticism of this study is that
the control and fragmentation nights were not randomised. Performance
tests are susceptible to learning effects and although subjects were trained
on the divided attention test it is unclear how much practice subjects had. As
the screening night came before the fragmentation nights any decrement in
performance due to fragmentation may have been overcome by increased
proficiency on this test.
These studies suggest that fragmentation affects daytime sleepiness
but not performance on the tests used in these studies. On 2 out of these 3
studies there was no randomisation schedule (Bonnet 1987, Roehrs et al
1994) with Bonnet (1987) comparing daytime function after different total
sleep times. Furthermore there was little information about how successful
the sleep fragmentation protocol was in inducing arousals (Philip et al 1994,
Bonnet 1987). All 3 studies used monotonous tests excluding short complex
tests upon which SAHS patients also have poor performance.
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2.12 Modelling Hypoxemia
Modelling nocturnal hypoxemia is the other approach to determine the
cause of deficits in daytime function in SAHS patients. There has only been
one study of this nature by Colt et al (1991). Patients with sleep apnea
performed 2 experimental limbs in a randomised crossover design. Patients
either spent 2 nights in the laboratory where they had sufficient CPAP
pressure to eliminate their respiratory events, sleep fragmentation and
hypoxemia or they spent 2 nights on CPAP sufficient to eliminate their
respiratory events and sleep fragmentation with intermittent hypoxemia
induced through the CPAP mask. Subjects had an MSLT before and after
both experimental conditions. There was no difference between experimental
conditions in the improvement in daytime sleepiness after CPAP. There were
significantly more desaturations on the hypoxemia condition but there was no
difference in any nocturnal sleep variable, including the number of arousals,
apart from 8 minutes less stage 2 on the hypoxemia condition. These results
suggest that intermittent hypoxemia alone does not cause daytime
sleepiness in SAHS patients.
In conclusion patients with sleep apnoea have impairments of their
daytime cognitive function which correlates with their severity of sleep
apnoea, nocturnal hypoxemia and sleep fragmentation. It is difficult to
separate out the relative contributions of hypoxemia and sleep fragmentation
as they are highly interrelated themselves. Modelling studies have suggested
that sleep fragmentation causes daytime sleepiness (Colt et al 1991, Philip
et al 1994) but not cognitive dysfunction (Phillip et al 1994).
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2.13 Improvements in Daytime Function after CPAP in SAHS Patients
Further evidence on the relationships between daytime function and
nocturnal variables comes from studies on daytime function after CPAP
therapy with the suggestion that daytime impairment in SAHS patients is
somewhat reversible.
The effects of CPAP therapy on patients can be dramatic with some
relief of daytime sleepiness occurring after one night (Lamphere et al 1989).
Lamphere et al (1989) studied daytime sleepiness in three groups of patients
with sleep apnoea before commencing on CPAP and again after either one,
14, or 42 nights on CPAP. They found that sleep architecture normalised
during the first night of treatment and that daytime sleepiness improved
significantly from 3 to 6 minutes after one night and from 3 to 10 minutes
after 14 nights on CPAP. There was no further improvement after 42 nights.
There was no difference between study groups for baseline severity of sleep
apnoea or daytime sleepiness that could have explained these results,
although there were no data on the age or weight of each group. Daytime
sleepiness on the MSLT appeared to return to the normal range of greater
than 10 minutes after 2 weeks on CPAP.
Although Bedard et al (1993) found a similar increase in MSLT from 5
to 9 minutes after CPAP there was residual sleepiness with post treatment
MSLT significantly lower than that of age matched controls (14 minutes).
Furthermore other studies have demonstrated even smaller, although
significant, increases in the MSLT with CPAP therapy. Engleman et al (1993)
found an increase of 2.1 minutes and 1.1 minutes (Engleman et al 1994a),
and Kribbs et al (1993) an increase of 2.4 minutes with CPAP therapy.
Sangal et al (1992b) did not find any significant increase in MSLT
after treatment however their sample was biased by the inclusion of patients
who had had UPPP and whose severity of sleep apnoea had not
subsequently decreased. They therefore divided their sample into patients
treated with CPAP or UPPP and found a significant improvement from 18 to
32 minutes in sleep onset latency on the MWT after CPAP therapy.
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Unfortunately results for changes in MSLT for the CPAP treated group alone
were not reported. Sforza and Krieger (1992) asked patients with sleep
apnoea to lie down in a dark room for 30 minutes without any instructions to
fall asleep or to stay awake. Mean sleep onset latency for six naps every 2
hours improved from 17 minutes untreated, to 20 minutes after CPAP, but,
similar to Bedard et al (1993), did not normalise remaining significantly
shorter than in the control group (27 mins).
The failure of CPAP to normalise daytime sleepiness in some studies
has been attributed to poor rates of compliance. Lamphere et al (1989), and
Bedard et al (1993), who found the largest improvements in daytime
sleepiness with CPAP, did not monitor objective compliance. Objective
CPAP use in other studies were 3.7 hours (Engleman et al 1994a), 5.9 hours
(Engleman et al 1993), 5.3 hours (Sforza and Krieger 1992) and 4.9 hours
(Kribbs et al 1993). These rates are short of the ideal 8 hour per night.
Correlation analysis to determine what drives the SAHS patient to use their
machine shows that there is no relationship between CPAP compliance and
severity of disease (Engleman et al 1994b, Kribbs et al 1994), baseline
sleepiness, or improvement in daytime sleepiness with CPAP (Engleman et
al 1994b).
An alternative explanation is that the MSLT tests how well subjects
are able to fall asleep when they try to sleep. Patients with sleep apnoea
may be well trained to fall asleep whenever the opportunity arises and this
could persist some months into CPAP therapy. This problem may be
circumvented by using the MWT. However even though the improvements in
MWT with CPAP are impressive (14 minutes difference in mean sleep onset
latency between MWT done before and after CPAP) there is no normal data
to compare these changes with (Sangal et al 1992b).
Condos et al (1994) offered a further explanation of low CPAP
compliance. They suggested that residual periods of increased UAR, which
cause microarousals, after CPAP titration may account for the non-
normalisation of the MSLT after CPAP therapy and thus the relatively low
compliance rates seen in studies of objective CPAP use (Kribbs et al 1993,
Engleman et al 1994a, 1994b). This idea is supported by the recent findings
of Engleman et al (1997) that mild SAHS patients who complied well with
CPAP had significantly higher baseline AHI and microarousal indices.
However this suggestion assumes that there is a relationship between CPAP
use and patient benefit. Although subjective perception of benefit is
associated with acceptance of CPAP, objective benefits do not appear to
influence CPAP use. Patients who did not use CPAP had similar AHI on
CPAP to those patients who did use CPAP (Rauscher et al 1991, Hoffstein
et al 1992). In addition Engleman et al (1994b) demonstrated that there is no
relationship between CPAP use and change in objective daytime sleepiness
on the MSLT after CPAP.
Further evidence of the efficacy of CPAP therapy comes from testing
cognitive function. Findley et al (1989), Bearpark et al (1987), Kribbs et al
(1993), Bedard et al (1993) have all found significant improvements in
performance and cognitive function after CPAP therapy. Results from these
studies should be interpreted with care due their longitudinal nature which
does not allow for the learning effects inherent in many cognitive tests with
multiple adminstrations.
Although Bedard et al (1993) ran subjects through 3 practice runs on
the four choice reaction time test subjects were not familiarised on the 11
other cognitive function tests. This makes it difficult to factor out true
improvements in function caused by CPAP. Engleman et al (1993) found
improvements in cognitive function with both CPAP and conservative therapy
but they did not find any difference between treatments. They concluded that
any improvements in cognitive function were due to learning effects and
therefore controlled for this by comparing the effects of CPAP on cognitive
function with an oral placebo in a randomised crossover design (Engleman et
al 1994a). Subjects also performed a practice session with the cognitive tests
prior to entry into the study to minmise the effects of learning. They found
significant improvements in 4 out of 14 cognitive tests measuring vigilance,
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general function, and mental flexibility. Improvements in vigilance, tested with
Steer Clear for 30 minutes, may have been secondary to resolution of
daytime sleepiness. However the improvements seen in complex tests of
short duration, Digit Symbol substitution (90 sees) and Trailmaking B (mean
time to completion on CPAP; 66 sees), suggests that at least some of the
deficits in SAHS patients are reversible and are not due to irreversible
hypoxic damage to cognitive centres in the brain as suggested by Berry et al
(1986) and Bedard et al (1993).
Some studies have used auditory event related potentials (AERPs) as
an index of brain function in patients with sleep apnoea, and to assess their
response to CPAP (Wasleben et al 1989, Engleman et al 1995). These
potentials consist of EEG waveforms within the first 800 msec of
presentation of a higher pitched tone among a series of low tones. The
latencies to particular waveforms reflect speed of cognitive processing, and
waveform amplitudes reflect attention and motivation. Wasleben et al (1989)
found that latencies to N2 and P3, were impaired in SAHS patients and P3
returned close to normal levels after 2 nights on CPAP. These results
suggest that cognitive slowing that occurs with sleep apnoea may be
reversible. Preliminary results from Engleman et al (1995) however are
inconclusive.
2.14 Mood in Sleep Apnoea
As described previously (section 2.3) instantaneous mood has a
biological basis and can be manipulated using physiological stressors such
as acute hypoglycaemia (Gold et al 1995, Hepburn et al 1995, Hepburn et al
1996). The range of physiological changes occurring during apnoeas and the
resulting disturbance of sleep architecture in the SAHS patient would be
expected to have some impact on mood. Due to the chronicity of sleep
apnoea these changes should not be instantaneous but may manifest
themselves as an affective disorder.
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In their original case series Guilleminault and Dement (1977) noted
that SAHS patients can suffer from symptoms of depression. Kales et al
(1985) measured this and demonstrated that SAHS patients had similar
personality profiles to general medical outpatients, suffering from depression
based on physical vulnerability. Millman et al (1989) found that 45% of SAHS
patients had scores consistent with depression on the Zung self rating
depression scale and although there was no relationship between these and
severity of sleep apnoea the AH I was significantly greater in the depressed
patients. Cheshire et al (1992) in addition to finding that a similar percentage
of SAHS patients were in the clincally significant range for anxiety or
depression (41%) on the Hospital Anxiety and Depression (HAD) (Zigmond
and Snaith 1983) scale also found that scores on this scale correlated
significantly with cognitive function; particularly Trailmaking A, testing
processing speed, and the Auditory verbal learning test, testing memory.
These previous studies used patients who had moderate to severe
sleep apnoea. A preliminary report by Gall and Kryger (1993) using 6
validated questionnaires, suggests that patients with mild sleep apnoea
(mean AHI= 9/ hour slept) suffer from impairments in social functioning and
alertness compared to normals. The authors point out that although SAHS
patients scores were in the abnormal range they were not pathological. This
appears to be a crucial point as studies by Lee (1990) and Cassel (1993)
show no incidence of clinical depression in patients with sleep apnoea.
Cassel (1993) found no personality changes consistent with clinical
depression in patients with sleep apnoea, and Lee (1990), out of 60 patients
with sleep apnoea, did not find anyone who fulfilled the DSM-III-R criteria for
depression. Cassel (1993) assessed patients prior to any diagnosis of sleep
apnoea and therefore avoided patients' knowledge of their diagnosis having
an influence on their scores. Furthermore Cassel suggests that the results of
Kales et al (1985) may be due to patient concerns about undergoing a
radical surgical procedure (tracheostomy) and the results of Millman et al
(1989) may be due to their inclusion of questions that relate to sleepiness.
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The latter would bias the sleepy patient towards scoring highly on a
depression scale.
However, similar to other aspects of daytime function these
measurements of mood can also improve with CPAP therapy. Derderian et
al (1988), Kribbs et al (1993) and Engleman et al (1994a) found
improvements in scores on a variety of well validated mood scales (McNair
et al 1971, Matthews et al 1990, Zigmond and Snaith 1983, Goldberg and
Hillier 1979, Hunt et al 1984) which incorporated questions about social
functioning, depression/ anxiety, fatigue and alertness/ sleepiness.
In summary validated mood scales may be useful to look for
improvements in SAHS patients with CPAP therapy but their baseline results
should be interpreted with care.
2.15 Snoring and Daytime Function
Patients with mild sleep apnea (AHI 5 to 15) have improved daytime
function with CPAP therapy (Engleman et al 1997). Snoring is an even milder
form of sleep disordered breathing. It is very common in the general
population and investigating whether it causes decrements in daytime
function is important in determining whether it should be actively treated.
Snoring is a major symptom of sleep apnoea. Some patients are
symptomatic for sleep apnoea but do not have apnoeas and hypopnoeas
during sleep. Hillerdal et al (1991) demonstrated that heavy snorers and
SAHS patients could not be separated on their symptoms alone. Nocturnal
polysomnography does not reveal any difference in sleep architecture
between snorers and non-snorers that may account for the proliferation of
symptoms of SAHS in snorers (Hoffstein et al 1991). There was however no
measure of sleep fragmentation used in this study, a parameter which some
authors suggest may be raised in heavy snorers (Guilleminault et al 1991).
In that study Guilleminault et al (1991) investigated 15 male heavy
snorers who all had AHI<5 and normal nocturnal oximetry. They found that
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snoring in conjunction with large increases in inspiratory effort could be
associated with microarousals. Inspiratory effort was measured using
oesophageal balloons, a technique which can itself profoundly disturb sleep.
Baseline daytime sleepiness was therefore measured with an MSLT after a
'normal' polysomnography night. Objective daytime sleepiness at baseline in
these subjects was within the normal range, and it improved significantly
after CPAP therapy. There was no difference in any polysomnographic
variable between the 2 nights prior to the MSLTs except for a significant
decrease in the arousal index on the CPAP night, suggesting that decreased
arousals cause improvements in daytime sleepiness.
In a further study Guilleminault et al (1993) investigated a group of 15
patients who were originally diagnosed as having idiopathic hypersomnia
with a mean sleep onset latency on the MSLT of 5.1 minutes. These subjects
actually had large increases in inspiratory efforts prior to decreases in flow
and subsequent microarousals. This increased upper airway resistance
causing microarousals was suggested as the cause for these subjects'
pathological daytime sleepiness as mean sleep onset latency on the MSLT
increased to 13.5 minutes coincident with a decrease in microarousal
frequency after a one month trial of CPAP therapy.
These 2 studies suggest that patients with mild SDB (snoring,
increased UAR) may have daytime sleepiness which is mediated by
microarousals. Two self report studies suggest further impairments in
function due to snoring.
Stradling et al (1991b) found that questions relating to daytime
sleepiness were correlated with self reported snoring independent of
confounding variables for sleep apnoea, in particular 2 questions related to
sleepiness while driving. This suggests that snorers may have impaired
cognitive function.
In a epidemiological follow up study Jennum et al (1994) measured
self reported snoring, daytime sleepiness, and cognitive complaints. In the
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total population snoring did not relate to memory or concentration problems
irrespective of different severities of hypersomnia. Hypersomnia itself was
significantly associated with memory and concentration problems. In both
studies data was self reported and therefore the incidence of snoring may
have been underreported, and patients with sleep apnoea may have been
included. The results suggest that any potential cognitive impairment in
snorers may be secondary to the incidence of daytime sleepiness.
Telakivi et al (1988) performed cognitive function tests in middle aged
self-reported habitual and occasional snorers, and non-snorers. They
investigated various aspects of objective cognitive function including verbal
and performance IQ, memory, psychomotor function and mental flexibility.
Indices of severity of SDB were indicated by the periodic breathing index,
from the Biomatt monitor, and the 4% desaturation index. Excessive daytime
sleepiness was assessed subjectively from a questionnaire. There was no
difference in age or cognitive function beween subject groups, however in
habitual snorers excessive daytime sleepiness correlated with cognitive tests
of memory, concentration, verbal fluency and psychomotor function. After
adjusting for age and obesity in habitual snorers the number of 4%
desaturations was associated with memory and spatial orientation tests.
When subjects with oxygen desaturation indices greater than 10 per hour
(subjects with sleep apnoea) were excluded from the analysis there were no
significant relationships between hypoxemia and cognitive function tests.
These results suggest that snoring itself does not cause cognitive impairment
but that snorers' subjective perception of daytime sleepiness relates to their
general performance. Although the authors suggest that daytime sleepiness
is secondary to sleep fragmentation, there were no objective measures of
sleep, sleep fragmentation, or daytime sleepiness used in this study to
support this. The suggestion is however in agreement with objective results
from Guilleminault et al (1991) and self report data from Jennum et al (1994)
suggesting that snorers do suffer from daytime sleepiness.
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Concluding Remarks
Previous research demonstrates that patients with SAHS have deficits
in daytime function which are related to their nocturnal hypoxemia and sleep
fragmentation. These are themselves interrelated making it difficult to
distinguish which is the cause of daytime impairment. Current theory
suggests that irreversible deficits in daytime function may be caused by
hypoxemia and reversible deficits may be caused by sleep fragmentation.
Previous modelling studies have focused on sleep disruption and have not
answered this question fully. Part of the problem may be in the description of
sleep fragmentation upon which there is poor agreement. The subsequent
experiments describe sleep fragmentation more fully both manually and
using computerised analyses. The main focus for this thesis remains the





The studies presented in this thesis were all performed in the sleep
laboratories in either the Rayne laboratory, City Hospital, Edinburgh, or ward
48, Royal Informary of Edinburgh. The methods used included overnight
polysomnography and daytime function testing. Testing daytime function
consisted of measurements of daytime sleepiness, mood and cognitive
function. Studies were performed on both normal subjects and patients with
SAHS.
3.1 Nocturnal Polysomnography
All studies were performed in sound proofed, electrically screened,
air-conditioned bedrooms. In normal subjects we measured sleep,
respiratory movement and electrocardiography (ECG), and in SAHS patients
we measured sleep, leg electromyography (EMG), respiratory movement,
oro-nasal flow and oxygen saturation. In addition in fragmentation protocol 2,
beat to beat arterial blood pressure was measured using the Finapres
device. Sleep was measured using electrooculography (EOG),
electroencephalography (EEG), and submental electromyography (EMG).
Silver chloride electrodes were placed at the left and right outer
canthi, international 10/20 EEG classification positions Fp1, Fp2, CZ and PZ
(Cooper et al 1980). A subset of subjects had electrodes positioned at F3
and F4. All subjects had an earth electrode positioned at FpZ. Bipolar signals
were derived from various combinations of these electrodes as follows.
Left EOG; right outer canthus/ Fp1.
Right EOG; left outer canthus/ Fp2.
Central EEG; CZ/ PZ.
Central EEG (backup); PZ/ CZ.
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Left Frontal EEG; Fp1/ F3.
Right Frontal EEG; Fp2/F4.
Submental EMG was measured from 2 electrodes positioned under the chin
on the belly of the genioglossus muscle.
Leg EMG was measured from 2 electrodes positioned on the belly of the
anterior tibialis muscle.
All signals were subjected to high and low bandpass filtering to exclude any
artefactual electrical signals. Notch filtering (50hz) was also applied to
exclude any interference from electrical mains.
Thoraco-abdominal movement was measured with inductance
plethysmography (Respitrace, Ambulatory Monitoring Inc) using bands
attached to the subject's ribcage and abdomen. Oronasal airflow was
monitored with thermocouples at the nose and mouth. Oxygen saturation
was recorded with an Ohmeda 3700 oximeter using and ear probe
positioned on the earlobe.
Polygraphic recordings were made onto paper, and 2 computerised
polysomnography systems. Paper recordings were made with a multi
channel polygraph (SLE 16b, Specialised Laboratory Equipment, Croydon,
U.K) running at a paper speed of 15 mm/ second or 10 mm/ second giving
epochs of 20 or 30 seconds respectively. In order to standardise these
records for sleep scoring purposes the recordings made at 15 mm/ sec were
renumbered into epochs of 30 seconds. Sleep studies were also recorded
onto optical disk using either the Healthdyne Alice 3 computerised
polysomnography system or Compumedics computerised polysomnography
(Melbourne, Australia). Nine normal subjects had both their sleep
fragmentation limbs studied on paper polysomnography, 14 had both
fragmentation limbs on Healthdyne computerised polysomnography and 19
had both fragmentation limbs on Compumedics computerised
polysomnography. Sixty SAHS patients had their overnight studies recorded
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onto paper and the remaining 3 were recorded onto Healthdyne
computerised polysomnography.
3.2 Measuring Arterial Blood pressure
Beat to beat arterial blood pressure was measured using digital
infrared plethysmography with the Finapres (Ohmeda) device. The device
functions according to the method described by Penaz (1973). A finger cuff
is fitted onto the finger and inflated to a pressure equal to intra-arterial
pressure, thus the pressure difference across the arterial wall, transmural
pressure, equals zero. Arterial blood pressure is then determined indirectly
from the cuff pressure. The finger cuff contains a plethysmograph which
monitors blood volume underneath it and clamps it at a set point which is
regularly adjusted by an electropneumatic servo controller to allow for shifts
in arterial blood pressure. This is contained in a box, attached to the finger
cuff, and strapped to the subject's hand. Parati et al (1989) successfully
validated the Finapres with intra-arterial blood pressure monitoring in
normals and hypertensive subjects, both at rest, and when performing a
series of physiological manoeuvres known to produce fast and significant
increases in blood pressure. The Finapres device does not measure
absolute blood pressures accurately, however it does measure changes in
blood pressure in response to stimuli with accuracy (Parati et al 1989).
In the studies presented in chapter 6, beat to beat systolic, diastolic
and mean arterial blood pressure and heart rate were recorded in a digital
data stream onto a PC. Due to the sensitivity of the Finapres device to finger
or arm movements, during blood pressure recordings subjects were
monitored with a video camera and any data obtained during periods of
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Figure 3.1; Sample of Finapres output available during sleep studies. The
top of each vertical line is the systolic blood pressure and the bottom of each
line is the diastolic blood pressure for each heartbeat. Millimetres of mercury
(mmHg) is represented on the y axis and study time on the X-axis. Five
minutes of data is shown here.
3.3 Sleep Scoring
Sleep was staged in 30 second epochs according to Rechtschaffen
and Kales' (1968) guidelines. These consist of categorising sleep into 1 of 7
stages including wakefulness.
Stage WAKE is scored if more than 50% of that epoch consists of waking
EEG frequencies, in the alpha (8 to 11 Hz (cycles per second)) or beta
(greater than 16 Hz) range. In addition there may be eye blinks on the EOG
and high EMG activity.
Stage 1 is scored if more than 50% of the epoch consists of theta EEG
frequencies (4-7 Flz). EMG activity may be somewhat decreased and there
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are usually slow rolling eye movements on the EOG channels (approximately
7 seconds in duration). Stage 1 is a transient sleep stage.
Stage 2 (figure 3.2) is characterised by more than 50% of the epoch
consisting of EEG frequencies in the theta range (4 to 7 Hz). The epoch
should include sleep spindles, which are short bursts (0.5 to 2 seconds) of
sigma (12 to 15 Hz) EEG frequencies, and/ or K complexes, which consist of
a rapid depolarisation followed by a rapid repolarisation (0.5 seconds in
duration).
Figure 3.2; Example of a 30 second epoch of stage 2 sleep from a 25 year
old male subject showing characteristic sleep spindles and a K complex.
Stage 3 is scored if between 20% and 50% of the epoch consists of delta or
slow waves (0 to 3 Hz) of at least 75pv in amplitude. Slow waves can be
mistaken for K complexes, however K complexes occur as isolated
waveforms whereas slow waves occur in runs. This is another transient sleep
stage.
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Stage 4 (figure 3.3) is scored if more than 50% of the epoch consists of slow
waves. Sleep spindles and K complexes have usually disappeared.
Stage 4 10 sees
Figure 3.3; Example of a 30 second epoch of stage 4/ slow wave sleep
(SWS) from a 25 year old male subject.
Stage REM (figure 3.4) is characterised by mixed frequency low voltage
EEG frequencies similar to stage 1 and includes runs of sawtooth and vertex
sharp waves. Rapid eye movements proliferate and EMG activity will be
reduced to its overnight minimum apart from phasic twitches. In epochs
where there are no rapid eye movements but the remainder of the record
has the appearance of REM sleep, REM sleep should be scored provided 3
minutes has not passed since the last rapid eye movement. REM sleep
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Figure 3.4; Example of a 30 second epoch of REM sleep from a 25 year old
male subject showing eye movements and low chin EMG.
Movement Time; this is used when more than 50% of the epoch consists of
movement artefact and the underlying sleep stage cannot be determined
from any EEG or EOG channel.
The sleep of normal young adults who have good sleep hygiene and
no sleep complaints may consist of; less than 5% of wake, 2-5% of stage 1,
45 to 50% stage 2, 3 to 8% stage 3, 10 to 15 % stage 4, and 20 to 25%
stage REM (Carskaddon and Dement 1989).
Patients with severe sleep apnoea have disrupted sleep which often
alternates between stage 2 (i.e. presence of sleep spindles and K
complexes) and Wake. This presents a scoring difficulty due to
Rechtschaffen and Kales' (1968) guidelines suggesting that stage 1 is
scored prior to stage 2 after an awake epoch. I followed this laboratory's
policy in these cases, which is to score these epochs as stage 2 if they can
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be defined as such and thus in SAHS patient studies there are small
amounts of stage 1.
3.4 Respiratory Events
These are classified into central, mixed and obstructive apnoeas, and
hypopnoeas.
Obstructive; (figure 3.5) complete cessation of flow for a minimum of 10
seconds but with continued respiratory effort throughout the apnoea.
Central; complete cessation of flow and respiratory movement for a
minimum of 10 seconds.
Mixed; complete cessation of flow for a minimum of 10 seconds. Respiratory
effort is initially missing but returns mid way through the apnoea.
Hypopnoea; a minimum of 50% reduction in thoracoabdominal movement
for a minimum of 10 seconds.
10 sees
Figure 3.5; A 30 second epoch of stage 2 sleep with an example of an
obstructive apnoea with continued respiratory effort while there is no
oronasal airflow. The apnoea is terminated by a visible EEG arousal.
Thor; thoracic movement, Abd; abdominal movement.
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Definitions of hypopnoea vary between laboratories with some using a
50% reduction in flow as the guideline and other laboratories requiring an
additional minimum 4% oxygen desaturation. The above definition has been
validated in a series of patients with clinical features of sleep apnoea but
who do not have apnoeas (Gould et al 1988).
3.5 Scoring Sleep Fragmentation (Arousals)
In this thesis 5 definitions of arousals were used.
1. The American Sleep Disorders Association (ASDA) has published a set of
guidelines for arousal scoring (1992). These require a minimum of 3
seconds return to alpha or theta on the EEG channels during non-
REM sleep with the additional criterion of a minimum concurrent 3
seconds increase in EMG tone during REM sleep. This is due to
phasic muscle twitches being commonplace during REM sleep.
2. Modified ASDA (mASDA); This definition was modified in house to include
the above criteria but for 1.5 seconds only.
3. Cheshire (1992); A minimum of 1.5 seconds return to alpha or theta on
the EEG accompanied by any increase in EMG tone however brief.
4. Sleep fragmentation (figure 3.6); A return to alpha or theta EEG frequency
for a minimum of 3 seconds regardless of sleep stage.
In the above 4 definitions 10 seconds of prior sleep was required as
the minimum interval between arousal events.
5. Rechtschaffen and Kales awakenings (R&K); These were defined as a
shift in sleep stage to stage Wake from any sleep stage. By definition
they were longer than 15 seconds in duration.
During pilot studies of sleep fragmentation in normal subjects it was
difficult to produce EMG increases during REM sleep without causing
awakenings lasting longer than 15 seconds. Therefore we omitted any EMG
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criterion for arousal scoring from this definition (no. 4). This approach was
also used by Philip et al (1994) in their study modelling sleep fragmentation,
although it was not specified that their arousal definition was modified for the
above reason.
Figure 3.6: Sample trace of an arousal scored by the sleep fragmentation
definition during REM sleep. A tone was delivered at the mark shown and
produced alpha frequency on the EEG but there was no increase in EMG
activity. 30 seconds of data is shown here.
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3.6 Reliability of Arousal Scoring
This thesis is concerned specifically with sleep fragmentation and for
this reason analysis of the reliability of arousal scoring was essential. Ten
overnight sleep records from normal subjects and 10 from SAHS patients
were selected for analysis. In the normal subjects arousals were rescored
using the sleep fragmentation definition 6 months after their original score. In
the SAHS patients arousals were rescored at least 18 months after their
original score for the Cheshire (1992) definition only. All rescoring was
carried out blind to patient information and previous results. Data from SAHS
patients and normals was combined.
There were no significant differences between the first and second
scores for arousals in normal subjects or SAHS patients.
Score 1 Score 2 p value
Normal subjects 23.9 ±6.3 23.4 ±5.4 0.6
SAHS patients 53.4 ±30.6 48.5 ±21.9 0.3
Combined data 38.7 ±26.2 36.0 ±20.2 0.7
Table 3.1: Data for reliability of arousal scoring. All data are given as arousal
frequencies per hour of sleep ± standard deviation.
Figure 3.7 (a) and (b) demonstrates the error between the 2 sets of arousal
scores. Although figure 3.7a shows that the arousal scores are numerically
close to each other, (b) shows that there are 2 data points which are more
than 20 arousals per hour of sleep different to each other. Both of these are
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Figure 3.7; (a) Scatterplot showing the relationship between the first and
second arousal score. Data points are arousal frequency/ hour of sleep. r=



























20 40 60 80
Mean of 2 scores
100 120
Figure 3.7; (b) Bland and Altman plot demonstrating the error between the 2
arousal scores. The difference between the 2 scores is score 1 - score 2.
Data points are arousal frequencies per hour of sleep.
70
3.7 Fast Fourier Transformation
This technique works on the basis that physiological signals can be
described as a series of sine waves of different frequencies. The underlying
assumption is that EEG amplitude is inversely proportional to frequency, as
EEG frequency (Hz) decreases EEG amplitude (pv) increases. Fast Fourier
Transformation (FFT) calculates the power of the EEG which is equal to the
square of the amplitude.
Raw data was downloaded from the overnight sleep studies using the
facility on the Compumedics Replay version 5.25. The rawdata files were
then entered into the FFT analysis programme and files of transformed data
produced. This FFT analysis was developed by in house computing support
(see acknowledgement) using moving windows of 2 seconds with a
resolution of 1 second. Therefore there were FFT data points generated
every second. Frequency bandwidths could be altered as required, for
example; to investigate the changes in alpha frequency the bandwidth 8-11
Hz could be specified.
This FFT analysis is an improvement on that used by Rees et al
(1995) and Drinnan et al (1996). Both studies performed FFT analysis on
EEG data with windows of 4 seconds. The ability to select different EEG
frequencies in this analysis is again an improvement on that of Rees et al
(1995), who investigated changes in total EEG frequency.
Once the transformed data files were generated a further programme
allowed for selection of peak EEG power within a specified number of
seconds, after specified times. These times were taken from the raw data
and were most likely to be the start times for arousals or the times at which
tones were presented to normal subjects during the sleep fragmentation
studies.
In conclusion there was a large amount of flexibility built into this FFT
analysis of the EEG. FFT is used in chapters 6 and 8.
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3.8 Daytime Sleepiness
Daytime sleepiness was measured objectively using the multiple sleep
latency test (MSLT) (Carskaddon et al 1986, Thorpy 1992) and the
Maintenance of Wakefulness Test (MWT) (Poceta et al 1992) as described
in section 2.2. Subjective daytime sleepiness was measured in normal
subjects using the Stanford Sleepiness Scale (SSS) and the Epworth
Sleepiness Scale (ESS).
On the objective sleepiness tests sleep was monitored using EOG,
EEG and EMG as previously described (section 3.1). For the MSLT normal
subjects lay down in a dark room and were asked to try and sleep for 20
minutes at 10.00, 12.00, 14.00 and 16.00. For the MWT they were seated
upright in bed in a dimly lit room and asked to try to stay awake for 40
minutes at 10.45, 12.45, 14.45, and 16.45. They were not allowed to read or
exercise during the MWT. The naps were terminated as soon as one epoch
of stage 1 sleep was seen during any nap on the MSLT or the MWT. If
subjects did not fall asleep naps were terminated at 20 minutes on the MSLT
or 40 minutes on the MWT. This was to prevent subjects obtaining any
recuperative sleep which may have affected their subsequent daytime
sleepiness. In practice caution was exercised in the termination of these
tests to prevent terminating the test when sleep onset had not truly occurred,
and many subjects may have had a second epoch of sleep prior to
termination of the nap. As suggested in section 2.11.3, there may be a
minimum duration of sleep that is critical for improvement in sleepiness. If
this is as low as 4 minutes, combined with the fact that student subjects are
a notoriously sleepy subject group (Levine et al 1988), then running naps on
the MSLT for 20 minutes may allow these subjects to obtain recuperative
sleep.
In SAHS patients the MSLT was administered at 10am, 12pm, 2pm,
4pm, and 6pm. The naps were terminated 15 minutes after sleep onset,
determined as the time to the first epoch of any sleep stage, or after 20
minutes whichever occurred first (Thorpy 1992). Although it is possible that
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SAHS patients may have obtained recuperative sleep using this protocol,
SAHS patients by definition would have had fragmented sleep, and therefore
any sleep they may have had on the MSLT naps would not have been
restorative.
Subjective daytime sleepiness was measured using the Stanford
Sleepiness Scale (SSS). This is 7 point scale from alert (1) to excessively
sleepy (7) upon which subjects have to assess their instantaneous
sleepiness. This scale was administered at 7am and, in the sleep
fragmentation studies presented in chapters 6 and 7, prior to each nap on
the MSLT. Thus circadian variations in subjective sleepiness were assessed.
3.9 Reliability of MSLT and MWT Scoring
The reproducibility of sleep onset recognition was assessed by
rescoring 48 daytime sleepiness (24 MSLT and 24 MWT) records from
normal subjects at least 3 months after their initial score. Half of the studies
were recorded after an undisturbed night's sleep and the other half came
after a fragmented night. Data from the MSLT and MWT were combined.
Mean sleep onset latency did not change significantly between scores (score
1; 17.2 ± 12.4 (SD), score 2; 17.4 ± 12.4 mins, p=0.2).
The differences between the first and second scores of sleep onset
latency are best demonstrated in figure 3.8 (a) and (b). In (a) all the data
points lie on or close to the line of identity whereas in (b) there are 2
occasions when there are 3 minutes difference between the 2 scores. All
these rescores were inserted as alternative data points in the sleep
fragmentation studies from which they were taken but they had no significant
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Figure 3.8; (a) Scatterplot showing the relationship between the 2 daytime
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Figure 3.8 contd.; (b) Bland and Altman plot showing the error between the 2
scores for mean sleep onset latency on the MSLT and MWT.
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3.10 Mood
Mood was tested using the University of Wales Institute of Science
and Technology (UWIST) mood adjective checklist (Matthews et al 1990),
the General Health Questionnaire (Goldberg and Hillier 1979), the Hospital
Anxiety and Depression scale (Zigmond and Snaith 1983) and part 2 of the
Nottingham Health Profile (Hunt et al 1984).
UWIST mood adjective checklist (UMACL)
This scale consists of 24 adjectives testing three dimensions of mood,
energetic arousal, tense arousal, and hedonic tone. Each dimension consists
of 8 adjectives (table 3.2). Subjects are asked to read the adjectives and rate
whether they are definitely, slightly, slightly not, or definitely not, e.g.sluggish,
at the time. Subjects have to do this for each adjective.









Table 3.2; The adjectives used in each mood dimension on the UWIST
mood adjective checklist.
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Subjects score 1 to 4 points according to the adjective, for example
scoring 'definitely' sluggish gives 1 point and 'definitely not', 4. High scores
are positive for energetic arousal and hedonic tone, and negative for tense
arousal.
General Health Questionnaire (GHQ)
This is a 28 question scale which is divided into 4 subscales; somatic
symptoms, anxiety and insomnia, social dysfunction, and severe depression.
Subjects are asked to relate their answers to how they have been feeling
over the last few weeks. They are asked to answer the questions according
to one of four choices, 2 of which constitute no change from usual, and 2 of
which suggest that subjects feel worse than usual.
Hospital Anxiety and Depression scale (HAD)
This is a 14 item scale which is divided into two seven item subscales;
anxiety and depression. Subjects are asked to read each item and agree
with one of 4 statements, whichever comes closest to how they have been
feeling in the last week. Scores for answers range from 0 to 3 therefore
scores for both subscales range from 0 to 21. Scores of 11 or above for
either subscale were considered clinically significant.
Nottingham Health Profile part 2 (NHP)
Subjects are asked 20 questions relating to 6 areas of their daily lives, work,
jobs around the house, home, social, sex, and hobbies and interests. These
are chosen as they are areas of daily living which may be affected by health
problems. Subjects can answer 'yes' or 'no' to the questions in this scale.
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3.11 Cognitive Function.
Cognitive function was tested in normal subjects and in SAHS patients. The
selected tests reflected a wide range of function and included tests that we
have previously found were sensitive to one month on CPAP therapy in
SAHS patients (Engleman et al 1994a).
Digit Symbol (Weschler 1981)
This is a Performance subtest of the Weschler Adult Intelligence Scale-
Revised battery of tests. The test consists of 93 single digit numbers which
have spaces below them for subjects to complete with pencil drawn symbols
according to a code. The code of symbols corresponding to the numbers is
displayed above the test. The subject has 90 seconds to fill in as many of the
symbols as possible beneath the numbers. The score is the number of
correctly drawn symbols. This tests subjects' coding speed.
Block Design (Weschler 1981)
This is another Performance subtest in the WAIS-R IQ battery. Subjects are
given cubic blocks with which to construct 2 dimensional images displayed to
them. The blocks have 2 sides which are all white, 2 sides all red, and 2
sides diagonally divided into half red and half white. The images displayed to
subjects require either 4 or 9 blocks to construct, and scores are based on
how quickly subjects complete the picture with a time limit on each. There
are 9 images to construct in total. This tests the subject's visuo-spatial ability.
Estimated Performance IQ
This is calculated using scores from the digit symbol and block design tests.
Scores from these tests are scaled as instructed (Weschler 1981). Scaled
scores are then added and the total multiplied by 2.5 to give an approximate
scaled score. This is then translated into a Performance IQ dependent on
age using published tables (Weschler 1981).
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Steer Clear (Findley et al 1988).
This is a vigilance task which lasts for 30 minutes. Subjects sit down in front
of a computer screen upon which there is a bird's eye view of a 2 lane road.
There is a car travelling up the road at a predetermined speed. The subject
has to avoid obstacles which pop up in front of the car, at irregular intervals -
on average 40/ minute - by changing lanes, using the space bar. This test is
monotonous and further tests subjects' ability to remain vigilant by including
periods when no obstacles appear in front of the car.
Trailmaking A and B (Lezak 1983)
This test is part of the Halstead-Reitan neuropsychological test battery. In
part A subjects are shown a page with numbers 1 to 25 displayed on it. They
are then required to join up the numbers in ascending order with a pencil as
quickly as possible. In part B subjects are shown a page with numbers 1 to
13 and letters A to L displayed on it. They are required to join up alternate
increasing numbers and later letters of the alphabet 1-A-2-B etc (figure 3.9,
page 80). Both parts test subjects' tracking speed and psychomotor ability
with part B testing mental flexibility also.
Rapid Visual Information Processing (RVIP) (Petrie and Deary 1989).
Subjects are seated in front of a computer screen in a darkened room. Single
digit numbers from 1 to 8 inclusive flash up in the centre of the screen at the
rate of 1 per 0.6 seconds (100 per minute). Embedded in these random
numbers are sequences of 3 odd or 3 even numbers which subjects have to
recognise by pressing the space bar ('hits'). 'False alarms' are noted if
subjects press the space bar when there was no triplet sequence. There are
8 sequences to be recognised in any minute. The test usually lasts for 10
minutes. RVIP tests stimulus encoding speed and response caution
mechanisms.
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Paced Auditory Serial Addition Test (PASAT) (Lezak 1983)
Subjects listen to a tape of a person calling out single digit numbers either
every 4 or 2 seconds. They are required to add up the last two numbers that
the person calls out and give the answer to the experimenter. There are 61
numbers and, therefore, the subjects can score a maximum of 60. We used
both 4 and 2 seconds parts of the test. This tests subject's attention and
concentration.
Over page for figure 3.9





In all the sleep fragmentation studies described in this thesis sleep
was fragmented with tones. These were generated using an in-house noise
generator which consisted of a control box attached to a loudspeaker. The
loudspeaker was positioned on the headboard of the bed directly above the
subject's head. Arbitrary units were drawn along the volume control position
and these were calibrated against a sound level meter in the Audiology
department of this hospital. The minimum sound generated was 38dB and
the maximum was 101dB. Tone administration in each sleep fragmentation
protocol is described in greater detail in subsequent chapters 5, 6 and 7.
3.13 Pilot Studies
In order to test whether sleep could be fragmented adequately with
sound according to the different sleep fragmentation paradigms pilot studies
were performed in normal volunteers. In these pilot studies various methods
of measuring autonomic activity during sleep were tested, including normal
subject's ability to tolerate the Finapres device for whole or part night studies.
Pilot studies were conducted in 6 (4 men, 2 women) volunteer subjects
recruited from the employees within the Respiratory Medicine Unit and
student population. They were aged 21 (M), 21 (M), 24 (F), 24 (F), 26 (M),
and 34 (M).They slept in the laboratory for one night each only. In addition to
the standard electrode placement, 2 subjects wore the Finapres device, one
subject wore an ear oximeter to measure heart rate, and another subject
wore 3 ECG leads and a finger pulse oximeter to measure pulse transit time.
In two pilot subjects I aimed to fragment their sleep to produce
changes in EEG frequency on the EEG channels. Tones were delivered from
the noise generator described above. For half of each night sleep was
fragmented in a regular fashion every 2 minutes of sleep and for the
remaining half of each night sleep was fragmented in a clustered fashion,
allowing the subject to sleep for an hour and then administering tones every
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30 seconds for half an hour. It was clear that the sleep of both subjects could
be cortically fragmented with tones, with sleep stage and time of night as
factors for determining tone volume and duration as previously described
(Williams et al. 1964). There were however differences between the 2
subjects in the volumes and durations of tones required to produce visible
EEG arousals during the same sleep stages at similar times of night.
Therefore due to subject variability the process of inducing sleep
fragmentation with tones could not be automated.
In the 2 pilot studies where the subjects wore the Finapres the aims
were twofold, to investigate whether normal subjects could tolerate the
Finapres device for whole night studies and to investigate the possibility of
fragmenting sleep using blood pressure changes, without any visible change
on the EEG, as a marker of arousal. During one pilot study night the subject
could not tolerate the Finapres device which was removed after 2 hours of
intermittent sleep. During the second pilot study the subject slept well with
the device switched on for the first sleep cycle, approximately 90 minutes,
but subsequent to this, switching on the device woke the subject easily. In
the first pilot study any tones that I administered to the subject while they
were wearing the Finapres device caused cortical arousals or awakenings. In
the second study sleep was fragmented to induce transient increases in
arterial blood pressure, without any visible cortical arousals, during the first
sleep cycle only. In subsequent sleep cycles sleep was intermittent and if the
subject did stay asleep tones caused cortical arousals or R&K awakenings.
Due to the problems with toleration of the Finapres device, the
possibility of using PTT (as described in section 2.5.2) and heart rate as
markers of autonomic sleep fragmentation was also investigated. The RM50
(Parametric Recorders), a prototype portable sleep study device, which has
PTT as one of its measurements, was tried out as a method of measuring
autonomic activity. PTT can be calculated in real time from the ECG signal
and the pulse oximeter on the finger, provided the device is linked to a PC.
We studied on line PTT during a night of cortical sleep fragmentation and
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found that it was not sensitive enough to indicate transient changes in PTT,
and consequently blood pressure, within the range required.
Heart rate was investigated with an ear oximeter attached to a chart
recorder during a night of cortical sleep fragmentation. There were changes
in heart rate in response to tones that produced cortical arousals, however
this response was too variable to be used alone as a reliable indicator of
visible EEG arousal. Therefore it would not be suitable as an autonomic
marker of arousal in response to tones that did not produce visible EEG
arousals. Parallel processing of the heart rate signal to obtain beat to beat
rather than averaged heart rates may have been of use, however this is not
available on our computerised polysomnography system.
Due to the above problems with monitoring autonomic markers of
arousal from sleep it was decided to use the Finapres device for part of the
sleep study in combination with heart rate as a guideline for the remainder of
the night. The actual fragmentation paradigm for this fragmentation study is
described in further detail in chapter 6.
3.14 Study Design
There were 3 sleep fragmentation protocols which were all based on a
randomised, within subject comparison design.
1. Fragmentation to induce visible EEG arousals.
2. Fragmentation to induce autonomic responses to tones without
inducing visible EEG arousals that could be scored as
microarousals by current definitions.
3. Fragmentation to induce visible EEG arousals in either a regular
fashion or a clustered fashion.
Each study required subjects to spend 2 pairs of 2 nights in the sleep
laboratory. Prior to the first night in the laboratory subjects received
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instructions on the tests of mood and cognitive function that were used in
these studies and had one practice session. The nights were divided into 2
pairs of 2 nights a week apart. The first night of each pair was for
acclimatisation to the laboratory to avoid any "first night effect", and without
which subjects may have had abnormally disrupted sleep. On the second
night of each pair subjects were randomly assigned to having one or other of
the study nights depending on the protocol (figure 3.10).
STUDY DESIGN








MSLT, MWT, Mood, Cognitive Function
Figure 3.10; Schematic diagram of the randomised study design used in the
sleep fragmentation studies.
Subjects spent the day following each pair of nights undergoing
testing of daytime sleepiness, mood and cognitive function. Subjects had
their tests of daytime function tested at similar times on both study limbs to
avoid any circadian variation between assessments.
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3.15 Normal Subject Recruitment
Normal subjects for the sleep fragmentation studies were recruited
from the local student population using advertisements that did not refer to
sleep. Subjects who responded were sent a questionnaire without any
information about the study. This was our in house sleep/ wake
questionnaire which is used to assess patients prior to their attendance at
this sleep laboratory. Subjects with possible sleep disorders were excuded if
they had abnormal sleep hygiene or if their answers on the questionnaire
were symptomatic for SAHS, narcolepsy or PLMS. In addition the
questionnaire includes the Epworth Sleepiness Scale. Subjects were also
excluded if they had Epworth Sleepiness Scores greater than 9, 10 being the
upper limit for normal daytime sleepiness (Johns 1991). The full
questionnaire is given in Appendix 1. Subjects were paid an inconvenience
fee of £90 if they completed all assessments within any one sleep
fragmentation study. They were not allowed to participate in more than one
protocol. Ethical permission was obtained for this study from the Lothian




Comparison and validation of different microarousal definitions in patients
with Sleep Apnoea/ Hypopnoea Syndrome (SAHS).
4.1 INTRODUCTION
Scoring microarousals has recently become more common in clinical
sleep studies particularly when the patient's daytime sleepiness can not be
attributed to sleep apnoea or narcolepsy. The raised microarousal
frequencies seen in some patients who do not have sleep apnoea may be
due to heavy snoring (Guilleminault et al 1991) or increases in upper airway
resistance (Guilleminault et al 1993). The conclusion is that microarousals
cause daytime sleepiness. This is largely due to the finding that upon
application of CPAP therapy, there is a decrease in microarousal frequencies
seen coincident with an improvement in daytime sleepiness, as measured by
the MSLT.
In heavy snorers Guilleminault et al (1991) defined short EEG
arousals as increases in EEG frequency, or EMG tone, or changes in R-R
interval, that did not lead to full awakenings. There was however no
indication of a minimum timescale required for scoring microarousals. In
patients with increased upper airway resistance syndrome Guilleminault et al
(1993) used a stricter definition of microarousal, which was a burst of alpha
lasting for at least 3 seconds.
The original description of sleep apnoea by Gastaut et al (1965, 1966)
includes descriptions of arousals from sleep of different durations that
terminated apnoeas. It is possible to extract indices of sleep fragmentation
from the sleep staging guidelines of Rechtschaffen and Kales (1968) by
scoring the number of stage shifts to wakefulness (section 3.5), or stage
shifts to a lighter sleep stage. This does not allow for the recurrent brief
arousals (less than 15 sees) that are seen in patients with sleep apnoea.
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Phillipson and Sullivan (1978) drew the attention of researchers to arousals
as responses to respiratory events in sleep apnoea. This was an editorial
encouraging researchers in the field to study the mechanisms of arousal
responses and did not give any guidelines as to how to score them. Roth et
al (1980) suggested a more sensitive measure of arousals using an increase
in EMG (leg or chin) for longer than 3 seconds associated with respiratory
events.
Although sleep fragmentation should be measured in as sensitive a
manner as possible it is unclear whether duration of arousals is critical in
contributing to daytime sleepiness. Stepanski et al (1984) approached this by
using a four level arousal scoring system in normal subjects and patients
with sleep apnoea, insomnia and periodic leg movements. Arousals were
scored as: 1. an increase in EEG frequency and EMG amplitude; 2. alpha
burst on the EEG for (a) 0-5 seconds, or (b) 6-29 sees, with accompanying
EMG amplitude increase during REM sleep; 3. stage shift to a lighter sleep
stage; 4. awakening from (a) stage 1 or REM, or (b) stage 2, 3, or 4. They
found that patients with sleep apnoea had more short arousals than
awakenings and that total number of arousals explained 23% of the variance
in objective daytime sleepiness in all subjects. In individual subject groups
there were no significant relationships between arousals and daytime
sleepiness, a fact that the authors attribute to the small amount of variability
in daytime sleepiness within each subject group. Alternatively this may have
been due to the small number of subjects in each group. In answer to the
question of arousal duration there were no significant relationships between
arousals of different durations and daytime sleepiness. There were however
trends for positive relationships between daytime sleepiness and arousals in
patients with sleep apnoea and patients with periodic leg movements, who
suffered from EDS, and for negative relationships in patients with insomnia,
who did not.
Gould et al (1988), in the definition of the sleep hypopnoea syndrome,
defined arousal as an episode lasting at least 1.5 seconds in which there
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was a return to alpha or theta on the EEG associated with an increase in
EMG activity. Cheshire et al (1992) subsequently used this definition to
correlate arousals with daytime sleepiness and cognitive function. In this
same study the arousal definition was re-evaluated to a return to alpha or
theta for at least 1.5 seconds accompanied by any increase in EMG activity,
which showed a better correlation with AHI (r=0.88) than the previous
definition (r=0.63). There was a larger number of significant correlations
between this definition of arousal and cognitive function, and these
relationships were more significant than with the previous definition.
Also in 1992 the Altas Task force of the American Sleep Disorders
Association published guidelines for the scoring of arousals; a return to alpha
or theta frequency on the EEG for at least 3 seconds with an associated 3
second increase in EMG activity during REM sleep. These guidelines are
based on research findings such as Roehrs et al (1991), Guilleminault et al
(1991), Roth et al (1980), and Stepanski et al (1984) that some variance in
daytime sleepiness can be attributed to sleep fragmentation.
The increases in EMG are vital for scoring arousals during REM
sleep. Alpha bursts are common during REM and are generally accepted as
part of the normal pattern of REM sleep and not as arousal phenomena.
Therefore adding a criterion of increases in EMG activity during REM sleep
would guard against erroneous scoring of microarousals. For a similar
reason bursts of EMG activity in the form of muscle twitches are also
accepted as part of normal REM sleep and therefore the EMG cannot be
used on its own as a method of scoring arousals. It can be argued that
during REM sleep alpha bursts could occur accompanied by muscle twitches
by coincidence and result in the erroneous scoring of arousals. This is a
problem regardless of the definition of microarousal.
The bulk of data on microarousal scoring comes from patients with
sleep apnoea and sleep disordered breathing. It is unclear what constitutes a
normal arousal frequency using any of these definitions. Mathur and Douglas
(1995b) compared 3 definitions of microarousal (ASDA, mASDA, and
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Cheshire), and stage shifts to wakefulness for their relative frequencies in a
group of control subjects ranging in age from 16 to 74. This group of subjects
had 21 ASDA arousals and 14 Cheshire arousals per hour of sleep. Although
this may seem high, the upper 95% confidence interval of 56 ASDA and 55
Cheshire arousals per hour of sleep was more surprising. These figures were
not altered by the exclusion of those subjects who were over 60 years of
age, had snoring, daytime sleepiness, or witnessed apnoeas, or who had
less than 4 hours of sleep on their polysomnography night. The authors
attributed these results in part to the invasive nature of polysomnography
which would bias subjects towards having poor quality sleep, however it
remains that normal subjects can have profoundly fragmented sleep on the
first night of polysomnography.
Scoring microarousals is a more sensitive estimate of sleep
fragmentation in SAHS patients than conventional sleep staging (Stepanski
et al 1984). There is however no agreement on which microarousal definition
is the definition of choice for use in routine clinical sleep studies as different
definitions correlate significantly with daytime function (Roth et al 1980,
Roehrs et al 1989, Cheshire et al 1992). Although high microarousal indices
may cause daytime sleepiness results from single night polysomnography
studies in normal subjects suggest that the upper limit of normal is
surprisingly high.
Therefore 3 definitions of microarousal and 1 of arousal (>15 sees)
were compared for their frequencies in SAHS patients, their presence at the
termination of apnoeas and hypopnoeas and for their relative abilities to




Subjects were recruited from patients referred to the sleep laboratory
with suspected sleep apnoea who lived within 50 miles. They had to have 2
or more symptoms of sleep apnoea and an AHI > 5 per hour of sleep on an
overnight polysomnography prior to being invited to take part in this study. A
consecutive series of 63 patients (55 men) were recruited. Group mean data
shows that they were relatively obese and most had some degree of daytime
sleepiness as shown by their Epworth sleepiness scores (Johns 1993) (table
4.1).
n 63 (55 men, 8 women)
Age (years) 49 SD 10
BMI (kg/m") 31 SD 8
AHI per hour of sleep 36 SD 31
ESS (0 to 24) 12 (range 5 to 19)
Table 4.1; Descriptive data for the study sample. BMI; body mass index. AHI;
apnea/ hypopnea index. ESS; Epworth Sleepiness Score.
Protocol
Subjects had full overnight polysomnography according to our
standard procedures (Douglas et al 1992). EEG, EOG, submental EMG,
anterior tibialis EMG, thoracoabdominal movement, oro-nasal airflow and
oxygen saturation were recorded as described in section 3.1 onto a 16
channel polygraph (SLE) at 10 mm/ second paper speed giving epochs of 30
seconds. Sleep and respiratory events were scored according to standard
criteria (see sections 3.3 and 3.4). A single polysomnographer scored sleep
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fragmentation with 3 microarousal definitions and 1 definition of awakening.
Separate passes through each overnight study were made for each
definition. Data for test-retest reliability of microarousal scoring for this
experimenter are presented in section 3.6. Subjects had assessment of
subjective and objective daytime sleepiness, mood and cognitive function
within 6 months of the original polysomnography night. Subjects did not have
CPAP therapy in the intervening period between polysomnography and
daytime function testing.
Arousal Definitions
There were 3 definitions of microarousal employed in this study:
ASDA, mASDA, Cheshire; and 1 definition of awakening; R&K awakening.
They are described in greater detail in section 3.5. It was also noted whether
microarousals were associated with apnoeas or hypopnoeas. A microarousal
was defined as being associated with an apnoea or hypopnoea if it occurred
within 10 seconds of the termination of the respiratory event. Total
microarousal frequencies could therefore be divided into microarousals
occurring spontaneously and microarousals occurring in association with
respiratory events.
Daytime Function
Objective daytime sleepiness was assessed using the MSLT performed as
described in section 3.8. Subjective daytime sleepiness was assessed in a
subgroup of 30 subjects using the Epworth Sleepiness Scale (Johns 1991).
Mood and psychosocial function was assessed using the HAD scale
(Zigmond and Snaith 1983), the NHP part 2 (Hunt et al 1984), and the GHQ-
28 (Goldberg and Hillier 1979) (section 3.10). Instantaneous mood was
assessed using the UWIST mood adjective checklist (Matthews et al 1990)
as described in section 3.10. Cognitive function was assessed using Digit
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Symbol, Steer Clear, and Trailmaking B as described in section 3.11.
Engleman et al (1994b) previously found that these mood scales and
cognitive function tests showed significant improvements in SAHS patients
after one month on CPAP therapy.
Statistical Analysis
Frequency tables for all variables were drawn up and examined for
normality. The nocturnal variables; AHI and arousal frequencies, were
skewed and therefore non-parametric statistical tests were used to analyse
these data. Comparisons of arousal frequencies were made using the
Wilcoxon matched pairs test with Bonferroni corrections for multiple
comparisons where appropriate. Relationships between nocturnal variables
and daytime sleepiness were investigated using Spearman correlation
coefficients. Interrelationships between microarousal frequencies were
investigated using Pearson correlation coefficients.
There were a large number of daytime function variables to enter into
a correlation matrix with nocturnal variables. This could lead to problems with
multiple comparisons and increases the likelihood of finding significant
relationships between nocturnal and daytime variables by chance. In a set of
measurements where there is redundancy among the measured variables,
principal components analysis (PCA) is a useful technique to reduce the
number of outcome measures. There were significant interrelationships
between outcome measures on the mood scales and therefore PCA (Child
1990) was used to reduce the number of mood variables. In a similar fashion
there were significant interrelationships between outcome measures on the




There were significantly more total microarousals per hour of sleep by
any definition than R&K awakenings. There were significantly more mASDA
and Cheshire microarousals than ASDA microarousals (both p<0.001) but
there was no significant difference between the number of either 1.5 second
definitions-Cheshire and mASDA (p>0.7). There were significantly more
spontaneous microarousals by any definition than R&K awakenings. There





with A or H
total
ASDA 12 ± 1* (40 ± 3%) 27 ± 3** 39 ± 3**
mASDA 14 ± 1 (41 ±3%) 29 ±3 43 ±3
Cheshire 14 ± 1 (41 ±3%) 29 ±3 43 ± 3
R&K 4 ± 1** (44 ± 4%) 6 ± 1** 10 ± 1**
Table 4.2; Mean ± SEM (with percentages where appropriate) number of
spontaneous arousals, arousals associated with respiratory events and total
arousals per hour of sleep scored by each definition. A+H;
apneas+hypopneas, ** p<0.0001 significantly different to all other definitions.
* p<0.01 ASDA significantly different to Cheshire.
Significantly more respiratory events were terminated by
microarousals than by R&K awakenings (all p<0.001) (table 4.2). More
apneas and hypopneas were terminated by 1.5 second microarousals than
by ASDA microarousals (both p<0.001) but there was no significant
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difference between either 1.5 second definition (p>0.7) (table 4.2). The
percentage of respiratory events that were terminated by arousals of
different definitions is shown in table 4.3.
ASDA mASDA Cheshire R&K
75 ±4 83 ±4 81 ±4 18 ± 1
Table 4.3; The mean ± SEM percentage of apnoeas and hypopnoeas that
terminated in the various different arousals.
Microarousal frequencies were all significantly correlated with AHI and
with each other although the r values for relationships between ASDA,
mASDA and Cheshire arousals were higher than with R&K awakenings.
ASDA mASDA Cheshire R&K
AHI 0.84 0.83 0.82 0.59
ASDA 0.97 0.94 0.79
mASDA 0.98 0.78
Cheshire 0.77
Table 4.4: Interrelationships between AHI and arousals scored by the
different definitions. All p<0.0001.
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The relationships between AHI and microarousals are similar to that
found by Cheshire et al (1992) (figure 4.1). It is interesting to note that in
patients with AHI < 20 per hour of sleep, all the microarousal frequencies are

























p = 0.84, p< 0.0001
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Figure 4.1: Scatterplot demonstrating the relationship between AHI and
ASDA microarousal frequencies. Line of Identity.
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Correlation with Daytime Function
There was no significant relationship between objective daytime

















p =0.01, p=0.5, n=30
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Figure 4.2; Scatterplot showing the relationship between objective (MSLT)
and subjective (ESS) daytime sleepiness.
Apneas and hypopnea frequency correlated significantly with mean
























p = -0.30, p=0.01
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Figure 4.3; Scatterplot showing the relationship between daytime sleepiness
on the MSLT and AHI.
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There was a significant but weak relationship between microarousals
scored by any definition and mean sleep onset latency (all p > -0.22, all p <
0.04) (figure 4.4). There was no significant relationship between R&K
awakenings and mean sleep onset latency (p = -0.04, p=0.4). Stepwise
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mASDA arousals/ hour slept
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Figure 4.4; Scatterplot showing the relationships between ASDA (a) and
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Figure 4.4 contd.; Scatterplots showing relationships between Cheshire (c)
microarousal frequency and R&K awakenings (d), and daytime sleepiness on
the MSLT.
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There were no significant relationships between arousals scored by
any microarousal definition and subjective daytime sleepiness (all p <0.1, p
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ASDA Arousals/ hour slept
140 160
Figure 4.5; Scatterplot showing the relationship between ESS and ASDA
microarousal frequency. Relationships between other arousal definitions and
ESS were similar.
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Outcome measures from GHQ-28, HAD; anxiety and depression,
NHP pt 2, and UMACL; energetic arousal dimension, were entered into
principal components analysis. One factor with an eigenvalue greater than 1
was extracted which accounted for 71% of the total variance of all these
mood scales. Scores for each subject on this factor were saved as an extra
variable and correlation analysis performed between it and the arousal
definitions. There were no significant relationships between mood factor
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ASDA arousals per hour of sleep
Figure 4.6; Scatterplot showing the relationship between ASDA
microarousals and the mood factor score. Relationships were similar for all
other microarousal definitions.
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Baseline scores from the Digit Symbol substitution, Trailmaking B, and
Steer Clear performance tests were entered into principal components
analysis. One factor was extracted which accounted for 75% of the total
variance of these test scores. These factor scores were then correlated with
arousal frequencies scored by the different definitions. There were no
significant relationships between arousal frequencies and the cognitive
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Figure 4.7; Scatterplot showing the relationship between ASDA microarousal
frequency and cognitive factor scores.
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4.4 DISCUSSION
This study confirms the finding of Rees et al (1995) that not all apneas
and hypopneas are terminated by visible microarousals. In addition more
respiratory events are terminated by 1.5 second microarousals than by 3
second microarousals. In contrast to Cheshire et al (1992) but similar to
Roehrs et al (1989) there were significant but weak relationships between
AHI and objective daytime sleepiness, and microarousals and objective
daytime sleepiness. In contrast to Johns (1993) there was no relationship
between severity of sleep apnea and subjective sleepiness. Furthermore this
study has confirmed the finding of Kingshott et al (1995) that there is no
relationship between Epworth sleepiness scores and microarousal
frequency.
The interrelationships between microarousal definitions are all greater
than r=0.94 indicating that the differences between individual definitions are
stable across all 3 microarousal definitions. Refinement of the ASDA
guidelines to a shorter duration of 1.5 seconds significantly increased the
number of respiratory events terminated by microarousals from 75% to 83%.
Mathur and Douglas (1995) have previously tried to manually score
microarousals by shortening the duration criteria to less than 1.5 seconds but
found that this introduced methodological difficulties in the confusion of sleep
spindles for increases in EEG frequency. Rees et al (1995) had a shorter
duration for microarousal scoring of 1 second. It is unlikely that this slightly
shorter duration increased the likelihood of scoring arousals as a greater
percentage of respiratory events were not terminated by arousals in their
study (30%) compared with this study (25 to 17%). Rees et al (1995) only
used data from stage 2 sleep which may have had some effect on their
results. The slightly increased percentage of respiratory events terminated by
1.5 second ASDA arousals suggests that this maybe the most clinically
relevant definition to use.
All three microarousal frequencies correlated significantly with AHI
with p values similar to each other and to that of Cheshire et al (1992).
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Although the 3 second ASDA definition had a slightly stronger association
with AHI than either 1.5 second definition, the nature of the relationship was
similar in each case. The scatter of data points in Figure 4.1 is towards mild
SAHS patients having more spontaneous arousals that are not associated
with respiratory events, and those more severe cases of sleep apnoea
having less arousals than respiratory events. The finding of Rees et al of
30% of respiratory events not terminated by arousal may have been due to
their subject sample including more severe SAHS patients.
Seventeen percent of apneas and hypopneas were not terminated by
visible microarousals suggesting that more sophisticated analyses of the
EEG signal are required to truly assess sleep fragmentation in patients
referred to sleep laboratories complaining of daytime sleepiness. Rees et al
(1995) used Fast Fourier Transformation of EEG signals and found that
median EEG frequency increased significantly from the first half of an apnea
to the second half of an apnea even if that event did not terminate in a visible
cortical arousal. Davies et al (1993) using an artificial neural network, found
EEG changes in normal subjects in response to auditory/ vibratory stimuli
that were not visible to the human eye.
Alternatively non-EEG techniques may be more useful in determining
fragmented sleep. Rees et al (1995) found that the chemical and mechanical
stimuli to terminate an apnoea are similar regardless of whether the event is
terminated by a visible EEG arousal or not. In addition respiratory events are
terminated by transient increases in blood pressure whether or not there are
coincident cortical arousals (Rees et al 1995, Shepard 1986). Recording
blood pressure by digital infrared plethysmography (Finapres 2300, Ohmeda)
is the current method of choice for measurement of sub-cortical arousals
however it is cumbersome and poorly tolerated. Recently Pitson et al (1994)
have investigated pulse transit time (PTT), which is inversely proportional to
blood pressure, as a marker of arousal in normals, and of inspiratory effort in
patients with sleep apnea (Pitson et al 1995). In the 1994 study Pitson et al
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found that there were significant changes in PTT in response to tones that
did not cause "any discernible change" on the EEG.
The concept of measuring arousals by a technique not dependent on
EEG is attractive however it is uncertain whether arousals such as those (Oa)
described by Davies et al (1993) and Pitson et al (1994) have an impact on
daytime function. Although respiratory events that do not terminate in visible
EEG arousals, do terminate in blood pressure rises and increases in EEG
frequency preliminary results from Sahloul et al (1995) suggest that arousals
detectable by blood pressure rises alone may not have any impact on
daytime sleepiness. This question is addressed further in chapter 6 of this
thesis.
Patients with increased upper airway resistance (Guilleminault et al
1993) and heavy snoring (Guilleminault et al 1991) associated with cortical
arousals are less sleepy during the day after one night on CPAP. These
patients had been identified by their high cortical arousal indices which were
significantly reduced with CPAP therapy. Although the 1.5 second definitions
score more microarousals that the 3 second definition neither 1.5 second
definition has a markedly more significant relationship with daytime
sleepiness. This is as anticipated as all 3 microarousal definitions are scoring
similar numbers of events. Furthermore neither mood nor cognitive function
correlated with any microarousal definition. This is in contrast to the results
of Cheshire et al (1992) who found in a smaller study that 3 measures of
cognitive function were significantly correlated with microarousal frequency. It
should be added however that these were not the same cognitive function
tests that were used in this study. The disparity of results between these two
studies may be due to the inclusion of mild sleep apnoea patients (AHI< 15)
in this study although Engleman et al (1997) has shown that mild SAHS
patients show objective benefit in mood and cognitive function after 1 month
on CPAP therapy. In particular the mild SAHS patients who complied well
with CPAP (more than 3 hours per night) had twice as many microarousals
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per hour of sleep on their diagnostic polysomnography than those who did
not comply well with CPAP.
The lack of routine measurement of Davies et al (1993) and Pitson et
al's (1994) Oa arousals may account for the consistently poor relationships,
found in this and other studies (Guilleminault et al 1988, Roehrs et al 1989,
Cheshire et al 1992), between daytime sleepiness and severity of sleep
fragmentation. A further source of error may be in the site of EEG
measurement. Sleep studies usually measure EEG from central sites on the
scalp (Rechtschaffen and Kales 1968). Preliminary evidence from O'Malley
et al (1996) suggests that more respiratory events may be associated with
microarousals scored from frontal EEG scalp sites. They found that 96% of
respiratory events were terminated by EEG arousals scored from frontal
EEG channels compared with 73% of respiratory events terminated by
arousals scored at the central sites. In order to further investigate this
question frontal EEG was measured in normal subjects undergoing sleep
fragmentation in chapter 6 of this thesis.
In conclusion 1.5 second microarousal definitions provide the best
visual measure of the sleep disruption resulting from respiratory events and
the 1.5 second ASDA definition may be clinically most useful. This should be
qualified however by suggesting that none of these definitions are adequate
in predicting deficits in daytime function in patients with SAHS.
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Chapter 5
The Effect of Cortical Sleep Fragmentation on Daytime Function.
5.1 INTRODUCTION
Patients with the sleep apnea/ hypopnoea syndrome (SAHS) suffer
from impaired daytime function (Roth et al 1980, Greenberg et al 1987,
Cheshire et al 1992, Naegale et al 1995). They are severely sleepy during
the day as measured by the MSLT (Dement et al 1978, Roth et al 1980) and
they suffer from impaired cognitive function compared to age and
educationally matched controls (Greenberg et al 1987, Neagale et al 1995).
Cheshire et al (1992) and Millman et al (1989) previously found that SAHS
patients had scores in the clinically significant range for anxiety and
depression on the HAD scale and the Zung self rating depression scale
respectively. Furthermore Kribbs et al (1993) found that both mood and
daytime sleepiness, which had improved after CPAP therapy, had returned
to pretreatment levels during the day after one night off CPAP.
The nocturnal sequelae of apneas and hypopnoeas in SAHS patients
are recurrent drops in oxygen saturation and frequent sleep fragmentation in
the form of short (<15 seconds) microarousals (Cheshire et al 1992, ASDA
1992). There is controversy (Roth et al 1980, Greenberg et al 1987,
Guilleminault et al 1988, Roehrs et al 1989, Bedard et al 1991a, Cheshire et
al 1992) as to which of these is the cause of the daytime sleepiness and
cognitive dysfunction seen in patients with SAHS.
Excessive daytime sleepiness in SAHS patients was best predicted by
the level of nocturnal sleep disturbance (Guilleminault et al 1988) and sleep
fragmentation (Roth et al 1980, Roehrs et al 1989). However Bedard et al
(1991a) found that daytime sleepiness was predicted by severity of nocturnal
hypoxemia whereas Cheshire et al (1992) found no relationship between
daytime sleepiness and nocturnal hypoxemia or sleep fragmentation. In a
similar fashion cognitive dysfunction in SAHS patients has been related to
both their nocturnal hypoxemia (Greenberg et al 1987, Bedard et al 1991b,
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Cheshire et al 1992, Neagale et al 1995) and their sleep disruption/
fragmentation (Bedard et al 1991b, Cheshire et al 1992).
Unfortunately the magnitude of sleep disruption and the extent of
oxygen desaturation in SAHS patients are interrelated (Cheshire et al 1992)
confounding attempts to determine in SAHS patients what specifically
causes daytime dysfunction. Sleep disturbance in normal subjects causes
increased daytime sleepiness (Bonnet 1985), and impaired mood and
altered cognitive function (Bonnet 1987). However these studies had
decreased total sleep time on the disruption nights compared with baseline,
and they did not all mimic the short repetitive microarousals found in SAHS
patients. Therefore the hypothesis tested in this study is that sleep
fragmentation causing repetitive visible EEG microarousals may lead to the




Eighteen subjects started the study, and 2 subjects dropped out
midway, one man due to his inability to sleep in the laboratory environment,
and one woman for personal reasons. Sixteen subjects completed the study.
They had a mean age of 24 (SD 3) years, were all non-obese (BMI; 23 SD 3
kg/m^) and had Epworth sleepiness scores (Johns 1991) within the normal
range (median 4, range 0 to 9).
Protocol
The study was designed as described in section 3.14. In this sleep
fragmentation protocol the second night of each pair of nights was either an
undisturbed night's sleep or subjects had their sleep fragmented with tones
to cause visible EEG arousals that could be scored by the sleep
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fragmentation definition described in section 3.5. The order of conditions was
randomised with 8 subjects having the fragmented limb first and 8 having the
undisturbed limb first.
Subjects were allowed to reach stage 2 sleep, every 2 minutes after
which the duration and volume of tones was varied to try to produce a similar
microarousal response after each tone; i.e. a return to alpha or theta rhythm
for longer than 3 seconds but, where possible, not longer than 15 seconds
on the EEG channels. If this response was achieved, the 2 minute intertone
interval began from the reappearance of stage 2 sleep defined as the first
occurrence of a well defined K complex or sleep spindle. If a microarousal
response did not occur on the first tone 10 seconds were allowed to elapse
before repeating with a louder and/ or longer tone. Minimum tone volume
was 38dB, and minimum tone duration was 0.28 seconds.
Lights out on all nights was standardized to 11 pm and the study time
finished at 6.30 am on all nights except on the fragmented study night when
study time was extended by 20 minutes in all subjects regardless of previous
sleep quality to allow for any possible sleep loss due to the fragmentation.
Fragmentation continued throughout this extra 20 minutes.
The arousal frequency consisted of, the number of microarousals
scored according to the Sleep Fragmentation definition plus the number of
R&K awakenings (section 3.5) per hour of time slept. Arousals were further
divided into durations of 3-5 seconds, 5-10 sees, 10-15 sees and 15+ sees (if
not scored as a stage shift to wakefulness).
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Daytime Assessment
The daytime function testing schedule was as follows;
7am to 9am; Stanford Sleepiness Scale (Hoddes et al 1973).
UWIST mood adjective checklist (Matthews et al 1990)
WAIS-R subtests- Digit Symbol substitution, Block Design
Trailmaking A and B
Steer Clear
RVIP
PASAT at 4 and 2 seconds.
10am, 12pm, 2pm, 4pm; UWIST mood adjective checklist + MSLT
10.45am, 12.45am, 2.45pm, 4.45pm; MWT
Statistical Analysis
Paired data were analysed using a mixed two-way analysis of
variance (SPSS-PC+) for repeated measures with study night as a within
subjects effect and order of conditions as a between subjects effect. The
only test with a significant order effect was the Stanford Sleepiness Scale
This variable was therefore analyzed as suggested by Hills and Armitage




There was no significant difference in total sleep time (TST) between
the undisturbed and fragmented study nights, however, there was a trend
towards a greater percentage of time awake on the fragmented night
(p=0.06) (table 5.1). There was a significant general shift towards lighter
sleep on the fragmented night, with significantly more stage 1 (p<0.02) and
stage 2 (p<0.001) sleep and significantly less SWS (p<0.001) and REM
(p<0.02) sleep (table 5.1).
Undisturbed Fragmented p value
TST (mins) 400 ± 20 396 ± 24 0.6
Wake (SPT) % 8.0 ± 3.9 11.2 ± 5.8 0.06
Stage 1 % 3.2 ±2.0 5.4 ±2.5 0.02
Stage 2 % 42.9 ±7.1 59.3 ±6.7 0.0001
SWS % 29.1 ±11.2 15.4 ±9.1 0.0001
Stage REM % 23.0 ±5.0 19.1 ±3.3 0.02
Table 5.1; Comparison of sleep architecture between study nights. Values




There was a mean of 183 SD 20 tones presented to subjects during
the fragmented night of which a mean of 82 ± 8% resulted in arousals. While
18% of tones failed to produce arousals between 3 and 15 seconds in
duration, 10 + 4% of tones caused R&K awakenings. The maximum tone
volume used to produce a visible EEG arousal in any subject was 100dB and
the maximum duration was 13 seconds.
Fragmentation more than doubled the arousal frequency (p=0.0001)
(table 5.2). There were significantly more R&K awakenings per hour of sleep
on the fragmented night than on the undisturbed night. There were
significantly more arousals per hour slept of any duration on the fragmented
night (all p<0.01) (table 5.2). On the fragmented night 31% of arousals were
less than 5 seconds in duration compared to 25% on the undisturbed night.
Furthermore 68% of arousals were less than 10 seconds in duration on the
fragmented night compared to 55% on the undisturbed night.
Duration (sees) Undisturbed Fragmented p value
3-5 3.8 ±2.6 10.9 ±3.8 0.0001
5-10 4.7 ± 1.7 12.3 ±2.2 0.0001
10-15 1.9 ± 1.7 3.5 ±1.7 0.002
15+ 1.0 ±0.6 1.9 ±1.2 0.0001
R&K 4.1 ± 1.1 5.7 ± 1.9 0.01
Total arousal
frequency
15.5 ±3.7 34.3 ±5.0 0.0001
Table 5.2; Comparisons of arousal frequencies/ hour slept of different
durations between study nights. Values are mean ± SD.
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Daytime Sleepiness
There were significant decreases in mean sleep onset latencies on
the MSLT (undisturbed; 11 ± 3, fragmented; 7 ± 2 mins) (figure 5.1a) and the












































Figure 5.1; Individual paired point graphs for mean sleep onset latencies on
MSLT (a) and MWT (b) for both study nights. Single points are mean ± SD
for all subjects.
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On the MSLT there were significant decreases in individual naps at
10.00, 12.00 and 16.00 after fragmentation (figure 5.2a). On the MWT there
were significant decreases in naps at 12.45, 14.45 and 16.45 after
fragmentation (figure 5.2b).
(a)
10.00 12.00 14.00 1 6.00




1 0.45 12.45 1 4.45 16.45
Time of Day (24hrs)
Figure 5.2; Sleep onset latencies for individual naps on the MSLT and MWT.
Values are expressed as mean ± SD for each time of day. * p<0.05, **
p<0.01, ***p<0.001. —•— undisturbed, — O—; fragmented.
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There was no change in subjective sleepiness on the SSS after
fragmentation (p=0.8).
Mood
In addition to individual scores on the UMACL the mean of the 5
assessments was calculated for each dimension. The mean energetic
arousal score (undisturbed; 22 SD 4, fragmented; 19 ± 4, score range 8 to
32; p<0.001) and the mean hedonic tone score (undisturbed; 29 ± 4,
fragmented; 27 ± 4; p=0.05), were significantly lower after fragmentation.
Fragmentation did not affect mean tense arousal scores (undisturbed 11 ± 3,
fragmented 11 ± 3, p=0.3). The individual energetic arousal scores were
significantly lower after fragmentation at all times except 12pm (figure 5.3a).
Individual hedonic tone scores were significantly lower after fragmentation at
10am (undisturbed; 30 SD 3, fragmented; 27 ±4, p=0.005) only (figure 5.3b).
The individual tense arousal scores were increased after the fragmentation
night at 8am (undisturbed; 11 SD 3, fragmented; 13 ± 3; p=0.01) and 10am





















































08.00 10.00 12.00 14.00 16.00
Time of Day (24 hr)
Figure 5.3; (a) Individual Energetic Arousal, (b) Hedonic Tone and (c) Tense
Arousal scores for both test days. Values are mean + SD.
undisturbed, - - -O- - - fragmented. * p<0.05, ** p<0.01, *** p<0.001.
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Cognitive Function
Subjects had a significantly slower time to complete the Trailmaking B
task (p=0.05) (figure 5.4) and scored significantly fewer correct additions on
the PASAT 4 second test (p<0.03) after the fragmented night (table 5.3). No
other cognitive variables were altered significantly by sleep fragmentation
(table 5.3).
COGNITIVE TEST Undisturbed Fragmented p value
Digit Symbol 76 ± 11 76 ± 11 0.5
Block Design 45 ±6 45 ±6 1.0
Est. PIQ 132 ± 16 131 ± 15 0.9
Steer Clear hits 31 ± 16 36 ± 19 0.3
RVIP hits 47 + 7 46 ± 10 0.8
RVIP misses 6 ± 13 2 ±2 0.2
Trailmaking A (sees) 20 ±6 19 ±4 0.5
Trailmaking B (sees) 40 ± 14 43 ± 10 0.05
PASAT 4 sec 59 ±2 58 ±3 0.03
PASAT 2 sec 48 ±9 49 ±8 0.8
Table 5.3; Mean ± SD for cognitive outcome measures after both study
nights. Est PIQ; estimated performance IQ, RVIP; rapid visual information















Figure 5.4; Paired point graph showing individual data points for scores on
the Trailmaking B test after the undisturbed and fragmented study nights.
Single points are mean ± SD for all subjects.
5.4 DISCUSSION
This study confirms recent findings by Philip et ai (1994) and Roehrs
et al (1994) that one night of sleep fragmentation with short arousals causes
increased objective daytime sleepiness. In addition this study demonstrates
that sleep fragmentation causes decrements in the mood and cognitive
performance of normal subjects. This sleep fragmentation design improves
on previous studies, which did not include an acclimatization night to the
laboratory (Philip et al 1994, Roehrs et al 1994), or a randomised control
undisturbed night (Bonnet 1987, Roehrs et al 1994). Previous studies by
Bonnet (1985, 1986b, 1987) have induced longer and more marked arousals
than often occur in SAHS, with a subsequent decrease in total sleep time.
This study also improved on the daytime assessments of the aforementioned
studies as Bonnet (1985, 1986b, 1987) investigated daytime sleepiness with
one morning nap only whereas the full MSLT was used in this study, none of
the above studies assessed daytime sleepiness with the MWT, and the
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studies by Roehrs et al (1994) and Philip et al (1994) did not look at the
effects of fragmentation on mood.
Subjects in this study became sleepier after fragmentation than in
previous studies (Roehrs et al 1994, Philip et al 1994) and in this study
subjects' ability to stay awake was also impaired. The instruction to "stay
awake" without stimulation mimics more closely daytime situations in which
the excessively sleepy patient may find themselves, trying to keep
themselves awake, and thus the MWT may give more relevant clinical
information than how quickly the patient falls asleep. These results show that
after a single night of sleep fragmentation normal subjects have similar
difficulty in staying awake as untreated SAHS patients (Poceta et al 1992,
Sangal et al 1992a). Clearly SAHS patients may clinically respond differently
to normal subjects with a similar degree of objective daytime sleepiness. For
example their ability to alert themselves may be affected by years of
experience of sleepiness.
Sleep fragmentation impaired performance in 2 tests; Trailmaking B,
testing mental flexibility and attentional capacity, and PASAT 4 sec, a
sustained attention task. Thus sleep fragmentation is probably affecting
attention. A previous study from this laboratory found both these measures
to be improved by treatment in SAHS patients (Engleman et al 1994a).
Bonnet (1985) found that 2 nights of sleep disruption (not fragmentation)
decreased performance on a simple reaction time task, the Wilkinson
addition task and digit symbol substitution. However total sleep time was
significantly reduced by an hour which may have accounted for the changes
in daytime function found in this study. In further studies Bonnet (1986b,
1987) found that the Wilkinson addition task only was impaired after sleep
disruption.
In contrast to results in this study however, the studies of Roehrs et al
(1994) and Philip et al (1994) which induced short arousals similar to those
seen in SAHS patients found no change in performance after fragmentation.
They did not use either Trailmaking B or PASAT but had selected tests for
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their monotonous quality. Steer Clear (30 minutes) was used in this study to
assess vigilance and there was no change in performance. It appears that
normal subjects can overcome the effects of sleep fragmentation on such
monotonous tasks. Wilkinson (1965) demonstrated that performance after
sleep deprivation is most likely to be impaired on monotonous tasks and that
normal subjects can upregulate their function to baseline on short complex
tasks. In particular Wilkinson (1965) demonstrated that performance over the
first five minutes of a simple reaction time test remains similar to baseline
even after 60 hours of sleep deprivation. The daytime function tests in this
study which were altered after sleep fragmentation are short complex tasks.
Trailmaking B is subject paced, and the mean duration to completion was
less than 45 seconds after either study night. The PASAT 4 second test is
experimenter paced and lasts for 4 minutes. These results suggest that
sleep fragmentation may impair cognitive function in a different manner to
sleep deprivation. These decrements, similar to those found in SAHS
patients, may not be a result of increased daytime sleepiness after sleep
fragmentation but may be due to functional impairment of cognitive
processing pathways. This is in contrast to the suggestion by Bedard et al
(1991b) that sleep fragmentation causes daytime sleepiness and that it is
this increased sleepiness that explains some of the variance in decrements
of cognitive function in SAHS patients.
Alternatively these decrements in cognitive function tests may be due
to a type 1 statistical error, due to the number of comparisons that were
made. Although there may be some redundancy within the cognitive function
measures used in this study the aim of this study was to model the sleep
fragmentation found in SAHS patients. Studies of daytime function in SAHS
patients (Greenberg et al 1987, Naegale et al 1995, Engleman et al 1994a)
used individual cognitive tests to describe deficits and therefore individual
analyses were used in this study in order to make them comparable.
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In this study one night of fragmentation resulted in energetic arousal
scores in normal subjects similar to those of untreated SAHS patients
(Engleman et al 1994a). Decrements in energetic arousal after fragmentation
mirror the decreases seen on the individual MSLT and MWT naps
suggesting that the energetic arousal dimension of mood maybe a subjective
indicator of objective daytime sleepiness. Totterdell et al (1994) found that
self reported sleep quality and number of awakenings correlated significantly
with scores on the energetic arousal dimension of mood. Mood is most
susceptible to an external stress in the early part of the day as demonstrated
by the global changes in mood at 10am after fragmentation. Sleep
deprivation has similar global effects on mood (Matthews et al 1990). These
results suggest that sleep fragmentation is as detrimental to mood as sleep
deprivation. These mood results also agree with the theory of Thayer (1989)
that arousal has its basis in biological systems and can therefore be
manipulated using sleep fragmentation (see section 2.3).
In this study the arousal frequency during the fragmented night was
similar to that seen in untreated SAHS patients (Greenberg et al 1987, Gould
et al 1988). The arousal frequency, even when altered for spontaneously
occurring arousals from sleep was still greater than that of Roehrs et al
(1994) whereas Philip et al (1994) refer to the number of stimulations during
the fragmented night but do not give data as to the number of arousals.
The decrements in daytime function found in this study may be due to
the small, but significant changes in sleep architecture on the fragmented
night. Philip et al (1994) found a significant relationship between nocturnal
slow wave sleep (SWS) and mean sleep latency on the MSLT but did not
examine the relationship with arousal frequency. Furthermore there were 2
data points for each subject which artefactually increases the power of the
regression analysis. Bonnet (1986a) found that daytime sleepiness on a
single (MSLT like) morning nap was similar after 2 limbs of equal amounts of
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sleep disruption but with one limb manipulated to eliminate SWS. Thus
presence or absence of SWS did not impact on daytime sleepiness given
equal amounts of sleep disruption. This should however be interpreted with
caution due to the lack of a full MSLT.
These results have implications for the diagnosis and treatment of
patients with sleep disordered breathing especially those with low AHI (AHI <
15) and no nocturnal hypoxemia. Results from chapter 4 show that for
patients with and AHI less than 20 per hour of sleep the arousal frequency is
higher than the AHI. Further to this an elevated microarousal index may be
the only indicator of a milder form of sleep disordered breathing which may
be mis-diagnosed as idiopathic hypersomnolence (Guilleminault et al 1993).
These results show that an elevated microarousal index alone may lead to
impairments of daytime function.
This study shows that a single night of sleep fragmentation to induce
visible EEG arousals can cause increased objective daytime sleepiness and




The effect of non-visible (autonomic) sleep fragmentation on daytime
function.
6.1 INTRODUCTION
Apnoeas and hypopnoeas can be terminated by intermittent dips in
nocturnal oxygen saturation and arousals from sleep both of which correlate
with daytime function (section 2.7, 2.10). Although previous studies show
that daytime sleepiness in SAHS patients is best predicted by sleep
fragmentation the variance in daytime sleepiness due to arousals is at best
13% (Roehrs et al 1989). In the previous study in this thesis, sleep
fragmentation that caused visible EEG arousals produced similar deficits in
daytime function as those found in SAHS patients. This suggests that
elevated microarousal frequencies alone can cause deficits in daytime
function.
Brief EEG arousals from sleep are accompanied by transient
increases in blood pressure. Results from chapter 4 of this thesis
demonstrate that not all sleep related apneas and hypopneas are terminated
by visible EEG arousals, a finding similar to that of Rees et al (1995). Rees
et al (1995) demonstrated that although these apnoeas and hypopnoeas
were not terminated by visible EEG arousals they were terminated by the
blood pressure rise of arousals. Davies et al (1993) demonstrated that this
autonomic response can be induced in normal sleeping subjects with tones,
without causing any discernible change on the EEG. Rees et al (1995) also
found increases in computer detectable EEG frequency whether or not there
was a visible EEG arousal at the end of the apnoea or hypopnoea.
Given the low amount of variance in daytime sleepiness described by
visible EEG arousals the hypothesis for this study is that sleep fragmenting
events may occur which are unaccompanied by visible EEG change and that
these events may contribute towards impairments in daytime function found
in SAHS patients. In this study the sleep of normal subjects was fragmented
122
and its effects on subsequent daytime function investigated. Sleep was
fragmented to induce recurrent arousals as detected by transient blood
pressure and/ or heart rate increases alone, without any change in EEG




Subjects were recruited as described in section 3.15. Fourteen
subjects entered this study; 8 men and 6 women. One woman dropped out
of the study due to technical and lab scheduling problems and one man was
dropped after the first night due to his inability to sleep in the laboratory.
Twelve subjects were studied (7 men, 5 women) with a mean age of 25 ± 6
years. They were all non-obese (body mass index, 22 ± 2 kg/m2) and had
Epworth sleepiness scores within the normal range (median 5, range 2 to 8)
(Johns 1991).
Protocol
On the second night of each pair of nights subjects were randomly
assigned to having either an undisturbed night's sleep or having their sleep
fragmented with tones. Sleep was recorded and scored as described in
section 3.3. All study nights were recorded on computerised
polysomnography (Compumedics, Melbourne, Australia). In addition in 8
subjects 2 frontal EEG channels were recorded from 10/20 standard EEG
recording sites Fp1/ F3 and Fp2 / F4.
Sleep was fragmented with tones to produce what was termed a non-
visible arousal response. This was defined as an increase in arterial blood
pressure or heart rate without any visible change on the EEG that could be
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scored by the sleep fragmentation definition of arousal (section 3.5) (figure
6.2 (a) and (b)).
Beat to beat blood pressure was recorded with the Finapres device
(Ohmeda) (see figure 3.1 for example of online output). Recorded data can
be examined offline from a beat to beat output as follows;
Time (hr min sec) Systolic Diastolic Mean BP Pulse rate
12 58 13 93 58 72 48
12 58 14 84 53 72 48
12 58 15 87 54 65 48
12 58 17 88 54 67 48
12 58 18 87 54 68 51
12 58 19 89 57 68 53
Table 6.1; Sample of beat to beat recording of output from the Finapres. Six
individual beats of data are shown; from subject no. 1, undisturbed study
night.
Due to the Finapres device causing disrupted sleep as ascertained
from pilot studies in 2 subjects (section 3.13), blood pressure was recorded
continuously for the first one and a half hours of sleep from the onset of slow
wave sleep. If subjects had a full awakening the device was switched off and
subjects were allowed to go back to stage 2 sleep before switching the
device on again. During blood pressure recording heart rate responses to
tones that produced non-visible arousal responses as defined were closely
monitored and used as a guideline for non-visible responses to tones during
the remainder of the study night after the Finapres had been removed from
the subjects' hand. The volume and duration of tones was increased during
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the night in accordance with data showing that normal subjects acclimatise to
arousing stimuli (Williams et al 1964, Bonnet 1985, Bonnet 1987). By doing
this it is assumed that the autonomic response to arousing stimuli
acclimatises to repetitive stimuli in a similar fashion to the visible EEG
arousal response to repetitive stimuli. Subjects were monitored by video
camera to check for any movement which may have affected blood pressure
recording.
Every 1 minute from the onset of slow wave sleep (SWS) the duration
and volume of tones was varied to produce, not a visible EEG change but an
autonomic response, i.e. a minimum increase in systolic blood pressure of 4
mm Hg or, when the subject was not wearing the Finapres, an increase in
heart rate of at least 4 beats per minute without any visible cortical arousal
response on the EEG channels. The response should occur within 15
seconds of the tone, and because blood pressure varies with the respiratory
cycle, should be sustained over at least 3 beats compared to blood pressure
over the 15 seconds prior to the tone. Blood pressure responses were
assessed by the experimenter from a real time display on a PC situated next



















Figure 6.1; Sample of online beat to beat blood pressure output from the
Finapres device that is available in real time during an overnight sleep study.
Time is displayed on the X axis, with blood pressure on the Y axis (mmFlg).
Five minutes of data is displayed with tones delivered at the arrows shown.
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Beat to beat heart rate was also assessed from a real time display on
a cardiac rate monitor. If this required arousal response was achieved, the
next tone came 1 minute after the previous tone. If tones produced cortical
arousals I waited until the reappearance of the first sleep spindle or K-
complex and then waited 1 minute before applying the next tone. If this non-
visible arousal response was not achieved on the first tone 30 seconds was
allowed to elapse before repeating with a louder or longer tone.
Sample visible and non-visible EEG responses to tones are depicted
in Figure 6.2 (a) and (b). Tones of 1000Hz were presented to subjects via a














Figure 6.2 (a); Sample visible EEG responses to tones. The channels
depicted are central EEG; CZ/ PZ, Frontal EEG; Fp 1 / F3, Fp2/ F4, Chin EMG
and tone marker channel. A tone was administered at the mark shown. Peak
EEG power, in the range 8-11 Hz, within 5 seconds of the tone was 3.3 Hz
and maximim blood pressure increase within 15 seconds of the tone was 16
mmHg. 15 seconds of data is shown.
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Figure 6.2 (b); Sample non-visible EEG response to a tone. A tone was
administered at the mark shown. Peak alpha EEG power within 5 seconds of
the tone was 2.6 Hz and maximum BP increase after the tone was 5 mmHz.
Lights out on all nights was at 11 pm, with study time finishing at 6.30
am on all nights except for the fragmented night when study time was
extended by 15 minutes to allow for any sleep loss due to fragmentation
regardless of prior sleep quality. Fragmentation of sleep continued
throughout this extended study time.
On the fragmented study night the change in systolic blood pressure
in response to tones was calculated for 10 seconds around the maximum
blood pressure response and, as a control, for 10 seconds prior to each
tone. The mean delay to maximum BP response was noted for each subject.
In order to compare blood pressure responses to tones between study nights
the blood pressure records from the undisturbed study night were randomly
marked with an equal number of sham tones to the fragmented study night.
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The "maximum" blood pressure response to the sham tone was taken as the
blood pressure X seconds after each tone, X being the mean delay to
maximum blood pressure within 15 seconds of a tone from that subject's
fragmented study night. The mean systolic blood pressure was then
calculated for the 10 seconds prior to each "tone" and for the 10 second
period 5 seconds before and after the "maximum" blood pressure response.
Subject Mean delay to Max Mean rise in Mean rise in systolic
ID no. BP after tone systolic BP after BP after "sham"
(sees) tones tones
(mm Hg) (mm Hg)
201 8 8.7 0.4
202 8 10.4 0.6
203 7 4.7 -0.2
204 11 6.8 -1.6
205 14 9.5 0.4
206 8 10.5 -1.5
207 9 5.4 0.7
208 8 15.0 0.2
209 12 7.0 -1.6
210 9 6.5 -0.3
211 8 12.1 0.1
212 7 6.7 0.6
Mean ± 9 ± 2 8.0 ±2.2 -0.2 ± 0.8
SD
Table 6.2; Individual mean data for the delay to maximum blood pressure
after tones on the fragmented night, and blood pressure increases after
tones on the fragmented night and after "sham" tones on the undisturbed
night.
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Arousals were defined according to the sleep fragmentation definition
(section 3.5). This definition was used regardless of sleep stage and whether
arousals were induced by tones or not. The arousal frequency consisted of
the number of spontaneous + induced arousals and the number of
Rechtschaffen and Kales awakenings per hour of sleep. Frontal (Fp1/ F3,
Fp2/ F4) and occipital (CZ/ PZ) arousal frequencies were scored separately.
One hour sections of stage 2 sleep were also scored for 1.5 second arousals
from the frontal leads.
Fast Fourier Transformation
Using in-house computing support (see acknowledgement) the frontal
EEG raw data signal from stage 2 sleep were analysed using Fast Fourier
transformation (section 3.7). Raw data was taken from all the stage 2 sleep
in the fragmentation study nights of all 12 subjects. In selection of frequency
bands for this analysis we were guided by the instructions in arousal
definitions which are to look for a return to alpha or theta on the EEG for a
given duration (section 3.5). I selected the alpha frequency range; 8-11 Hz,
as stage 2 sleep consists largely of EEG in the theta frequency range and
arousals are usually scored as a return to alpha EEG frequency. Time point
data files corresponding to the times at which tones were administered to
subjects were generated along with control time point files either 30 seconds
before or after the tones. These were used to allow selection of peak alpha
EEG power, within 5 seconds of tones and control time points. Five seconds
was chosen as the time window within which any change in EEG in response
to tones should be apparrent, due to the finding in the previous chapter, that
if an arousal stimulus was sufficiently strong to induce a visible EEG arousal,
then it would do so within a few seconds of applying the stimulus.
129
Daytime Assessment
The daytime assessment schedule was as follows;
7am to 9am; UMACL (UWIST mood adjective checklist) + SSS
Digit Symbol substitution
Block Design,
Trailmaking A and B
Steer Clear
PASAT (4 and 2 sees).
10.00 to 17.25; MSLT + MWT.
UMACL + SSS prior to each nap on the MSLT.
The RVIP test was dropped from the test battery as previous studies from
this laboratory had found that it was not sensitive to changes in cognitive
function after one month of CPAP therapy (Engleman et al 1994a) or after
one night of cortical sleep fragmentation (chapter 5). Subjects were asked to
stay awake during the day between the cognitive function tests and the
daytime naps and were encouraged to sit in an area of the laboratory
different to their bedroom in order to facilitate this.
Statistical Analysis
All outcome measures, both nocturnal and daytime variables, were
analysed using a mixed 2 way analysis of variance (SPSS-PC+) for repeated
measures on 2 study limbs, with order of conditions as a between subjects
effect. The outcome measures were examined for non-normal distributions
and ceiling effects found on all individual naps on the MWT and all measures
of Hedonic Tone. These can occur because subjects who score the
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maximum on the fragmented limb are unable to show an improvement in
function during the undisturbed limb, assuming that it is present. These
variables were analysed using the Wilcoxon matched pairs test.
Peak alpha EEG power was selected within 5 seconds after control
times and after time points at which tones were administered. These values
were then compared using paired t-tests. Tones were divided into those that
induced arousals and those that did not. This was selected as a factor which
may have contributed to any significant differences found between peak
EEG power after control and tone time points. Differences between individual
subjects may also have contributed to any significant differences found in
peak EEG power after control and tone time points. Therefore Multivariate
Analysis of Variance (MANOVA) was performed on the difference between
peak EEG power after control and tone time points with outcome (whether




There were no significant differences between study nights in total
sleep time (TST), amounts of wakefulness, stage 1, stage 2, or REM sleep.
However there was significantly less slow wave sleep (SWS) on the
fragmented study night (p=0.007).
UNDISTURBED FRAGMENTED p Value
TST (mins) 419.0 ±27.4 414.0 ±32.2 0.5
Wake (% SPT) 7.4 ±4.2 8.3 ±4.4 0.5
Stage 1 (% TST) 3.3 ± 1.9 3.7 ± 1.8 0.5
Stage 2 (% TST) 49.8 ±4.8 53.8 ±6.2 0.1
SWS (% TST) 23.9 ±5.0 19.5 ±4.3 0.007
Stage REM (% TST) 23.0 ±4.2 23.1 ±4.2 0.9
Table 6.3; Comparison of sleep architecture between undisturbed and
fragmented study nights. TST; total sleep time, SPT; sleep period time,
SWS; slow wave sleep. Values are expressed as mean ± SD.
Arousals
The minimum tone volume and duration used was 38dB for 0.25
seconds. The maximum volume and duration of tones required to produce a
non-visible arousal response in any subject was 65dB, and all tones were
applied for less than 4 seconds.
Subjects had a mean of 253 (SD 23) tones presented to them during
the fragmented study night, 21 ± (SD) 7% of which caused central arousals
and 23 ± 9% of which caused frontal arousals. There was no significant
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difference between these; p=0.3. The central arousal frequency on the
fragmented night was divided into arousals induced by tones and
spontaneous arousals. The arousal frequency on the fragmented night
consisted of the induced arousal frequency (7.8 ± 2.2 per hour of sleep) and
the spontaneous arousal frequency (16.7 ± 4.4 per hour of sleep). The
spontaneous arousal frequency from the fragmented night was significantly
smaller than the arousal frequency on the undisturbed night (22.4 ± 4.3 per
hour of sleep; p=0.001). The spontaneous and induced arousal frequencies
from the fragmented night were not significantly different to the arousal
frequency from the undisturbed night (table 6.4). There were no significant
differences in either frontal or 1.5 second arousal frequencies between study
nights (table 6.4).
UNDISTURBED FRAGMENTED p value
Central arousals/ hr. 22.4 + 4.3 24.5 ± 5.7 0.4
Frontal arousals/ hr. 22.8 ±6.0 26.3 ±5.0 0.1
1.5 sec arousals/ hr. 26 ± 12 27 ± 12 0.7
R&K awakenings/
hr.
3.7 ± 1.6 3.8 ± 1.2 0.8
Table 6.4; Arousal frequencies per hour of sleep. Values are expressed as
mean ± SD. Central; CZ/PZ, Frontal; Fp1/F3 and Fp2/F4, 1.5 sec arousals
scored from frontal leads.
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Fast Fourier Transformation
Events were divided into tones that produced visible EEG arousals
(n=191) and those that did not (n=575). Peak a EEG power was significantly
greater after tones compared to controls both when tones induced visible
EEG arousals (control 4.9 ± (SD) 2.2, tone 10.6 ± 4.9 pv; p<0.0001) and
when tones did not (control 5.3 ± 2.7, tone 7.4 ± 3.3 pv; p<0.0001). There
was a significantly greater increase in peak EEG power after tones that
caused arousals than those that did not (Figure 6.3) (p=0.008) with no
significant contribution from between subject variability.
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Figure 6.3; Peak alpha EEG power (pv) within 5 seconds of a control time
point compared to that within 5 seconds of a tone for tones that cause
arousals (filled bars) and for those that do not (hatched bars).
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Daytime Sleepiness
There were significantly shorter mean sleep onset latencies on the
MSLT (undisturbed; 8.0 ± SD 3.1, fragmented; 6.2 ± 2.1 mins; p=0.01)
(Figure 6.4a) and the MWT (undisturbed; 29.0 ± 10.0, fragmented; 25.7 ± 9.7
















































Figure 6.4; Paired points for individual subjects' mean sleep onset latencies
on the MSLT (a) and the MWT (b) after undisturbed and fragmented study
nights. Single points are mean ± SD for all subjects.
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On the MSLT there were significantly shorter sleep onset latencies on
individual naps at 10.00 (p=0.01) and at 16.00 (p=0.01) after fragmentation
(figure 6.5a). On the MWT there were trends towards significant differences
in sleep onset latencies on individual naps at 10.45 (p=0.09) and at 16.45








































p = 0.09 p<0.07
1 1.00 13.00 15.00 17.00
(b)
Time of Day
Figure 6.5; Sleep onset latencies for individual naps during the day on the (a)
MSLT and (b) MWT. Values are mean ± SD; —•— undisturbed, —O—
fragmented.
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There was no difference in subjective daytime sleepiness as
measured by the Stanford sleepiness scale (SSS) (mean SSS; undisturbed 3
± 1, fragmented 3 ± 1; p=0.7) after either study night.
Mood
There was a significant decrease in Hedonic tone at 7am (p=0.03)
and there was trend towards a significant increase in tense arousal at 7am
(p<0.09) after fragmentation. (Figure 6.6a and b). There was no change in


































Figure 6.6; Individual paired data points for mood dimensions of (a) Hedonic
Tone and (b) Tense Arousal at 7am after undisturbed and fragmented study




Fragmentation did not have any adverse effects on cognitive function
in the performance tests that were used in this study. Performance on the
Trailmaking B test was affected by fragmentation but in a counterintuitive
direction (table 6.5).
UNDISTURBED FRAGMENTED p value
Digit Symbol 74 ± 10 72 ± 13 0.3
Block Design 42 ±7 43 ±8 0.4
Est. PIQ 127 ± 16 126 ± 18 0.8
Steer Clear 47 ±27 45 + 28 0.7
Trailmaking A 19 ±4 20 + 5 0.6
Trailmaking B 46 ± 15 39 ± 11 0.03
PASAT 4 sec 58 ±2 58 ±2 0.8
PASAT 2 sec 47 ± 10 45 ± 12 0.1
Table 6.5; Mean ± SD for cognitive outcome measures after both study




This study shows that non-visible sleep fragmentation affects sleep
architecture, daytime sleepiness, as measured by the MSLT and the MWT,
and mood upon awakening. There was no coincident significant increase in
the number of visible cortical arousals on the EEG, however this study
demonstrates that small but significant increases in EEG power do occur in
response to tones that do not cause visible EEG arousals that can be scored
according to current criteria.
In the previous study (chapter 5) inducing visible EEG arousals every
2 mins decreased the MSLT from 11 to 7 mins and the MWT from 34 to 24
mins, impaired all mood dimensions in the morning and energetic arousal for
the rest of the day as well, and caused decrements in cognitive function.
Non-visibly detected arousals decreased the MSLT from 8 to 6 mins and the
MWT from 29 to 26 mins. In addition induced non-visible arousals caused
impairment of hedonic tone and a trend towards impairment of tense arousal
mood dimensions on awakening only, but they had no deleterious effect on
cognitive function. These results contrast with preliminary results from
Sahloul et al (1995) who found, in 4 subjects, that there was no difference in
sleep onset latency on the MSLT after non-visible sleep fragmentation during
3 hours of recovery sleep compared with 3 hours of undisturbed recovery
sleep. The differences between this current study and that of Sahloul et al
(1995) may be due to a number of reasons; this study included more
subjects, whole night studies were used here compared to 3 hour study
durations in the study of Sahloul et al 1995, and this study design
incorporated acclimization nights on both study limbs. In addition mood and
cognitive function were tested, and daytime sleepiness was tested with the
maintenance of wakefulness test as well as the multiple sleep latency test.
In this study there were small but significant changes in daytime
sleepiness in response to non-visible sleep fragmentation. Despite the
changes in MSLT and MWT there was no difference in subjective sleepiness
after fragmentation. This is not suprising as there was no change in SSS
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after cortical sleep fragmentation which is more disruptive to sleep than this
protocol. In addition previous studies have shown that these Stanford
Sleepiness scores and objective sleepiness do not always move in parallel
(Dement et al 1978). Thirty four tones per hour were presented to subjects to
induce non-visible arousals compared to 30 tones per hour to induce visible
EEG arousals in the previous study (chapter 5). Although there were slightly
more tones per hour presented presented to subjects to induce non-visible
arousals they were of shorter duration and lower volume and the more subtle
changes in daytime sleepiness between the 2 studies reflect this difference.
The maximum volume and duration of tones required to produce a non-
visible arousal response was 65dB for less than 4 seconds which is much
less than that required to induce visible cortical arousal in the previous
fragmentation study; 100dB for up to 12 seconds.
On the MSLT this 2 minute change in daytime sleepiness after non-
visible sleep fragmentation is similar in magnitude to that seen in patients
with sleep apnea after they have been established on CPAP therapy
(Engleman et al 1993, Kribbs et al 1993). Sangal et al (1992b) found that
sleepiness on the MWT improves with CPAP therapy by a magnitude (8 min)
in between the size of the decrease seen in normal subjects after induced
visible EEG arousals (10 min), as seen in the previous study (chapter 5), but
by a greater magnitude than the decrease after non-visible arousals (4 min)
seen in this study.
These subjects appeared to be sleepier after the undisturbed night
than those in the previous fragmentation study. Therefore subjects' working
habits were inspected closely. Three of our student subjects had evening
jobs at weekends which ran into the early morning. Each was studied at the
same time in the week on both limbs and always after at least 2 nights of
normal sleep at home plus the acclimization night before the study night.
These 3 subjects may have increased the overall sleepiness of the study
sample.
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Blood pressure was monitored for the first sleep cycle only, because
during pilot studies normal subjects were not sleepy enough to tolerate blood
pressure monitoring for the whole night without sleep disruption (section
3.13). The Finapres device may have increased arousal frequency on study
nights as the arousal frequency on the undisturbed night in this study was 22
per hour compared to 15 per hour on the undisturbed night in our previous
fragmentation study. Bonnet (1985, 1987) found that mood, cognitive
function and daytime sleepiness in normal subjects are impaired by sleep
disruption and thus monitoring blood pressure over the whole night may have
compromised this study.
There was no significant difference between study nights in arousal
frequencies measured centrally or frontally. Nor was there a difference
between study nights when the arousal duration criterion was shortened to
1.5 seconds. There was no significant difference between cortical areas in
the number of tones that caused arousals. Frontal EEG monitoring was
included in the study montage because O'Malley et al (1996), in a provisional
report using topographic brain mapping, found that in patients with mild sleep
apnea frontal arousals were seen at the termination of 95% of respiratory
events, whereas only 73% were detected at occipital sites. In contrast in this
study visual scoring of the frontal EEG did not increase the detection of
visible EEG arousals in response to tones in normal subjects.
Frontal EEG from stage 2 sleep was subjected to Fast Fourier
transformation (FFT). There were significant increases in EEG frequency in
response to tones that did not cause visible EEG arousals. Davies et al
(1993) tracked changes in EEG in normals in response to auditory stimuli
using a computerised artificial neural network without seeing visible cortical
arousals. These changes were always accompanied by transient increases
in arterial blood pressure. Rees et al (1995) Fast Fourier Transformed the
EEG of SAHS patients and found increases in EEG frequency coincident
with increases in blood pressure at the end of respiratory events whether or
not they terminated in cortical arousals. This evidence taken together with
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the induced decreases in daytime sleepiness that we have demonstrated in
this study suggests that perhaps a more sophisticated analysis of the EEG
or, a non-visible marker of arousal such as Pulse Transit Time (PTT) (Brock
et al 1993) should be included in routine sleep studies to assess the true
extent of sleep fragmentation suffered by patients being assessed for sleep
disorders.
The results from this study and the previous study (chapter 5) may
also suggest that there is a gradient of cortical arousal from sleep. Although
the arousals induced in this study could not be scored according to
conventional criteria the fact that computer detectable increases in alpha
frequency on the cortical EEG were found after tones suggests that they are
also cortical arousals of some kind. This could be represented as milder
tones inducing less obvious arousals on the EEG which had a milder effect
upon daytime function.
There was a significant decrease in hedonic tone and a trend towards
an increase in tense arousal on awakening after non-visible fragmentation.
This is consistent with findings in studies using acute hypoglycaemia as a
physiological stressor (Hepburn et al 1995, Hepburn et al 1996). Normal
subjects had decreased hedonic tone and increased tense arousal maximal
with the onset of autonomic reactions to acute hypoglycaemia (Hepburn et al
1995) whereas adrenalectomised subjects, who do not have the normal
adrenaline response to hypoglycaemia, did not show these changes
(Hepburn et al 1996). Together these results suggest that changes in
hedonic tone and tense arousal could be autonomically mediated, while
changes in energetic arousal are due to cortical stimulation. This hypothesis
is supported by the findings here of transient changes in mood due to
repetitive non-visible arousal from sleep, and in the previous sleep
fragmentation study, more longer lasting impairment of energetic arousal due
to cortical sleep fragmentation.
Although there was no adverse impact of fragmentation on cognitive
function there was an improvement in performance on the Trailmaking B test
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after fragmentation. This test is a well validated test of general cognition and
is widely used to assess cognitive impairment in a range of illnesses (Lezak
1983). In SAHS patients, Cheshire et al (1992) found that scores on this test
correlate with mood impairment, and Engleman et al (1994) have found
improvements in performance on this test after one month of CPAP therapy.
In normals subjects it shows decrements in cognition after sleep
fragmentation (chapter 5) and in patients with nocturnal asthma it is sensitive
to cognitive impairment (Fitzpatrick et al 1991). Yesavage et al (1985) found
that it correlates with respiratory disturbances in the elderly and Findley et al
(1986) found that it distinguishes between hypoxemic and non-hypoxemic
patients with sleep apnoea. The widespread use of this test in studies
measuring cognitive function suggest that this counterintuitive change in
performance after non-visible sleep fragmentation may be a spurious result.
In this study one night of induced non-visible sleep fragmentation
causes increased daytime sleepiness and impaired mood upon awakening.
The importance of sleep fragmentation with non-visible EEG arousals in
patients with sleep disorders needs to be assessed.
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Chapter 7
The Effect of Clustered Versus Regular Sleep Fragmentation on Daytime
Function.
7.1 INTRODUCTION
As outlined in the introduction to this thesis (chapter 2) SAHS patients
suffer from impaired daytime function. There is debate as to whether the
cause of these deficits is the nocturnal hypoxemia or sleep fragmentation
suffered by these patients. Roehrs et al (1994) and Philip et al (1994) found
that one night of cortical sleep fragmentation makes normal subjects sleepier
during the day. Further to these studies an earlier study in this thesis
(chapter 5) found that one night of acoustically induced sleep fragmentation,
causing regular visible EEG arousals, impairs daytime sleepiness, mood and
cognitive function in normal subjects. These decrements in function
demnonstrate that fragmentation can induce reversible deficits in daytime
function similar to those found in SAFIS patients.
Sleep fragmentation in association with apnoeas and hypopnoeas
occurs in a clustered fashion in 2 subsets of patients with sleep apnea; those
with REM sleep related apnea and those with supine/ postural related apnea.
In the description of disease progression from snoring to severe sleep
apnoea by Lugaresi et al (1983) they dismissed REM related respiratory
events as non-pathological citing the inherent respiratory instability of REM
sleep (Douglas 1994). As REM sleep occurs approximately every 90 minutes
during a night's sleep any sleep fragmentation resulting from REM specific
respiratory events therefore occurs in a clustered fashion during sleep.
These clusters of sleep fragmentation are interspersed with periods of
uninterrupted sleep, in particular slow wave sleep, the duration of which
correlates with objective daytime sleepiness on the MSLT (Philip et al 1994)
and is thought to be vital for cerebral restitution (Florne 1988) and efficient
cognitive functioning.
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In addition patients that suffer from PLMS have periods of
uninterrupted sleep (Montpiaisir et al 1994). This disorder is characterised by
repetitive limb movements during sleep which may or may not induce visible
EEG arousals. These limb movements are only found during NREM sleep,
as motor inhibition during REM sleep ensures that they do not occur in this
sleep stage, and they are often clustered to either the beginning or the end
of the night. Daytime sleepiness is a common symptom of this disorder.
It is uncertain whether these periods of uninterrupted sleep are
sufficiently restorative for these patients to overcome the effects of
fragmentation on daytime function. Therefore this study investigated the
relative effects of similar frequencies of fragmentation, but dispersed in either




Eleven subjects (6 men, 5 women) entered this study but one woman
dropped out after the first limb due to sickness. Ten subjects completed the
study. They were 23 SD 3 years old, were all non-obese (body mass index,
21 ± 3 kg/m2) and had Epworth sleepiness scores (Johns 1991) in the
normal range (mean 5; range 0 to 8).
Protocol
This study consisted of 2 limbs of sleep fragmentation with subjects
spending 2 nights in the sleep laboratory on each limb. On the second night
of each pair of nights subjects were randomly assigned to having either of 2
fragmentation paradigms: Regular- sleep fragmentation every 90 seconds
from the onset of stage 2 sleep; or Clustered- sleep fragmentation every 30
seconds, for 30 minutes every 90 minutes thus allowing subjects to obtain 60
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minute long periods of uninterrupted sleep. On the clustered paradigm
fragmentation starts one hour after the onset of stage 2 sleep. Five subjects
had the clustered fragmentation limb first and 5 had the regular
fragmentation limb first. These 2 paradigms are designed to increase arousal
frequencies by a similar number on both study nights while allowing for
periods of uninterrupted sleep on the clustered study night. Seven out of the
ten subjects had both study limbs recorded onto the Compumedics
computerised polysomnography system, and the remaining 3 subjects were
recorded on the Healthdyne system.
During fragmentation the duration and volume of tones of 1000 hz
was varied to try to produce a standard microarousal response; i.e. a return
to alpha or theta rhythm for longer than 3 seconds but, where possible, not
longer than 15 seconds on the EEG channels. If an arousal or awakening
was achieved, the next intertone interval began from the reappearance of
stage 2 sleep defined as the first occurrence of a well defined K complex or
sleep spindle. If an arousal response was not achieved on the first tone 10
seconds was allowed to elapse before repeating with a louder and/or longer
tone. Lights out on all nights including acclimisation nights was standardized
to 11pm and the study time finished at 6.45 am on all nights.
On study nights arousals were scored according to the sleep
fragmentation definition of arousal (section 3.5). The arousal frequency
consisted of the number of microarousals plus the number of Rechtschaffen
and Kales awakenings per hour of total sleep time (TST).
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Daytime Assessment
At 7am after study nights subjects began the battery of mood and
cognitive function tests. They filled out the UWIST mood adjective checklist
and Stanford sleepiness scale. They then completed Digit Symbol, Block
Design, Steer Clear, Trailmaking A and B, Rapid Visual Information
Processing (RVIP) and Paced Auditory Serial Addition Test (PASAT) at 4
and 2 seconds. In order to make the RVIP more searching than in the
previous cortical sleep fragmentation study (chapter 5) three consecutive 10
minute tests were employed and the results from the three summed. The
remainder of the day was taken up with testing mood and daytime
sleepiness (MSLT, MWT) as previously described (chapter 6).
Statistical Analysis
Data were analysed using a mixed two-way analysis of variance
(SPSS-PC+) with study condition (regular or clustered study night) as a
repeated measure and order of conditions as a between subjects effect. All
outcome measures were examined for non-normal distribution. This was
done by checking through the rawdata to see if subjects had scored the
maximum or minimum on a particular variable after both study nights. If a
subject scores the maximum on a test after both study nights the test cannot
differentiate between conditions. Two or more subjects scored the maximum
of 60 correct additions after both limbs on the PASAT 4 second test. Again 2
or more subjects stayed awake for the maximum of 40 minutes on all
individual naps on the MWT after both study limbs. Two or more subjects
scored a minimum of zero misses on the RVIP test. These variables were




There was no difference in total sleep time (TST) (p=0.4), or the
percentage of wakefulness (p=0.9) between the clustered and regular
fragmentation study nights (table 7.1). There was significantly more stage 2
(p=0.05) and less slow wave sleep (SWS) (p=0.002) on the regular
fragmentation study night (table 7.1).
CLUSTERED REGULAR p Value
TST (mins) 391 SD 26 384 ± 35 0.4
% Wake (SPT) 11 ±4 11 ±7 0.9
% Stage 1 5 ±2 4 + 3 0.3
% Stage 2 55 ±4 61 ±7 0.05
% SWS 22 ±3 14 ±6 0.002
% Stage REM 19 ± 4 22 ±3 0.1
Table 7.1; Comparison of sleep stages on clustered and regular
fragmentation study nights. All values are mean ± standard deviation (SD).
Values for stages 1 to REM are expressed a percentage of TST. TST; total
sleep time, SPT; sleep period time.
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Arousals
There was no significant difference between study nights in the
arousal frequency, number of tones that were presented to subjects (p= 0.3)
or the percentage of those tones that caused arousals (p= 0.9) (table 7.2).
Clustered Regular p value
Arousal frequency 42 ±4 43 ±5 0.5
R&K awakenings/ hr. slept 6 + 3 5 + 2 0.6
number of tones 215 + 21 224 + 26 0.3
% tones causing arousals 79 ± 10 79 ± 12 0.9
%tones causing R&K 9 ±4 9 ±4 0.7
Table 7.2; Comparison of arousal statistics on clustered and regular
fragmentation nights. Arousal frequency; number of microarousals + r&k
awakenings per hour slept. All values are mean ± SD.
The arousal frequency was divided into arousal frequencies of
different durations (table 7.3). There was no significant difference between
study nights in the frequencies of arousals of different durations except
arousals of duration 5 to 10 seconds. There was a small but significantly
greater frequency of arousals of this duration on the regular fragmentation
study night (p=0.05) (table 7.3).
Duration (s) 3-5 5-10 10-15 15+ R&K
CLUSTERED 20.5 ±4.2 11.4 ± 5.3 3.1 ± 1.0 1.3 ± 0.7 4.1 ± 1.1
REGULAR 19.4 + 4.0 12.8 ± 5.0 * 3.7 ± 1.9 1.2 + 0.6 5.7 ± 1.9
Table 7.3; Microarousal and r&k frequencies per hour slept for varying
durations of microarousals. Values are mean ± standard deviation. *p=0.05
significantly different between study nights.
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Daytime Sleepiness
There was no difference between clustered or regular fragmentation
in their effects on mean sleep onset latency on the MSLT (clustered; 8 SD 4,
regular; 9 ± 4 mins) (figure 7.1a) or on the MWT (clustered; 32 SD 7, regular;

















































Figure 7.1; Paired point data of mean sleep onset latency on the (a) MSLT
and (b) MWT after both study nights. Single points are mean + SD for all
subjects.
150
There were no significant differences in individual nap latencies on
either the MSLT (all p> 0.1) (figure 7.3a) ot the MWT (all p> 0.2) (figure 7.3b)
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Figure 7.2; Sleep onset latencies for individual naps on the (a) MSLT and (b)
MWT. —#-Clustered, — O — Regular. Values are mean + SD.
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There was no difference in subjective sleepiness on the SSS at any
time of day after clustered or regular fragmentation (all p > 0.2).
Cognitive Function and Mood
There was no difference between clustered and regular fragmentation
in their effects on the cognitive function tests that were used in this study (all
p>0.1) (table 7.4).
Clustered Regular p value
Digit Symbol 73 ± 12 74 ± 11 0.3
Block Design 47 ± 3 45 + 4 0.5
Est. Perf. IQ 131 ± 15 132 ± 14 0.9
Steer Clear 39 ± 27 37 ± 30 0.7
Trailmaking A 20 ± 5 20 ± 4 0.9
Trailmaking B 40 ± 9 38 ± 9 0.4
RVIP hits 122 ± 55 124 ± 51 0.9
RVIP misses 14 ± 15 7 ± 6 0.1
PASAT 4 sec 58 ± 2 57 ± 3 0.7
PASAT 2 sec 48 ± 8 46 ± 10 0.1
Table 7.4; Mean ± SD for cognitive outcome measures after both study
nights. Est. perf. IQ; estimated performance IQ.
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There was no difference between either fragmentation paradigm in
their effects on mood dimensions at any time of day: Energetic Arousal; all
p>0.1, Tense Arousal; all p>0.2, Hedonic Tone; all p>0.4, (table 7.5).
Clustered Regular p value
Mean EA 16 + 4 15 + 4 0.4
Mean HT 27 + 3 26 + 3 0.9
Mean TA 12 + 3 11+2 0.5
Table 7.5; Mean ± SD values for all 5 mood assessments for the 3 different




This study shows no difference between clustered or regular sleep
fragmentation in their impacts on daytime sleepiness, mood or cognitive
function. This was despite the fact that there was significantly more slow
wave sleep and less stage 2 sleep on the clustered sleep fragmentation
night. The clustered sleep fragmentation night was designed to allow
subjects to obtain some uninterrupted sleep and this is reflected in the
decreased stage 2 and increased slow wave sleep on the clustered
fragmentation night.
There was no difference between study nights in their relative impacts
on daytime sleepiness as measured by the MSLT or MWT. Although Philip et
al (1994) found that slow wave sleep was the best predictor of daytime
sleepiness on the MSLT they did not report on any relationship, significant or
otherwise, between arousal frequency and daytime sleepiness. In chapter 5
of this thesis SWS duration decreased as arousal frequency increased,
indicating that arousal frequency and SWS duration are interrelated. In this
study however the arousal frequency has been manipulated on the clustered
limb to allow for minimal loss of SWS with no subsequent differences in
mood or cognitive function compared to after the regular fragmentation study
night. This suggests that the increased SWS found on the clustered study
night is not sufficient to lead to improved scores on the daytime sleepiness,
mood and cognitive function tests that were used in this study.
These data are in agreement with Bonnet (1986a) who compared
daytime function after induced sleep disruption -not sleep fragmentation- with
that after a similar frequency of sleep disruption targeted to eliminate slow
wave sleep. There were no significant differences in performance, mood and
daytime sleepiness scores between study limbs. This in conjunction with the
current results suggest that deficits in daytime function caused by sleep
fragmentation may not be dependent on SWS.
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On the clustered study night there were periods of uninterrupted sleep
which were not sufficient to allow improved daytime function compared to
one night of regular sleep fragmentation. These results suggest that it is the
overall frequency of sleep disruption rather that its spacing which determines
subsequent daytime function. This is in contrast to the suggestion that there
may be a minimum period of uninterrupted sleep required for it to be
restorative. This is known as the sleep continuity theory. Drawing together
results from Badia et al (1985), Magee et al (1987), Levine et al (1987) and
Bonnet (1986b) 4 minutes was suggested as that minimum. These
differences cannot be explained by differences in the techniques used to
assess daytime sleepiness as the studies of Magee et al (1987) and Levine
et al (1987) tested daytime sleepiness with the MSLT. In 6 out of 10 subjects
in the current study there was a cluster of fragmentation which terminated
within 25 minutes of wakening which may have negated the restorative
effects of the previous hour of sleep and would account for the similarity of
daytime function after clustered and regular fragmentation. This is unlikely to
be the case as in the study by Bonnet (1986b) performance was best after
2.5 hours uninterrupted sleep followed by regular disruption for the
remainder of the night suggesting that any restorative effects of periods of
uninterrupted sleep would last throughout the night regardless of subsequent
disruption. Bonnet (1986b) however did not use a full MSLT but used one
morning nap to test daytime sleepiness.
Alternatively the lack of significant differences in daytime function
between fragmentation study limbs may be due to a type 2 statistical error as
there were only 10 subjects in this study. However these results agree with
those of Bonnet (1986a) who studied 12 subjects over 2 conditions. The
power of the current study and that of Bonnet (1986a), although low, may be
greater than that of Bonnet (1986b) who studied 8 subjects over 4 conditions
and Downey and Bonnet (1987) who studied 5 subjects over 3 conditions. As
these studies (Bonnet 1986b, Downey and Bonnet 1987)are used as
evidence for the sleep continuity theory these conlcusions may be based on
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studies with low power. Badia et al (1985) and Magee et al (1987) studied
more subjects, 20 and 16 subjects respectively, however these were split
into 2 groups and a parallel study design used to compare different sleep
fragmentation conditions. Therefore there were only 10 (Badia et al 1985)
and 8 (Magee et al 1987) subjects in each sleep fragmentation condition
again suggesting that their conclusions are based on results from studies
which may have inadequate power.
The lack of a control limb in this study was deliberate as it has been
established in this thesis (chapter 5) and by previous studies (Bonnet 1987,
Philip et al 1994, Roehrs et al 1994) that regular sleep fragmentation has
marked effects on daytime sleepiness. Indeed the results from the regular
limb of the current study are similar to those found after regular sleep
fragmentation in chapter 5 of this thesis. Using unpaired t-tests a post hoc
comparison of daytime sleepiness (MSLT and MWT) after regular sleep
fragmentation in this study and in the previous cortical sleep fragmentation
study (chapter 5) was performed. There was no significant difference
between objective sleepiness measured by either the MSLT or MWT in the
regular fragmentation limb in this study and those in the previous study
(MSLT; p>0.1, MWT; p=0.3). The aim of the current study was to determine
whether clustered arousals had similar affects on daytime function to regular
arousals and that could only be assessed by a direct comparison between
these two limbs. The addition of a third, control, limb would not only have
decreased the power of the study but also may have made subject
recruitment more difficult as the subjects would have been required to spend
6 nights and 3 days in the sleep laboratory.
In this study the fragmention of normal subjects' sleep was successful
in increasing arousals and in inducing similar numbers of arousals on both
study nights. It may be expected that allowing subjects to have blocks of
uninterrupted sleep may lower their acclimatisation thresholds to tones
however this did not appear to be the case as there was no difference in the
number of tones that were presented to subjects. Seventy nine percent of
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tones caused arousals, and 9% of tones caused full awakenings on both
study nights. These figures include repeat tones if the initial tone was not
successful in inducing the standard microarousal response.
These study results may be applicable to the excessively sleepy
patient who has intermittent sleep fragmentation, due to sleep apnea which
only occurs during REM sleep (Kass et al 1996) or while the patient is lying
supine. They may also have relevance to patients with PLMS, whose limb
movements normally occur in a clustered fashion during NREM sleep
(Montplaisir et al 1994) and therefore these patients may have periods of
uninterrupted sleep, during the night. Recently Kass et al (1996)
demonstrated that a group of patients with mild SAHS (AHI<15) who had
moderately severe daytime sleepiness had a high AHI specific to REM sleep.
They also demonstrated that AHI and arousal frequency during REM sleep
alone are significantly correlated with sleepiness on the MSLT. Furthermore
Guilleminault et al (1991) and Guilleminault et al (1993) have found that
milder forms of sleep disordered breathing such as snoring and increased
upper airway resistance may also lead to fragmentation of sleep and
subsequent daytime sleepiness.
Patients who have respiratory events during REM or light sleep may
snore or have increased upper airway resistance during SWS. Series et al
(1994) have suggested that sleep fragmentation may contribute to increased
upper airway collapsibility during sleep. Subjects in this study either had a
night of sleep fragmentation or a night of sleep deprivation, followed by
recovery sleep during which upper airway collapsibility was monitored. They
found that upper airway collapsibility during recovery sleep after sleep
fragmentation was increased compared to that after sleep deprivation. These
data suggest that respiratory events during REM sleep alone may lead to
increased upper airway collapsibility during subsequent sleep stages.
Furthermore this may suggest that sleep fragmentation is instrumental in the
aetiology of sleep apnoea along the continuum from mild to severe sleep
disordered breathing.
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These results indicate that clustered arousals may produce similar
degrees of sleepiness, mood and cognitive function to that found after
regular arousals in patients with fragmented sleep.
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Chapter 8
Fast Fourier Transformation (FFT) analysis of the EEG during arousals from
sleep in normal subjects.
8.1 INTRODUCTION
The process of manual evaluation of sleep fragmentation is time
consuming and highly laborious. It requires expert technician time and in
patients with severe sleep apnoea may take a considerable length of time to
score fully (Biernacka and Douglas 1993). Although the relationships
between arousal frequency and daytime sleepiness or cognitive function in
SAFIS patients are significant arousals do not explain much of the variance
in daytime sleepiness (Roth et al 1980, Roehrs et al 1989). There may be
many contributing factors to this finding. Primarily current methods of
measuring arousals may not be accurate enough to reflect true sleep
fragmentation in patients with sleep disordered breathing. In chapter 4 of this
thesis a range of manual arousal definitions were equally poor predictors of
daytime sleepiness. In addition although more apnoeas and hypopnoeas
were terminated by shorter arousals (1.5 second definitions) the arousal
definitions used still left at least 17% of respiratory events terminating without
any indication of sleep disturbance. This suggests that there may not be any
change in the EEG at the termination of these apnoeas. Evidence from Rees
et al (1995) demonstrates that this is not the case.
Rees et al (1995) found that computer detectable changes in EEG
frequency occur at apnoea termination even when there is no visible change
in the EEG. Accompanied by these changes in EEG there are transient
blood pressure increases suggesting some form of increased autonomic
activation. In chapter 6 of this thesis there were increases in EEG power in
the alpha frequency bandwidth, as detected by FFT analysis, in response to
tones whether or not they induced visible EEG arousals. These results are in
agreement with Davies et al (1993). Further to this Davies et al (1993) have
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found transient increases in blood pressure in response to tones that caused
no computer detectable change in the EEG. However the evidence
suggesting that these blood pressure arousals have any impact on daytime
function is contradictory. Preliminary evidence from Sahloul et al (1995) in 4
subjects only found no increase in daytime sleepiness following 3 hours of
induced non-visible sleep fragmentation whereas in chapter 6 of this thesis a
whole night of sleep fragmentation to cause non-visible arousals on the EEG
made subjects significantly sleepier during the day on the MSLT and MWT.
Automatic detection of sleep fragmentation would cut the current
workload involved in scoring microarousals in clinical sleep studies. Manual
definitions as described in section 3.5 (Roehrs et al 1989, Cheshire et al
1992) are currently the best validated methods of measuring sleep
fragmentation and therefore have to be used as a starting point for the
development of any automatic arousal analyser. Ultimately this could be
used as a basis for development of a system which could detect more subtle
forms of sleep fragmentation as described by Davies et al (1993), Rees et al
(1995) and in chapter 6 of this thesis. Given that this kind of sleep
fragmentation can increase daytime sleepiness, albeit by small amounts,
there may be patients with subtle forms of sleep disordered breathing, such
as increased incidences of inspiratory flow limitation (Guilleminault et al
1993, Condos et al 1994), whose daytime sleepiness may be explained by
increased incidences of this kind of sleep fragmentation.
Therefore in this study EEG signals were analysed using the Fast
Fourier Transformation (FFT) system as described in section 3.7. Using this
technique the present study examines EEG frequency changes during visible
and non-visible EEG arousals in normal subjects where sleep was




Ten overnight sleep studies were selected from those recorded onto
computerised polysomnography using the Compumedics (Melbourne,
Australia) system. Studies recorded on computerised polysomnography
could be downloaded digitally for further computerised analysis. The studies
were selected from the clustered versus regular sleep fragmentation
protocol, as described in chapter 7, as I wished to study sequences of visible
EEG arousals. There were 10 subjects in this protocol however only the last
7 subjects had overnight studies recorded on the Compumedics system. For
this reason 3 subjects had both clustered and regular overnight sleep studies
sampled. Sections of stage 2 sleep which contained, where possible, a
continuous sequence of 30 arousals, were selected and downloaded into
raw data files. The visible EEG arousals selected contained both
spontaneous and induced arousals. Arousals which contained obvious EEG
artifact were excluded from the analysis. Visible EEG arousals had been
scored according to the sleep fragmentation definition described in section
3.5.
Non-Visible Arousals
All 12 overnight studies from the fragmentation limb were selected
from the non-visible sleep fragmentation protocol as described in chapter 6.
Ten events from each study in which tones did not cause visible EEG
arousals, as defined in section 3.5, were selected from stage 2 sleep and the
raw data downloaded into data files.
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EEG Analysis
Using programmes generated by departmental computing support
(see acknowledgement) Fast Fourier Transformation (FFT) was performed
on the raw data files. FFT was performed on the central EEG signals derived
from bipolar electrodes at positions CZ/PZ. EEG power was calculated
separately for the four predominant stage 2 sleep EEG frequencies; sigma
(12 to 16 Flz), alpha (8 to 11 Hz), theta (4 to 7 Hz), and delta (0 to 3 Hz). The
analysis programme allowed calculation of EEG power within these specified
frequencies in 2 second moving windows with a resolution of 1 second.
Therefore FFT data points were generated every second. In addition I made
time marker files containing start times (hr: min: sec) for each microarousal,
and control time points 10 seconds prior to the beginning of each visible
EEG arousal. For the non-visible arousals time marker files were generated
at each tone and control time points 10 seconds prior to each tone. A further
computer programme then searched the transformed EEG data to select the
peak EEG power within 5 seconds of the start of each arousal event, or tone,
and also during the 5 seconds after each control time point.
Statistical Analysis
The difference in peak EEG power after control and arousal or after
control and tone time points was calculated. These differences were
displayed as frequency plots and examined for normality. All outcome
variables were normally distributed and therefore parametric statistics were
used. Peak EEG power after control and microarousal time points, or control
and tone time points, were compared using paired t-tests. The changes in
peak EEG power during spontaneous and induced arousals were compared
using unpaired t-tests. Changes in EEG power during visible and non-visible
arousals were compared with unpaired t-tests. Bonferroni corrections were




Three hundred visible EEG arousals were studied. The mean duration of all
arousals was 7.4 seconds (range 3 to 92 seconds). There were 51
spontaneous and 249 induced arousals in the sample. The total number of
arousals longer than 5 seconds in duration was 110.
Subject mean max. no. no. arousals >
ID number/ study duration duration spontaneous 5 sec.
number (sees) (sees) arousals
310 clustered /1 6.1 25 0 8
304 12 8.7 41 2 16
305 13 6.9 35 1 8
306 /4 7.8 92 2 11
307 15 9.1 43 0 14
308 16 7.4 28 3 12
309 17 5.3 24 3 7
304 regular IS 5.0 16 6 5
305 19 8.1 18 17 16
310 /10 9.6 59 17 13
Table 8.1; Description of the visible EEG arousals used in this study
according to the 10 individual studies.
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Visible EEG arousals were divided into those that occurred
spontaneously and those that were induced by tones. There were significant
increases in peak EEG power during arousals compared to control periods
within all frequencies regardless of whether the arousal was spontaneous or
occurred in response to a tone.
SPONTANEOUS INDUCED
Control Arousal Control Arousal
Sigma 4.4 ±1.8 6.2 ±1.7* 4.2 ±1.9 5.6 ±2.0*
Alpha 5.6 ±2.4 10.3 ±3.6* 4.5 ±2.1 8.1 ± 3.6*
Theta 6.9 ±2.7 11.3 ±4.1* 6.5 ±3.4 9.1 ±4.7*
Delta 17.4 ±11.0 39.1 ± 19.1* 14.2 ± 12.9 26.1 ±21.6*
Table 8.2; Mean ± SD values for EEG power in the different frequencies for
spontaneous and induced visible EEG arousals. * p<0.001 significantly
different between control and arousal.
Changes in EEG power during arousals were calculated separately for
spontaneous and induced arousals by subtracting control peak EEG power
from the peak EEG power during arousal. There was no significant
difference between spontaneous and induced arousals in the change in EEG







Induced Spontaneous Induced Spontaneous
Figure 8.1; Individual data points for the comparison of changes in EEG
power during arousals between spontaneous and induced arousals in the
various EEG frequency bands studied. Single points indicate mean.
Changes in EEG power in all frequency bands after control times and
during visible EEG arousals, both spontaneous and induced, were compared
separately for each of the 10 individual studies (figure 8.2). There were
significant increases in EEG power during arousals in all studies, in all
frequencies, apart from in study numbers 2 and 6, where there were no
significant increases in peak EEG power in the delta and theta frequencies
(figure 8.2).
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Figure 8.2 (a) and (b); Mean ± SEM of individual study's increases in EEG
power in alpha and theta EEG frequencies during arousals compared to











































































Figure 8.2 contd. (c) and (d); Mean ± SEM of individual study's increases in
EEG power in delta and sigma EEG frequencies during arousals compared




Changes in EEG power in all frequency bands after control times and
during non-visible arousals were compared separately for each of the 12
individual studies (figure 8.3). Peak EEG power in the delta frequency was
significantly increased during non-visible arousals in 9 out of 12 subjects.
Peak EEG power in the theta frequency was increased in 4 out of 12
subjects. There were significant increases in peak alpha EEG power in 5 out
of 12 subjects. There were significant increases in peak sigma EEG power in
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Figure 8.3 (a) and (b); Mean ± SEM of individual study's increases in peak
EEG power in the alpha and theta frequencies during non-visible arousals
compared to during control periods, ns: non-significant.
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Figure 8.3 contd. (c) and (d); Mean ± SEM of individual study's increases in
peak EEG power in delta and sigma EEG frequencies during arousals and
during control periods, ns: non-significant.
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All Arousals
Spontaneous and induced visible EEG arousals were analysed
together. For visible arousals there were significant increases in peak EEG
power in all the EEG frequencies studied (p< 0.001) (table 8.3). In response
to tones there were significant increases in peak EEG power during non-
visible arousals in delta, theta and alpha EEG frequencies (p< 0.001) (table
8.3). During non-visible arousals there was a trend towards a significant
increase in peak EEG power within the sigma frequency (p<0.08).
VISIBLE AROUSALS NON-VISIBLE AROUSALS
Control Arousal Control Arousal
Sigma (12-16 Hz) 4.2 SEM 0.1 5.7 ±0.1* 4.9 ±0.3 5.3 ±0.3
Alpha (8-11 Hz) 4.7 ±0.2 8.5 ±0.1* 4.8 ±0.2 6.4 ±0.3*
Theta (4-7 Hz) 6.5 ±0.2 9.4 ±0.3* 7.7 ±0.3 9.1 ±0.4*
Delta (0-3 Hz) 14.7 ± 0.7 28.3 ± 1.3* 15.9 ± 0.7 24.5 ±0.9*
Table 8.3; Comparison of peak EEG power after control and arousal time
points for the various EEG frequencies for visible and non-visible arousals.
Values are mean ± SEM. *p< 0.001.
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The change in EEG power during arousals compared to control times
was calculated as a percentage of the control value for individual EEG
frequencies during both visible and non-visible arousals. Unpaired t-tests
compared absolute changes in EEG power (Arousal - control) between
visible and non-visible arousals. There was a significantly greater change in
delta EEG power and a trend towards significantly greater change in alpha
EEG power during visible EEG arousals compared to during non-visible
arousals (table 8.4).
Visible Arousals Non-visible Arousals p value
% A Delta 139 SEM 14 74 ±8 0.008
% A Theta 55 ±4 24 ±4 0.2
% A Alpha 100 ±5 40 ±6 0.06
% A Sigma 56 ± 5 18 ±4 0.2
Table 8.4; Percentage change in EEG power in the different EEG
frequencies during visible and non-visible arousals. A; difference.
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8.4 DISCUSSION
This study demonstrates that there are group mean increases in all
physiologically relevant EEG frequencies during visible and non-visible EEG
arousals from stage 2 sleep. It confirms findings of increased EEG frequency
during visible EEG arousals and that FFT can be used to look at frequency
changes in the EEG during short events such as arousals (Rees et al 1995,
Drinnan et al 1996). However there appears to be a large amount of inter-
individual variability, with two subjects showing no change at all in delta and
theta EEG frequencies.
FFT analysis of the EEG in this study is very different to the process
of manual scoring of the EEG. In manual scoring of visible EEG arousals the
EEG is scanned for the reappearance of theta and/ or alpha frequencies and
the disappearance of delta frequencies when identifying arousals in SWS.
FFT analysis determines the relative amounts of the different frequencies
and therefore is a more quantitative approach. This finding of increases in all
EEG frequencies from 0-16 Hz during arousals confirms in a quantitative
fashion the qualitative results of Halasz (1993). The results of that study
show that there were increases in all EEG frequencies from 0-20Hz in
response to tones however there were no statistical tests performed on this
data. The sigma and delta frequencies are not usually used in manual
scoring associated with arousals. However this study was performed during
stage 2 sleep only and arousals from this stage of sleep may often include or
begin with a K- complex (ASDA 1992). In addition tones inducing non-visible
EEG arousals often produced a K complex as shown in figure 6.2. K
complexes have a similar frequency bandwidth to delta waves
(Rechtschaffen and Kales 1968) and this could therefore account for the
increase in delta EEG power seen during arousals. It is unclear whether K
complexes appear during arousals as an arousal phenomenon or as a
defensive mechanism against arousal. Johnson and Lubin (1967) have
suggested that K complexes are part of the "Orienting Reflex"; an
evolutionary arousal mechanism which enables the brain to remain in a state
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of readiness for physical activity during sleep. They found that K complexes
are followed by transient increases in arterial blood pressure similar to those
found in association with arousals in response to tones in normal subjects
(Davies et al 1993, chapter 6) and respiratory events in SAHS patients (Rees
et al 1995). In contrast to this Wauquier et al (1995) suggested that K
complexes are sleep protective. They found better defined and more K
complexes in stage 2 sleep in normal subjects compared to patients with
sleep disorders and they reasoned that this lack of K complexes in patients
with epilepsy, narcolepsy, insomnia and SAHS may have contributed to their
poor sleep quality.
Guidelines for manual arousal scoring specifically exclude sleep
spindles (sigma waves) as arousal phenomena. This is due to their role in
the maintenance of sleep and more specifically the generation of deep sleep
(Steriade et al 1992). It may be that increased EEG activity in this waveband
is present during visible EEG arousals as a sleep protective mechanism, as
suggested by Halasz (1993). A further reason for their presence during
visible EEG arousals is that they are often associated with K complexes as a
physiological marker for scoring of stage 2 sleep (Rechtschaffen and Kales
1968). If K complexes can be found during or at the start of arousals it is
logical to suggest that co-existing EEG activity within the frequency range of
sleep spindles may also occur. This would account for the significant
increases in sigma waves seen during arousals in this study.
There was no significant difference between spontaneous and
induced EEG arousals in increases in peak EEG power during arousals.
There was however a trend towards a larger change in alpha EEG power
during spontaneous arousals. This suggests that cortical arousals induced by
tones are similar to those occurring spontaneously. In chapter 5 of this thesis
there were more arousals of short durations (3 to 5 seconds) on the
fragmented study night than on the undisturbed study night. The longer
duration of spontaneous arousals however does not appear to allow
waveforms to become more pronounced.
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There may be different neural pathways involved in the generation of
spontaneous and induced arousals. Spontaneous arousals may be a side
effect of undergoing polysomnography (Mathur and Douglas 1995b) or they
may occur as a result of increased upper airway resistance which is as yet
undetected in routine clinical sleep studies and which could have an impact
on daytime sleepiness. Indeed what constitutes a normal or pathological
number of events of increased upper airway resistance during sleep is
unknown. Induced arousals were generated by auditory tones. However
these examples of different sensory inputs into arousal pathways did not
lead to increases of different magnitude in the various EEG frequencies as
expressed at the cortex.
As is evident from figures 8.2 and 8.3 there is a large amount of
variability between individuals in the changes in EEG frequencies during
visible and non-visible arousals. This largely reflects the inherent inter-
individual variability in EEG signals. Therefore it is impossible to suggest that
increases in various frequencies above a certain amount constitute arousals.
A method of standardisation could be to use some multiple of the standard
deviation of the EEG frequency change during arousals, similar to the
mobility index of EEG used by Drinnan et al (1996). This would require
screening of the EEG signals for artefacts which could skew the data.
However the global EEG frequency changes found in this study would make
it difficult to select a frequency upon which to focus. Drinnan et al (1996)
applied automated analyses to manually scored arousals and investigated
changes in the EEG before and during arousals. They found that the three
best analyses, i.e. those that found the most significant differences in EEG
between before, and during an arousal, (zero cross, mean frequency, and
mobility) were all indices of total EEG frequency. They did investigate alpha
EEG power alone and found significant increases during arousal, however
the overlap between before and during arousal was greater than with other
indices of EEG frequency and therefore it was not selected as an EEG index
which warranted further study. These results suggest that more than one
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EEG frequency may be required to accurately detect arousals from EEG
frequency analyses.
In SAHS patients using changes in delta EEG frequencies may lead to
inaccuracies in automated arousal detection. Krieger and Kurtz (1978)
reported that bursts of slow waves can occur prior to apnoea termination.
More recent data from Stradling et al (1995) and Svanborg and Guilleminault
(1996), found that there were computer detectable increases in slow wave
and delta activity prior to apnoea termination. Both studies suggest that this
constitutes a sleep protective mechanism against arousal. This is a similar
suggestion to that of Halasz et al (1985) who found that, in patients with
parasomnias who had confusional arousals, there was an increased
incidence of arousals preceded by a burst of slow waves. They concluded
that this may constitute a sleep protective mechanism. These results suggest
that using changes in delta frequency to detect arousals in patients with
sleep apnoea may be unreliable.
This study has demonstrated global EEG frequency changes during
visible arousals in normal subjects and suggests that quantitative EEG
changes can be used to detect arousals automatically in SAHS patients.
Furthermore this method detects increases in EEG power in non-visible
induced arousals. The present data suggest that the best combination of




CONCLUSIONS AND FUTURE WORK
The data presented in this thesis shows that some of the daytime
impairments in patients with SAHS can be modeled by inducing cortical
sleep fragmentation in normal subjects. Not only does this suggest that
nocturnal hypoxemia need not necessarily be present for SAHS to be
diagnosed but also that at least some of the deficits in daytime function
found in these patients are reversible. Given that in chapter 5 the arousal
frequency increased from 15/ hr to 34/ hr, this is equivalent to an apnoea +
hypopnoea index of 20 per hour of sleep which is in the moderate range of
severity of disease. This suggests that these induced impairments may be
applicable to patients with moderate sleep apnoea.
However results in chapter 4 show that at best only 83% of respiratory
events are terminated by cortical arousals. In addition cortical arousals
scored by a range of definitions are only weakly related to daytime
sleepiness. This leads to the question of whether the apnoeas and
hypopnoeas that do not terminate in a visible EEG arousal but do terminate
in an autonomic arousal are pathological in terms of daytime sleepiness.
Furthermore are the weak relationships between cortical arousals and
daytime sleepiness found by ourselves and others caused by the lack of
routine measurement of more subtle arousals from sleep?
Results from chapter 6 suggest that these autonomic arousals do
have a small but significant impact on daytime sleepiness. As previously
shown, using a different computer technique, by Davies et al (1993) there
were computer detectable changes in EEG, calculated by FFT analysis in
this thesis, during these non visible arousals from sleep. These subtle
changes in EEG may have lead to the increased daytime sleepiness after
autonomic fragmentation. Although changes in EEG have been detected
after induced autonomic arousals there is no evidence as yet how often
these blood pressure rises occur during a normal night's sleep. In addition
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Davies et al (1993) demonstrated that not all blood pressure increases in
response to tones occur with concurrent detectable EEG change, as
measured by Neural network analysis. Studies in normal subjects are
required to determine how often these blood pressure arousals occur during
a night's sleep and how often they are associated with changes in the EEG.
Furthermore studies of a similar nature in patients with different severities of
sleep disordered breathing may go some way to determining whether current
diagnosis techniques are missing significant sleep fragmentation. As an
adjunct to this the identification of significant non-visible sleep fragmentation
and its relationship to daytime sleepiness needs to be investigated as it may
account for the poor relationships found between visible arousals and
daytime sleepiness.
The clustered versus regular sleep fragmentation protocol is a more
subtle examination of the distribution of microarousals and their effects on
daytime function. There were similarities in daytime function outcome
measures after both types of fragmentation despite there being increased
SWS on the clustered limb. Although this contradicts the sleep continuity
theory of Downey and Bonnet (1987), this theory was developed using
results from sleep disruption studies (Bonnet 1986b, Downey and Bonnet
1987). As this kind of study decreases total sleep time the results, upon
which this theory is based, include a component of sleep deprivation.
Therefore the results from sleep fragmentation studies such as that
described in chapter 7 may not have relevance for this theory.
There is at least one potential further sleep fragmentation protocol
which is an extension of the 3 fragmentation protocols presented in this
thesis. The question of whether arousals during REM sleep are pathological
is contentious. This is mainly due to the phenomena of alpha intrusion and
EMG bursts being regarded as normal aspects of REM sleep. In addition
respiratory instability is inherent in REM sleep suggesting that arousals
resulting from hypo/ hyper ventilation is part of the normal sleep process.
Measuring daytime function after fragmentation during REM sleep only may
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go some way to answering this question. In addition it would more closely
model REM related sleep apnoea than the sleep fragmentation protocol
described in chapter 7.
There were significant changes in daytime function tests after cortical
sleep fragmentation. These impairments are similar to those found in SAHS
patients prior to CPAP therapy. The tests of daytime function used however
have limitations and further work using different technology may give
additional relevant information about the potential effects of sleep apnoea on
daily living. Daytime sleepiness testing using the MSLT/ MWT is never ideal
as these tests do not allow for testing in subjects' real-life situations. In
addition a component of the MSLT includes measuring subjects' ability to
sleep which is known to vary between individuals (Harrison and Home
1996a). The recent development of reliable portable systems for monitoring
of EEG signals (Compumedics; Melbourne, Australia) has made it feasible to
send a subject about their normal daily routine after one night of sleep
fragmentation. A true picture of their daytime sleepiness could be obtained
by examining their EEG for epochs of sleepiness or, in a slightly more
sensitive fashion, by looking for the occurrence of microsleeps (Harrison and
Home 1996b). A further application of the FFT technique described in this
thesis may be to ascertain daytime sleepiness by looking at changes in EEG
power as an indicator of sleep onset.
The cognitive tests that were used in these sleep fragmentation
studies give little indication of the neural pathways involved in their execution
and therefore cannot give any information about specific areas of the brain
that are affected by sleep fragmentation. The exception is the RVIP test
which examines information processing (Wesnes and Warburton 1983,
Petrie and Deary 1989). Wesnes and Warburton (1983) suggest that the
efficiency of this function is controlled by ascending reticular cholinergic
pathways. This test however did not show any significant changes in any of
the sleep fragmentation protocols. Future work in this area should focus on
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using more targeted theory based tasks for the measurement of cognitive
function.
Measuring topographic mapping of sensory evoked potentials may be
an improvement in the measurement of cortical function. Sensory evoked
potentials are usually performed either with visual or auditory stimuli. They
are usually performed using one electrode recording site at CZ however
topographic mapping of these potentials using the full 10/20 electrode
placement is now available. This increases the amount of information that
can be recorded from a test of this kind and allows for closer examination of
discrete areas of the cortex. A study using this technique may pinpoint which
areas of the cortex have altered function after one night of sleep
fragmentation.
There is evidence that sleep fragmentation itself may have an impact
on the development of sleep disordered breathing. Snoring and sleep
apnoea are likely to be part of the same disease process, (Lugaresi et al
1983) both resulting from narrowing of the upper airway. The mechanisms
whereby a snorer becomes a patient with sleep apnoea are uncertain
however both snoring and respiratory events result in arousals from sleep
(Guilleminault et al 1991). Espinoza et al (1991) found that there was a
significant increase in AHI during 2 nights of fragmented sleep in normal
subjects. During fragmentation sleep efficiency was decreased and stage 1
sleep was increased. Respiratory instability is greater during sleep onset and
stage 1 sleep, leading to a greater likelihood of respiratory events occurring
(Trinder et al 1992). The increase in AHI may have been due to the above
effect or it may reflect a direct effect of sleep fragmentation on upper airway
compliance and muscle function.
A study by Series et al (1994) addresses this question by investigating
upper airway collapsibility (Pcrjt) during recovery sleep after a night of sleep
deprivation and after a night of sleep fragmentation. Pcrit was significantly
lower after fragmentation than after deprivation indicating increased upper
airway collapsibility. There was no control limb in this study however it would
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have been difficult to obtain data during recovery sleep in the morning
following a normal nights' sleep. However this data suggests that increased
upper airway narrowing that could lead to a period of increased upper airway
resistance or snoring during a normal night's sleep, may, due to an increase
in upper airway collapsibility, become a hypopnoea or apnoea during or after
a night of sleep fragmentation.
The mechanism whereby upper airway collapsibility is increased after
fragmentation may be due to fragmentation itself causing an increase in
arousal threshold. Recently Berry et al (1996) demonstrated that in SAHS
patients on the 3rd night off CPAP respiratory events are longer, and the
maximum negative inspiratory effort prior to arousal is increased by 10 cm
H20 compared to 1 night off CPAP. This suggests that the increased drive to
sleep due to sleep fragmentation increases the negative pressure threshhold
for termination apnoeas and hypopnoeas with arousals. This and the
increased drive to sleep caused by sleep fragmentation may lead to an
occurrence of respiratory events. The resulting increase in upper airway
oedema may lead to increased upper airway collapsibility.
Further studies investigating the effects of sleep fragmentation on
upper airway muscle function are required to understand the links between
sleep fragmentation, upper airway collapsibility and the occurrence of
respiratory events.
It is clear that the sleep fragmentation model for sleep apnoea/
hypopnoea syndrome is a useful tool in dissecting out the causes of the
clinical problems that are associated with sleep apnoea. However animal
models may reveal more information about the underlying physiological
mechanisms involved in SAHS. Preliminary evidence from Brooks (1996a,
1996b) and Horner et al (1996) in a dog model of sleep apnoea
demonstrates that obstructive sleep apnoea or sleep fragmentation can be
induced over a 2-3 month period thus enabling more realistic modeling of
sleep apnoea than one night. Furthermore animal modeling in smaller
mammals may allow more invasive recording, particularly in a cellular
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fashion, from discrete nuclei in the brain controlling aspects of function which
are impaired in SAHS.
An approach in this direction may involve a series of experiments
starting with sleep fragmentation studies to determine the anatomical
location of neuronal pathways involved in the generation of cortical arousal
from sleep. Once located the neurones can be described in terms of their
neurotransmitter control. An obstructive model may then be applied to
determine the pathways which control apnoea termination prior to cortical
arousal. It is the interaction of these above pathways in conjunction with
sleep generating mechanisms that may determine what kind of respiratory
event occurs, its duration and its termination with or without cortical
involvement. Once established the model can be applied in conditions of
varying severity to explore whether SAHS could be the product of a positive
feedback mechanism. This kind of approach allows for the identification of
neural pathways involved in the aetiology of sleep apnoea and may lead to
suggestions of neuropharmacological alternatives to CPAP in the treatment
of sleep disordered breathing.
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This is the in house sleep/wake questionnaire used to assess subjects prior
to recruitment for sleep fragmentation studies. The Epworth Sleepiness
Scale (Johns 1991) is contained in question 8.
NAME : DATE
SLEEP/ WAKE QUESTIONNAIRE
Please find enclosed a questionnaire for you to fill out and return.
You may get help, from your partner in answering Questions 9, 11 and
20.
For most questions several options are available, underline the answer
which is most appropriate.
The answers will remain confidential.




















Are you a : smoker / non-smoker / ex-smoker (for years)
What did / do you smoke: cigarettes yes/no Number per day .
cigars yes/no Number per day .
tobacco (own rolled) yes/no Oz. per week
tobacco (pipe) yes/no Oz. per week
Do you drink: tea yes/no cups per day
coffee yes/no cups per day
wine yes/no glasses per day .
beer yes/no pints per week
spirits yes/no drinks per week
sherry/port yes/no glasses per week
Any alcohol immediately before going to bed: yes/no
What medication, including sleeping pills are you taking at present?









































1. When do you go to bed at night on average?
2. When do you finally wake up in the morning on average?
3. How long do you take to fall asleep at night?
4. How often do you wake between going to bed and getting up in the morning?
never / 1-3 times / 3-6 times / more than 6 times per night
5. Do you do shift work? If so, please specify shifts and how long you are on each shift
6. How many times have you wet the bed in the last year?
never / occasionally / 2-6 times / more than 6 times
7. How often have you woken with a headache each week?
never / 1-2 times / 2-5 times / more than 5 times
8. How likely are you to doze off or fall asleep, in the following situations, in contrast to
feeling just tired? This refers to your usual way of life in recent times. Even if you have not
done some of these things recently, try to work out how they would have affected you. Use
the following scale to choose the most appropriate number for each situation.
0 = would never doze
1 = slight chance of dozing
2 = moderate chance of dozing
3 = high chance of dozing
Situation Chance of Dozing
Sitting and reading
Watching TV
Sitting, inactive in a public place (eg a theatre or a meeting)
As a passenger in a car for an hour without a break
Lying down to rest in the afternoon when circumstances permit
Sitting and talking to someone
Sitting quietly after a lunch without alcohol
In a car, while stopped for a few minutes in traffic
TOTAL
207
Do you snore during sleep?
Yes/No
If yes:
a) How long have you snored loudly?
Always (since childhood / last 5 years / 3 years / 1 year
b) Do you snore every night / most nights/ occasional nights
c) Do you snore on your back only / on back and side / in all positions
Do you have a regular bed-partner or room-mate?
yes / no / previously but not currently
Has your bed-partner/room-mate ever noticed that you stop breathing when asleep?
yes / no
Do you need to go to the toilet at night?
never / occasionally /1-2 times / more than 2 times per night
Do your ankles swell? If so, for how long
yes / no months / years
Have you ever had hallucinations when you have been falling off to sleep or waking
up?
yes / no
Have you ever had episodes when you body or part of your body has become floppy
in response to an emotional stimulus?
yes / no
Have you ever had episodes when you have woken up and been unable to move?
yes / no
If so, how often?
once / less than 5 times / more than 5 times
In the morning do you feel that your nights sleep was refreshing/satisfactory?
always / 4-6 nights per week / 1 -3 nights per week / never
Have you or your partner noticed any change in your sex drive?
increased / unchanged / decreased / non-existent
How many times have you woken choking or suffocating in the past month?
never / 1 -2 times / 3-6 times / more than 6 times
How often is your bed-partner or room-mate, disturbed each week because of
excessive arm and/or leg movements?
never /1-5 times / 5-10 times / more than 10 times / no bed partner
Are you ever forced to have a nap during the day?
yes /no
If so, how many naps (5 minutes) do you have per day?
1-2 / 2-4 / 4-6 / more than 6
208
22. How many times have you fallen asleep against your will (for example, while eating,
driving or in company) in the last year?
never / 1-2 / 2-4 / more than 4 (give details below)
23. For how long have you been sleepy during the day?
3 months / 3-6 months / 6-12 months / over 12 months / over 10 years
24. Do you drive?
yes / no
25. Have you ever had, or nearly had an accident because of falling asleep while driving?
yes / no (give details below)
26. Have you, your partner or family noticed any change in your personality?
yes / no
If so, specify :
27. Has you weight changed in recent years?
yes / no down / up
If so, what is the change stones lbs
When did your weight change occur :
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The Effect of Sleep Fragmentation on Daytime Function
SASCHA E. MARTIN, HEATHER M. ENGLEMAN, IAN J. DEARY, and NEIL J. DOUGLAS
Respiratory Medicine Unit, Department of Medicine, Royal Infirmary, and Department of Psychology,
The University of Edinburgh, Edinburgh, Scotland
Patients with the sleep apnea/hypopnea syndrome suffer from impaired daytime function. This has
been attributed to both sleep fragmentation and hypoxemia. To help understand which is casual, we
studied the effects of sleep fragmentation alone on daytime function. Sixteen normal subjects were
studied on two pairs of two nights. The first night of each pair was for acclimatization, and on the
second the subject either slept undisturbed or had sleep fragmented with sound pulses every 2 min.
Sound volume and duration was titrated to cause a return to theta or alpha rhythm on the EEG for
at least 3 s. Study nights were followed by daytime testing of psychometric function and mood and
by a multiple sleep latency test (MSLT) and a maintenance of wakefulness test (MWT). Total sleep
time did not differ between study nights (400 ± 20 SD min undisturbed, 396 ± 24 min fragmented;
p = 0.6). Fragmentation decreased sleep latency on both the MSLT (11 ± 3, 7 ± 2 min; p = 0.001) and
the MWT (34 £ 8, 24 ± 10 min; p < 0.001). Energetic arousal (22 ± 4,19 ± 4; p = 0.005) and hedonic
tone (29 ± 4, 27 ± 4; p = 0.05) decreased after fragmentation. Fragmentation impaired daytime func¬
tion adjudged by the Traiimaking B (p = 0.05) and PASAT 4-s tests (p < 0.03). One night of sleep frag¬
mentation makes normal subjects sleepier during the day, impairs their subjective assessment of mood,
and decreases mental flexibility and sustained attention. Martin SE, Engleman HM, Deary I), Douglas
NJ. The effect of sleep fragmentation on daytime function.
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Patients with the sleep apnea/hypopnea syndrome (SAHS) suf¬
fer from impaired daytime function (1-4). They are severely sleepy
during the day as measured by the multiple sleep latency test
(MSLT) (5) and they suffer from impaired cognitive function com¬
pared with age- and educationally matched control subjects (1,
4). The nocturnal sequelae of apneas and hypopneas in patients
with SAHS are recurrent drops in oxygen saturation and frequent
sleep fragmentation in the form of short (< 15-s) microarousals
(2, 6). There is controversy (1, 2, 7-11) as to which of these is
the cause of the daytime sleepiness and cognitive dysfunction
seen in patients with SAHS.
Excessive daytime sleepiness in patients with SAHS has been
reported to be best predicted by the level of nocturnal sleep dis¬
turbance (7) and sleep fragmentation (8). However, Bedard and
colleagues (9) found that daytime sleepiness was predicted by
severity of nocturnal hypoxemia, whereas Cheshire and colleagues
f2) found no relationship between daytime sleepiness and noc¬
turnal hypoxemia or sleep fragmentation. Cognitive dysfunction
in patients with SAHS has been related to both their nocturnal
hypoxemia (1, 2, 4, 9, 10) and their sleep disruption/fragmenta¬
tion (2, 9). We have previously found that patients with SAHS
have altered anxiety and depression (2), and Kribbs and colleagues
(11) reported that the mood of patients with SAHS, which had
(Received in original form April 4, 1995 and in revised form August 3, 1995)
Correspondence and requests for reprints should be addressed to Neil J.
Douglas, M.D., FRCPE, Reader in Medicine, The University of Edinburgh, Depart¬
ment of Medicine, Royal Infirmary, Lauriston Place, Edinburgh, EH3 9YW, Scot¬
land, UK.
Am | Respir Crit Care Med Vol 153. pp 1328-1332, 1996
improved after CPAP therapy, returned to pretreatment levels
after one night without receiving CPAP (11).
Unfortunately, the magnitude of sleep disruption and the ex¬
tent of desaturation in patients with SAHS are correlated (2),
confounding attempts to determine in patients with SAHS what
specifically causes daytime dysfunction. Sleep disturbances in
normal subjects causes increased daytime sleepiness (12), impaired
mood, and altered daytime function (13). However, these studies
had decreased total sleep time on the disruption nights compared
with baseline, and they did not all mimic the short repetitive
microarousals found in SAHS. We have therefore tested the hy¬
pothesis that such sleep fragmentation may cause the increased




Subjects were recruited from the local student population using adver¬
tisements that did not refer to sleep. Subjects responding with possible
sleep disorders were excluded using our in-house sleep/wake question¬
naire, which is used to assess patients prior to attendance at the Scottish
National Sleep Laboratory. Ethical permission for the study was ob¬
tained from the Lothian Research Ethics Committee and the University
of Edinburgh. We studied 16 subjects (eight men) with a mean age of
24 ± 3 SD yr. They were all nonobese (body mass index, 23 ± 3 kg/m2)
and had low Epworth sleepiness scores (14) (4; range, 0 to 9).
Protocol
Subjects spent two pairs of two nights in the sleep laboratory. Prior to
the first night in the laboratory subjects received instructions on each
test of mood and cognitive function that we used in this study and un¬
derwent one practice session. The nights were divided into two pairs of
two nights a week apart. The first night of each pair was for acclimati-
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zation to the laboratory to avoid any "first night effect." On the second
night subjects were randomly assigned to having an undisturbed night's
sleep or to having their sleep fragmented with manually delivered acoustic
stimulations.
Every 2 min from the onset of Stage 2 sleep we varied the duration
and volume of tones of 1,000 Hz to try to produce a standard microarousal
response, ie., a return to alpha or theta rhythm for longer than 3 s but,
when possible, not longer than 15 s on the EEG channels. If we achieved
this response, we began the next 2-min intertone interval from the reap¬
pearance of Stage 2 sleep defined as the first occurrence of a well-defined
K complex or sleep spindle If we did not achieve an arousal response
on the first tone wc allowed a IC-s lapse before repeating with a louder
and/or longer tone
Lights-out on all nights was standardized to 11:00 p.m., and the study
time finished at 6:30 a.m. on all nights except the fragmented night when
study time was extended by 20 min in all subjects regardless of previous
sleep quality to allow for any possible sleep loss caused by the fragmen¬
tation. Fragmentation continued throughout this additional 20 min.
On study nights, sleep was recorded by our standard techniques (15)
and manually scored according to standard criteria (16) from electroen¬
cephalography (EEG), electrooculography (EOG), and submental elec¬
tromyography (EMG). The arousal frequency consisted of the number
of microarousals plus the number of Rechtschaffen and Kales awaken¬
ings (16) per hour of time slept. Arousals were further divided into du¬
rations of 3 to 5, 5 to 10, 10 to 15, and 15+ s (if not scored as a stage
shift to wakefulness). We also calculated mean duration of undisturbed
slow wave sleep (SWS), and the mean interarousal duration.
Subjects spent the day after each pair of nights undergoing testing
of daytime sleepiness, cognitive function, and mood.
Daytime Assessment
We assessed subjective daytime sleepiness at 7:00 a.m. using only the
■Stanford Sleepiness Scale (17). We measured objective daytime sleepi¬
ness using the multiple sleep latency test (MSLT) (18) and maintenance
of wakefulness test (MWT) (19). Both tests consisted of four naps at
2-h intervals throughout the day. We stopped all naps after one epoch
of Rechtschaffen and Kales Stage 1 sleep, thus preventing subjects from
obtaining any recuperative sleep that might affect their subsequent day¬
time function.
We assessed mood using the UWIST mood adjective checklist (20)
at 7:00 a.m. and prior to each nap during the MSLT, at 10:00 a.m. and
12:00 noon and at 2:00 and 4:00 p.m. This scores mood dimensions of
energetic arousal, hedonic tone, and tense arousal. Energetic arousal
is assessed by asking the subject to rate their feelings at the time accord¬
ing to eight adjectives, e.g., vigorous, sluggish; hedonic tone uses eight
adjectives, e.g., depressed, contented; tense arousal uses eight adjectives,
e.g„ relaxed, anxious. On each adjective subjects rate themselves on a
four-point scale ranging from definitely feeling, e.g., sluggish to definitely
not. Scores range from 8 to 32 for each dimension of mood, with high
scores being positive indications for all three dimensions.
Prior to the first daytime nap, subjects underwent a battery of per¬
formance tests. They were selected to test a broad range of function;
TABLE 1
COMPARISON OF SLEEP STAGES AND MICROAROUSALS ON
UNDISTURBED AND FRAGMENTED STUDY NIGHTS*
Undisturbed Fragmented p Value
TST, min 400 ±20 396 ±24 • 0.6
Wake (SPT), % 8.0 ± 3.9 112 ± 5.8 0.06
Stage 1, % 3.2 ± 2.0 5.4 ± 2.5 0.02
Stage 2, % 42.9 ± 7.1 59.3 ± 6.7 0.0001
SWS, % 29.1 ± 112 15.4 ±9.1 0.0001
Stage REM, % 23.0 ±5.0 19.1 ±3.3 0.02
Arousal frequency* 15.4 ±3.7 34.1 ± 5.0 0.0001
R&K 27 ±7 37 ± 11 0.02
WAIS-R subtests—digit symbol substitution and block design (21) —
testing general cognition; Trailmaking A and B (21), testing mental flex¬
ibility and attention; Steer Clear testing vigilance (22) and rapid visual
information processing (RVIP) (23) and paced auditory serial addition
test (PASAT) at 4 and 2 s (21), testing sustained attention and informa¬
tion processing. In addition we previously found that some of these tests
relate significantly to nocturnal hypoxemia and sleep fragmentation in
patients with SAHS (2) and that they are sensitive to improvements in
performance in these patients after CPAP therapy (24).
Statistical Analysis
We analyzed our data using a mixed two-way analysis of variance (SPSS-
PC+) for repeated measures with order of conditions as a between-
subjects effect The only test with an order effect was the Stanford Sleep¬
iness Scale. These data were therefore analyzed as suggested by Hills
and Arraitage (25) using an unpaired t test on first-limb data only.
RESULTS
Sleep Architecture
There was no difference in total sleep time between the undis¬
turbed and fragmented study nights; however, there was a trend
towards a greater percentage of time awake on the fragmented
night (p = 0.06) (Table 1). There was a significant general shift
towards lighter sleep on the fragmented night, with significantly
more Stages 1 (p < 0.02) and 2 (p < 0.001) sleep and significantly
less SWS (p < 0.001) and REM sleep (p < 0.02) (Table 1).
Arousals
We presented a mean of 183 ± 20 SD tones to each subject dur¬
ing the fragmented night, of which a mean of 150 (82%) ± 20
(8%) resulted in arousals. Fragmentation more than doubled the
arousal frequency (p = 0.0001 (Table 1). There were significantly
more Rechtschaffen and Kales awakenings on the fragmented
night (undisturbed, 27 ± 2; fragmented, 37 ± 3; p = 0.02). There
were significantly more arousals per hour slept of any duration
on the fragmented night (Table 2). On the fragmented night, 31%
of arousal? were less than 5 s in duration compared with 25 %
on the undisturbed night. Furthermore, 68% of arousals were
less than 10 s in duration on the fragmented night compared with
55% on the undisturbed night.
Daytime Sleepiness
There were significant decreases in the mean sleep onset laten¬
cies on the MSLT (11 + 3,7 ± 2 min; p = 0.002) and the MWT
(34 + 8, 24 ± 10 min; p < 0.0001) after fragmentation. On the
MSLT there were significant decreases in individual naps at 10:00
a.m. and at 2:00 and 4:00 p.m. (Figure 1) after fragmentation.
On the MWT there were significant decreases in naps at 2:45 and
4:45 p.m. (Figure 2) after fragmentation. There was no change
in subjective sleepiness on the Stanford Sleepiness Scale after
fragmentation (p= 0.8).
TABLE 2
MICROAROUSAL AND R&K FREQUENCIES PER HOUR OF
SLEEP FOR VARYING DURATIONS OF MICROAROUSALS*
Definition of abbreviations: TST = total sleep time; SPT = sleep period time; R&K = total
number of Rechtschaffen and Kales awakenings per night
* Values are mean ± SD. Values for Stages 1 to REM are expressed as a percentage of
TST.
^ Number of microarousals + R&K awakenings per hour of sleep.
Duration (s)













For definition of abbreviations, see Table 1.
* Values are means ± SD. All p < 0.01 for comparisons between study nights.
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Figure 7. Sleep onset latencies for individual naps on the MSLT. Values
are expressed as mean ± SD at each time of day. Oosed circles indi¬
cate undisturbed; open circles indicate fragmented (* p < 0.05; *" p <
0.001).
Mood
The mean energetic arousal score (22 ± 4, 19 ± 4, scores from
32; p < 0.001) and the mean hedonic tone score (29 ± 4, 27 ±
4; p = 0.05) were significantly lower after fragmentation. The
mean tense arousal score did not change. The individual ener¬
getic arousal scores were significantly lower after fragmentation
at all times except 12:00 noon (Figure 3). Individual hedonic tone
scores were significantly lower after fragmentation at 10:00 a.m.
(undisturbed, 30 ± 3; fragmented, 27 ± 4; p = 0.005) only. The
individual tense arousal scores were increased after the frag¬
mented night at 8:00 a.m. (undisturbed, 11 ± 3; fragmented, 13 ±
3; p = 0.01) and at 10:00 a.m. (10 ± 2, 12 ± 2; p = 0.05) only.
08.00 10.00 12.00 14.00 16.00
Time of Day
Figure 3. Energetic arousal scores throughout both test days. Values
are expressed as mean ± SD. Oosed circles indicate undisturbed; open
circles indicate fragmented (* p < 0.05; ** p < 0.01; *** p = 0.001).
Cognitive Function
Subjects had a significantly slower time to complete the Trail-
making B task (40 ± 14,43 + 10 s; p = 0.05) and scored signifi¬
cantly fewer correct additions on the PASAT 4-s test (60 ± 2,
58 ± 3; p < 0.03) after the fragmented night. No other cognitive
variables were altered significantly by sleep fragmentation.
Correlations with Daytime Sleepiness
Mean sleep onset latency on the MSLT and the MWT correlated
significantly with many nocturnal variables (Table 3). Multiple
linear regression analysis found that arousal frequency was the
single best predictor of daytime sleepiness measured by the MSLT
and that the percentage of SWS was the best predictor of mean
sleep onsent latency on the MWT. Mean length of undisturbed
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Figure 2. Sleep onset latencies for individual naps on the MWT. Values
are expressed as mean ± SD at each time of day. Oosed circles indi¬
cate undisturbed; open circles indicate fragmented (**p < 0.01).
DISCUSSION
This study confirms recent findings (26, 27) that one night of
sleep fragmentation with short arousals causes increased objec¬
tive daytime sleepiness, and it also shows that it causes decre¬
ments in mood and performance of normal subjects. Our sleep
fragmentation design improves on previous studies, which did
not include an acclimatization night in the laboratory (26, 27)
or a control undisturbed night (26). Previous studies have in¬
duced longer and more marked arousals than often occur in
SAHS (12,13,28), with a subsequent decrease in total sleep time
(12, 13, 28). We improved on daytime assessments in previous
studies (12, 13, 26-28) as they did not all include investigating
daytime sleepiness with the MSLT (12, 13, 28), the MWT (12,
13,26-28), or by looking at the effects of fragmentation on mood
(25, 27). Our subjects became sleepier than in previous studies
(26, 27), and we also demonstrated that maintenance of wake¬
fulness was impaired. The instruction to "stay awake" without
stimulation mimics more closely daytime situations in which the
excessively sleepy patients may find themselves and thus give more
relevant clinical information than how quickly the patients can
fall asleep. Our results show that after a single night of sleep
fragmentation normal subjects have as much difficulty staying
awake as untreated patients with SAHS (19,29). Clearly, patients
if. . . .• .. '*.• ■ • A, . .v* v.. llvv 4 ' c.vfsi.
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TABLE 3
CORRELATION MATRIX SHOWING RELATIONSHIPS BETWEEN DAYTIME
SLEEPINESS AND NOCTURNAL EEC VARIABLES
Wake Stage 2 SWS Arousal R&K Interarousal
(%) (%) (%) Frequency Frequency Duration
Mean MSLT r-0.24 -0.35 0.32 -0.39 -0.26 0.32
p 0.09 0.02 0.04 0.01 0.08 0.04
Mean MWT r -0.39 -0-52 0.45 -0.42 -O.40 0.32
p 0.01 0.001 0.005 0.007 0.01 0.04
Definition of abbreviations: SWS = slow-wave sleep; R&K = total number of RechtschaHen and Kales awakenings per night; MSLT = multi¬
ple sleep latency test; MWT - maintenance of wakefulness test
with SAHS may clinically respond in a way different from that
of normal subjects with a similar degree of objective daytime
sleepiness. For example, their ability to alert themselves may be
affected by years of experience of sleepiness.
Sleep fragmentation impaired performance in two tests: Trail-
making B, testing mental flexibility and attentional capacity, and
the PASAT 4-s test, a sustained attention task. Thus, sleep frag¬
mentation is probably affecting attention. We have previously
found both these measures to be improved by treatment in pa¬
tients with SAHS (24). Previous studies have found that two
nights of sleep disruption (not fragmentation) decreased perfor¬
mance on a simple reaction time task (12), the Wilkinson addi¬
tion task (12, 13, 28), and the digit symbol substitution (12). In
contrast to our results, however, studies inducing short arousals
similar to those seen in patients with SAHS (26, 27) found no
change in performance after fragmentation. They did not use
either Trailmaking or PASAT, but they had selected tests for their
monotonous quality. We used Steer Clear (30 min) to assess vig¬
ilance and did not find any change in performance. It appears
that normal subjects can overcome the effects of sleep fragmen¬
tation on such monotonous tasks.
In this study, one night of fragmentation resulted in energetic
arousal scores in the subjects similar to those of untreated pa¬
tients with SAHS (24). Decrements in energetic arousal after frag¬
mentation mirror the decreases seen on the individual MSLT and
MWT naps, suggesting that the energetic arousal dimension of
mood may be a subjective indicator of objective daytime sleepi¬
ness. Mood is most susceptible to an external stress in the early
part of the day as demonstrated by the global changes in mood
at 1C:00 a.m. after fragmentation. Sleep deprivation has similar
global effects on mood (20). Our results suggest that sleep frag¬
mentation is as detrimental to mood as sleep deprivation.
In our study the arousal frequency during the fragmented night
was similar to that seen in untreated patients with SAHS (1, 30).
The arousal frequency, even when altered for spontaneously oc¬
curring arousals from sleep, was still greater than that of Roehrs
and colleagues (26), whereas Philip and coworkers (27) refer to
the number of stimulations during the fragmented night and not
to the number of arousals.
Our decrements in daytime function may be due to the small
but significant changes in sleep architecture on the fragmented
night. Our data indicate that sleepiness on the MSLT and the
MWT correlated with a range of EEG variables, many of which
were themselves interrelated. Our regression analysis showed that
the single best predictors of daytime sleepiness was arousal fre¬
quency for the MSLT and SWS duration for the MWT. Philip
and colleagues (27) found a significant relationship between noc¬
turnal slow wave sleep and mean sleep latency on the MSLT, but
they did not examine the relationship with arousals. Bonnet (31)
found that eliminating SWS does not affect performance, mood,
or daytime sleepiness decrements after sleep disruption in nor¬
mal subjects. In patients with SAHS, daytime sleepiness was best
predicted by sleep disruptions (7) and respiratory-associated
arousals (8). However, neither ourselves (2) nor others (1) found
any significant relationships between sleep stages and daytime
function, whereas we have found a relationship between micro-
arousals and daytime function (2).
This study shows that a single night of sleep fragmentation
can induce objective sleepiness and altered mood and psycho¬
metric function similar to that found in patients with SAHS.
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Arousals and the Sleep Apnea/Hypopnea Syndrome -
Neil J. Douglas and Sascha E. Martin
Respiratory Medicine Unit, Department of Medicine, The University of Edinburgh.
Royal Infirmary, Edinburgh, Scotland. U.K.
Summary: As daytime deficits in sleep apnea/hypopnea syndrome (SAHS) correlate poorly with earlier definitions
of arousals, we investigated the relationship between microarousals and sleepiness in o3 patients with SAHS. There
was a poor correlation between mean sleep latency and microarousal frequency. To determine whether arousals not
detected by current definitions could account for some of the residual variance in normal subjects we used sound
to induce "arousals" that were detected by rises in blood pressure but produced no visible EEG change. Such
autonomic arousals produced an increase in sleepiness. We conclude that arousals not scored currently on polysom¬
nography may contribute to the sleepiness of patients with SAHS. Key Words: Sleep apnea—Arousals—Cognitive
function—Sleepiness.
Repetitive arousal from sleep is a key component of
the sleep apnea/hypopnea syndrome (SAHS). This pa¬
per describes investigations into the consequences of
recurrent brief arousals in both patients with the syn¬
drome and normal subjects.
In early studies, we showed that the daytime cog¬
nitive deficits in patients with the sleep apnea/hypo¬
pnea syndrome correlate best with the apnea + hy-
popnea frequency and more weakly with 1.5 second
definitions of microarousals (1). However, there was
no significant relationship in that study between arous¬
al and objective daytime sleepiness measured by the
multiple sleep latency test (MSLT) (1), while others
have found weak relationships between arousals and
objective sleepiness (2,3). We have now extended
those studies by looking at a group of 63 patients and
examining the coincidence between breathing irregu¬
larity at night and microarousals using three different
definitions of microarousals (4). Three-second ASDA
microarousals occurred at the termination of 75 SEM
4% of apneas and hypopneas, whereas significantly
more (p < 0.01) apneas and hypopneas were termi¬
nated by 1.5-second (1) microarousals (81 ± 4%) or
a 1.5-second microarousal definition based on the
ASDA neurophysiological criteria (83 ± 4%). There
was a significant relationship between apnea + hypo-
pnea frequency and the mean sleep latency on the mul¬
tiple sleep latency test (r = —0.3, p < 0.01) and even
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weaker but still significant relationships between mean
sleep latency and microarousals (0.24 > r > 0.2).
Many of the patients with sleep apnea/hypopnea syn¬
drome had arousal frequencies that were within the
normal range for one night polysomnography in our
laboratory (5). We conclude that there is a weak re¬
lationship between visible electromyelograph (EMG)
arousal and objective daytime sleepiness but that the
variance in objective sleepiness is not explained by
this relationship.
To further investigate the consequences of arousal
and the potential sources of variance in the above re¬
lationship, we first examined the effect of fragmenting
sleep by sound in 16 normal subjects (6). The study
was carried out in a randomized blinded fashion with
acclimatization nights and showed that the induction
of repetitive microarousals by sound impulses every
two minutes decreased sleep latency both on the
MSLT (p = 0.001) and the MWT (p < 0.001). There
were also impairments in cognitive function on the
Trailmaking B and Paced Serial Addition Test. We
then performed a study inducing arousal that was de¬
tectable by a blood pressure increment but no visible
electroencephalograph (EEG) change. Such "auto¬
nomic" arousals also produced increased sleepiness as
detected by the MSLT and MWT (p < 0.05). However,
no changes in cognitive function were observed.
It is possible that some of the unexplained variance
in the relationship between microarousals and objec¬
tive sleepiness in the patients with the sleep apnea/
hypopnea syndrome are due to "autonomic" type
arousals occurring in these patients that are not de¬





1. Cheshire K. Engleman H. Deary [, Douglas NJ. Factors im¬
pairing daytime performance in patients with the sleep apnea/
hvpopnea syndrome. Arch Int Med 1992:152:538-41.
2. Roehrs T, Zorick F. Wittig R. Conway W, Roth T. Predictors of
objective level of daytime sleepiness in patients with sleep-re¬
lated breathing disorders. Chest 1989:95:1202-6.
3. Poceta JS. Timms RM. Jeong DU, Ho S, Erman MK. Mitler
MM. Maintenance of wakefulness test in obstructive sieep ap¬
nea syndrome. Chest 1992:101:893-7.
SLEEP APNEA SI97
4. Martin SE, Engleman HM._ Deary [J. Douglas NJ. Comparison
of microarousal definitions in patients with sleep apnea. Am J
Resp Crit Care Med 1995; 151:A 154.
5. Mathur R, Douglas NJ. Frequency of EEC arousals from noc¬
turnal sleep in normal subjects. Sleep 1995;18:330-3.
6. Martin SE, Engleman HM, Deary IJ. Douglas NJ. The effect of
sleep fragmentation on daytime function. Am J Resp Crit Care
Med 1996:153:1328-32.
7. Martin SE. Deary U. Douglas NJ. The effect of autonomic
arousals on daytime function. Am J Resp Crit Care Med
1996;153:A354.
Sleep. Vol. 19. No. 10. 1996
The Effect of Nonvisible Sleep Fragmentation
on Daytime Function
SASCHA E. MARTIN, PETER K. WRAITH, IAN J. DEARY, and NEIL j. DOUGLAS
Departments of Medicine and Psychology, University of Edinburgh, Edinburgh, United Kingdom
Patients with sleep apnea/hypopnea syndrome (SAHS) suffer from impaired daytime function that
correlates with hypoxemia and visible electroencephalographic (EEG) arousals. However, not all breath¬
ing irregularities during sleep terminate with visible EEG arousal. We hypothesized that sleep distur¬
bance without visible EEG change may impair daytime function. Twelve normal subjects spent two
pairs of 2 nights each in the laboratory. The first night of each pair was for acclimatization. On the
second night, subjects either slept undisturbed or had sleep fragmented every minute to cause a tran¬
sient increase in arterial blood pressure or increase in heart rate without visible EEG arousal. We tested
daytime function after each study night. We presented 253 ± 23 tones (mean ± SD), 79 ± 7% of which
did not cause visible EEG arousals. Fragmentation did not alter total sleep time (undisturbed: 419 ±
27 min; fragmented: 414 ± 32 min; p = 0.5) or arousal frequency (undisturbed: 22 ± 4/h; fragmented:
25 ± 6/h; p = 0.4). Fragmentation reduced slow-wave sleep (undisturbed: 24 ± 5%; fragmented: 20 ±
4%; p < 0.01), mean sleep onset latency on the multiple sleep latency test (MSLT) (undisturbed: 8.0 ±
3.1; fragmented: 6.2 ± 2.1 min; p = 0.01) and the maintenance of wakefulness test (MWT) (undis¬
turbed: 29.0 ± 10.0 min; fragmented 25.7 ± 9.7 min; p = 0.04). Fragmentation decreased hedonic
tone at 7 a.m. (27 ± 4, 25 ± 6; p = 0.03). Nonvisible (autonomic) sleep fragmentation makes normal
subjects sleepier and impairs their mood. Martin SE, Wraith PK, Deary IJ, Douglas NJ. The effect
of nonvisibie sleep fragmentation on daytime function, am j rupir cxit care med i997,iss:is96~i6oi.
Patients with sleep apnea/hypopnea syndrome (SAHS) suffer
from impaired daytime function (1-3). They are pathologically
sleepy during the day as measured by the multiple sleep latency
test (MSLT) (4), and they have impaired cognitive function and
mood as compared with those of control subjects (1, 3). These
impairments in daytime function have been associated with both
the nocturnal hypoxemia and the sleep fragmentation/disrup¬
tion seen in patients with SAHS (2). They are, however, strongly
interrelated, making it difficult to elucidate which is the specific
cause of daytime dysfunction.
Previous studies modeling the effects of sleep disruption found
that normal subjects had impaired daytime function after sleep
disturbance (5, 6). In these studies, subjects had to respond be-
haviorally to tones presented during sleep, and consequently had
disturbed sleep. Recently, we have investigated the effects of in¬
duced sleep fragmentation, with recurrent brief cortical arousals
(3 to 15 s), on daytime function in normal subjects (7). We found
that one night of sleep fragmentation made the subjects sleepier
during the day on the MSLT and the maintenance of wakeful¬
ness test (MWT), and impaired their mood and cognitive func¬
tion (7).
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Recently, patients with mild sleep apnea (8), snoring (9), and
upper airway resistance syndrome (10) have shown improvement
in daytime function with continuous positive airway pressure
(CPAP) therapy. These milder forms of sleep-disordered breath¬
ing are invariably characterized by relatively normal nocturnal
oxygenation, but with more cortical arousals, and it is the elimi¬
nation of these arousals that is believed to lead to the improve¬
ment in daytime function.
In SAHS patients, sleep fragmentation accounts for about
16% of the variance in daytime sleepiness (11), and many SAHS
patients have a similar number of cortical arousals as normal
subjects when studied in a sleep laboratory (12). Thus, their day¬
time symptoms are not explained by sleep fragmentation caused
by visible electroencephalographic (EEG) arousals. Not all sleep-
related apneas and hypopneas are terminated by cortical arousals
(13). Because apneas and hypopneas unaccompanied by visible
EEG change may result in the blood-pressure (BP) increase of
arousals (14), we hypothesized that sleep disturbance unaccom¬
panied by visible EEG change may impair daytime function. We
therefore studied the effects on daytime function of recurrent
induced arousals detected by transient BP and/or heart rate (HR)
increases in normal subjects.
METHODS
Subjects
We recruited subjects from the local student population, using adver¬
tisements that did not refer to sleep. Responding subjects were screened
for sleep disorders with our in-house sleep-wake questionnaire, which
we use to assess patients prior to attendance at the Scottish National
Sleep Laboratory. We obtained ethical permission for this study from
the Lothian Research Ethics Committee and the University of Edinburgh.
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We studied 12 subjects (seven men and five women) with a mean age
of 25 ± 6 yr. They were all nonobese (body mass index [BMIJ: 22 ±
2 kg/m2) and had Epworth sleepiness scores in the normal range (mean
5, range 2 to 8) (15).
Protocol
Subjects spent 4 nights and 2 d in the laboratory. Prior to the first night,
subjects were familiarized with the tests of cognitive function used, and
underwent one practice session. The nights were divided into two pairs
of 2 nights a week apart. The first night of each pair was for acclimati¬
zation to the laboratory to avoid any "first night" effect. On the second
night of each pair, subjects were randomly assigned to having an un¬
disturbed night's sleep or having their sleep fragmented with tones.
On both study nights, sleep was recorded with our standard tech¬
niques (16), using a computerized recording system (Compumedics, Mel¬
bourne, Australia), and was staged manually according to standard
criteria (17) through electroencephalography, electrooculography, and
submental electromyography. In eight subjects we also recorded two fron¬
tal electroencephalographic (EEG) channels from standard EEG record¬
ing sites Fpl to F3 and Fp2 to F4. We monitored arterial blood pressure
with a digital infrared plethysmograph (Finapres; Ohmeda) set in beat-
to-beat digital data-stream mode and attached to a personal computer
(PC). Beat-to-beat systolic, cjiastolic, and mean arterial BP and pulse
rate were recorded in serial ASCII string format on both study nights (18).
In order to assess the plethysmograph for use in whole-night studies
we performed pilot studies with two normal subjects. Subjects tolerated
the device for the first sleep cycle (approximately 1.5 h), but had pro¬
foundly disturbed sleep for their remaining study time. We therefore
aimed to record BP continuously for the first 1.5 h of sleep, from the
onset of slow-wave sleep (SWS). If subjects had a full awakening, the
device was switched off and subjects were allowed to go back to Stage
2 sleep before the device was again switched on. During BP recording,
HR responses to tones that produced nonvisible arousals were closely
monitored and used as a guideline for nonvisible responses to tones during
the remainder of the study night after the plethysmograph had been re¬
moved from the subject's hand. The volume and duration of tones were
increased during the night in accordance with data showing that normal
subjects acclimatize to arousing stimuli (5, 6). Subjects were monitored
with a video camera to check for any movement that may have affected
6P recording.
At every 1-min interval from the onset of SWS, we varied the dura¬
tion and volume of tones to produce not a visible EEG change, but an
autonomic response (i.e., a minimum increase in systolic BP of 4 mm Hg
or, when the subject was not connected to the plethysmograph, an
increase in HR of at least 4 beats/min without any visible cortical arousal
response on the EEG channels that could be scored as an arousal). Brief
(less than 3 s) EEG changes in response to tones, including K complexes
or sleep spindles, were not counted as visible EEG responses to tones.
The response should occur within 15 s of a tone, and because BP varies
with the respiratory cycle, should be sustained over at least 3 beats as
compared with BP over the 15 s prior to the tone. BP responses were
assessed by the experimenter from a real-time display on a PC situated
next to the Compumedics polysomnography computer. HR was also as¬
sessed from a real-time display on a cardiac rate monitor. If we achieved
this response, the next tone came 1 min after the previous tone If tones
produced cortical arousals, we waited until the reappearance of the first
sleep spindle or K complex, and then waited 1 min before applying the
next tone If we did not achieve this nonvisible response on the first tone,
we allowed a 30-s lapse before repeating the process with a louder or
longer tone Sample visible and nonvisible EEG responses to tones are
depicted in Figure 1. In Figure lb, it can be argued that there is a visible
response to the tone in the form of a K complex. During this study, sleep
spindles and K complexes were seen on the electroencephalogram in re¬
sponse to tones, but were not counted as visible EEG arousals because
they did not meet the criteria for scoring of arousals. Tones of 1,000
Hz were presented to subjects via a loudspeaker positioned above the
subject's head.
Lights out on all nights was at 11:00 p.m., with the study time ending
at 6:30 a.m. on all nights except for the fragmented night, when the study
time was extended by 15 min to allow for any sleep loss due to fragmen¬
tation regardless of prior sleep quality. Fragmentation of sleep continued
throughout this extended study time.
On the fragmented study night, the increase in systolic BP in response
to tones was calculated for 10 s prior to each tone and for 10 s surround¬
ing the maximum BP response. The mean delay to maximum BP re¬
sponse was noted for each subject. In order to compare BP responses
to tones on different study nights, we randomly marked BP records from
the undisturbed study night with an equal number of sham tones as of
real tones on the fragmented study night. We took the "maximum" BP
response to the sham tone as the BP at x seconds after each tone, x be¬
ing the mean delay to maximum blood pressure within 20 s of a tone
on the subject's fragmented study night. We then calculated the mean
systolic BP for the 10 s prior to each "tone" and for the 10-s period from
5 s before to 5 s after the "maximum" BP response.
Arousals were defined as a return to alpha or theta frequency on the
electroencephalograph channels for a minimum of 3 s (7, 19), regard¬
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Figure T. Sample visible (a) and nonvisible (b) EEG responses to tones. The channels depicted are central EEG (cEEG); (C2/PZ) and frontal
EEC (fEEG); Fpl/F3, Fp2/F4; chin EMG; and the tone marker channel. Tones were administered at the marks shown. In a, Ar-SF indicates
visible EEG arousal. In a, the peak EEG power (in the range of 8 to 11 Hz) within 5 s of the tone was 3.3Hz, and the maximum BP increase
within .15 s of the tone was 16 mm Hg. In b, the peak EEG power was 2.6 Hz and maximum BP increase was 5 mm Hg.
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were induced by tones or not. We did not use any electromyographic
(EMG) criteria for scoring of arousals, as we had found that we could
not induce increases in EMG tone-without causing full awakenings. The
arousal frequency consisted of the number of arousals plus the number
of Rechtschaffen-and-Kales awakenings per hour of sleep. Frontal
(Fpl/F3, Fp2/F4) and occipital (CZ/PZ) arousal frequencies were scored
separately. We also scored 1-h segments of Stage 2 sleep for 1.5-s arousals
from the frontal leads.
Frontal EEG data from Stage 2 sleep were analyzed with fast Fourier
transformation to calculate EEG power in the alpha frequency band (8
to 11 Hz). Peak power was selected within 5 s of tones and control time
points either 30 s before or after tones. Subjects spent the day after each
pair of nights undergoing testing of daytime sleepiness, cognitive func¬
tion, and mood.
Daytime Assessment
We assessed objective daytime sleepiness with the MSLT (20) and MWT
(21). Both tests consisted of four naps at 2-h intervals. We terminated
all naps after one epoch of Rechtschaffen-and-Kales Stage 1 sleep, thus
preventing subjects from obtaining any recuperative sleep that might
have affected their subsequent daytime function. We assessed subjec¬
tive daytime sleepiness with the Stanford sleepiness scale (SSS) at 7:00
a.m. and prior to each nap on the MSLT, at 10:00 a.m., 12:00 p.m., 2:00
p.m., and 4:00 p.m. (22).
We assessed mood with the University of Wales Institute of Science
and Technology mood adjective checklist (23) at 7:00 a.m. and prior to
each nap on the MSLT. This checklist scores mood dimensions of ener¬
getic arousal, hecjonic tone, and tense arousal, as previously described (7).
Prior to the first daytime nap, subjects underwent a battery of per¬
formance tests designed to examine a broad range of cognitive func¬
tions. We have previously found that these tests relate to nocturnal hyp¬
oxemia and sleep fragmentation in patients with SAHS (2), and are
sensitive to improvements in cognitive function in SAHS patients after
1 mo of CPAP therapy (24). The tests were the Wechsler Adult Intelli¬
gence Scale-R (WA1S-R) subtests of digit-symbol substitution and block
design (25), trailmaking tests A and B (25), the steer clear test (26), and
the paced auditory serial addition test (PASAT) at 4 and 2 s (25).
Statistical Analysis
We analyzed our data with a mixed two-way analysis of variance
(ANOVA) (SPSS/PC* software; SPSS Inc., Chicago, IL) for repeated
measures, with the order of conditions as a between-subjects effect. We
examined our outcome measures for nonnormal distributions and found
ceiling effects on all individual naps on the MWT and all measures of
hedonic tone. We analyzed these variables with Wilcoxon's matched pairs
test.
We used paired l tests to compare peak EEG power after control times
and tones. Tones were divided into those that induced arousals and those
that did not. ANOVA was performed on the difference between tones
and controls, with outcome (whether tones caused arousals or not) and
intrasubject variability as factors. In order to reduce the number of out¬
come measures from the cognitive-function test battery, we subjected
them to principal-components analysis (27).
TABLE 1
COMPARISON OF SLEEP ARCHITECTURE ON
UNDISTURBED AND FRAGMENTED STUDY NIGHTS
Undisturbed Fragmented p Value
TST, min 419.0 ±27.4 414.0 ± 32.2 0.5
Wake (SPT), % 7.4 ± 4.2 8.3 ± 4.4 0.5
Stage 1, % 3.3 ± 1.9 3.7 ± 1.8 0.5
Stage 2, % 49.8 ± 4.8 53.8 ± 6.2 0.1
SWS, % 23.9 ± 5.0 19.5 ±4.3 0.007
Stage REM, % 23.0 ± 4.2 23.1 ± 4.2 0.9
Definition of abbreviations: TST = total sleep time, SPT = sleep period time, SWS = slow
wave sleep.
Values are expressed as mean ± SD.
TABLE 2
AROUSAL FREQUENCIES PER HOUR OF SLEEP
Undisturbed Fragmented p Value
Central arousals/h 22.4 ±4.3 24.5 ± 5.7 0.4
Frontal arousals/h 22.8 ± 6.0 26.3 ± 5.0 0.1
1.5-s arousals/h 26± 12 27± 12 0.7
RStK awakenings/h 3.7 ± 1.6 3.8 ± 1.2 0.8
Values are expressed as mean ± SD.
Central; CZ/PZ: frontal: Fpl/F3 and Fp2/F4; 1.5-s arousals scored from frontal leads.
RESULTS
Sleep Architecture
There were no significant differences between study nights in
total sleep time (TST), amounts of wakefulness, or Stage 1, Stage
2, or rapid eye movement (REM) sleep (Table 1). However,
there was significantly less SWS on the fragmented study night
(Table 1).
Arousals
The minimum tone volume and duration was 38 db for 0.25 s.
The maximum volume and duration of tones required to pro¬
duce a nonvisible arousal response was 65 db for less than 4 s
in all subjects. We presented a mean of 253 (SD = 23) tones to
subjects during the fragmented study night, 21 ± 7°7o of which
caused central arousals and a similar number (23 ± 9°7o; p =
0.3) of frontal arousals. The frequency of arousals induced by
tones was 7.8 ± 2.2 per hour of sleep. The spontaneous arousal
frequency on the fragmented night (16.7 ± 4.4 per hour of sleep)
was significantly smaller than the arousal frequency on the un¬
disturbed night (Table 2, p = 0.001). There were no significant
differences between study nights in central, frontal, or 1.5-s
arousal frequencies (Table 2). The mean systolic BP increase in
response to tones was 8 ± 2 mm Hg, which was significantly
greater than the response to control "tones"; (-0.2 ± 0.1 mm
Hg; p < 0.0001). The mean delay time to the maximum BP re¬
sponse was 9 ± 2 s.
Fast Fourier Transformation
Peak alpha EEG power was significantly greater after tones than
for controls, both when tones induced visible EEG arousals (n =
191 events; control: 4.9 ± 2.2 pV; tone: 10.6 ± 4.9 pV; p < 0.0001)
and when tones did not induce visible arousals (n = 575 events;
control: 5.3 ± 2.7 pV; tone: 7.4 ± 3.3 pV; p < 0.0001). There
was a significantly greater increase in peak EEG power after tones
that caused arousals than after those that did not (p = 0.008),
with no significant contribution from intrasubject variability.
Daytime Sleepiness
There were significantly shorter mean sleep-onset latencies in the
MSL.T (8.0 ± 3.1 versus 6.2 ± 2.1 min; p = 0.01) (Figure 2) and
MWT (29.0 ± 10.0 versus 25.7 ± 9.7 min; p = 0.04) (Figure
3) after nonvisible sleep fragmentation. On the MSLT there were
significantly shorter sleep onset latencies for individual naps at
10:00 a.m. (p = 0.01) and at 4:00 p.m. (p = 0.01) after fragmenta¬
tion. On the MWT there were trends toward significant differ¬
ences in sleep-onset latencies for individual naps at 10:45 a.m.
(p = 0.09) and at 4:45 p.m. (p = 0.07) after nonvisible fragmen¬
tation. There was no difference in subjective daytime sleepiness
as measured by the SSS (mean SSS score: undisturbed: 3 ± 1;
fragmented: 3 ± 1; p = 0.7) after either study night.
Mood
There was a significant decrease in hedonic tone at 7:00 a.m. (p =
0.03; Figure 4), and there was a trend toward a significant in-















Figure 2. Paired points for individual subjects' mean sleep-onset
latency on the MSLT after undisturbed and fragmented study nights.
*'
crease in tense arousal at 7:00 a.m. (p < 0.09; Figure 4) after frag-
mentation. There was no change in energetic arousal at any time
of the day after fragmentation.
Cognitive Function
We extracted the first cognitive factor from our principal-com¬
ponents analysis, which accounted for 39% of the total variance.
This factor correlated significantly with all cognitive-function
measures. We therefore standardized each measure, assigned
equal weightings to them, and summed them, to produce one
outcome variable for each subject for each study limb. Scores
for tests in which high scores indicated poor performance were
subtracted as opposed to added. Fragmentation did rot cause
significant impairment of cognitive function (undisturbed: 0.6 ±
2.8; fragmented: -0.01 ± 4.0; p = 0.7).
DISCUSSION
This study shows that nonvisible sleep fragmentation affects sleep
architecture, daytime sleepiness as measured with the MSLT and

















Figure 3. Paired points for individual subjects' mean sleep-onset
latency on the MWT after undisturbed and fragmented study nights.
nificant increase in the number of visible cortical arousals on
the electroencephalogram; however, we have shown that small
but significant increases in EEG power do occur in response to
tones that do not cause visible EEG arousals. We have previously
found that one night of cortical sleep fragmentation makes nor¬
mal subjects sleepier during the day on the MSLT and MWT,
and impairs mood and cognitive function (7).
We previously found that inducing visible EEG arousals ev¬
ery 2 min decreased the MSLT from 11 to 7 min and the MWT
from 34 to 24 min, impaired all mood dimensions in the morn¬
ing and energetic arousal for the rest of the day as well, and caused
decrements in cognitive function. Nonvisibly detected arousals
decrease the MSLT from 8 to 6 min and the MWT from 29 to
26 min, cause mood impairment on awakening only, and have
no deleterious effect on cognitive function. The current results
contrast with preliminary results from Sahloul and coworkers
(28), who found, in four subjects, that there was no difference
in sleep-onset iatency on the MSLT after nonvisible sleep frag¬
mentation during 3 h of recovery sleep as compared with a base¬
line night. We believe that our results differ from those of Sah¬
loul and coworkers (28) because we studied more subjects and
performed whole-night studies after acclimatization nights on
both study limbs, tested mood and cognitive function, and tested
daytime sleepiness with the MWT as well as the MSLT.
We found small but significant changes in daytime sleepiness
in response to nonvisible sleep fragmentation. Despite the changes
in MSLT and MWT results, there was no difference in subjective
sleepiness after fragmentation. Previous studies have shown that
SSS scores and objective sleepiness do not always move in paral¬
lel (4). We presented 34 tones per hour to induce nonvisible
arousals, as compared with 30 tones per hour inducing visible
EEG arousals (7), and the more subtle changes in daytime sleep¬
iness reflect this difference. On the MSLT, this small change is
similar in magnitude to that seen in patients with sleep apnea
after they have been established on CPAP therapy (29, 30). San-
gal and associates (21) found that sleepiness on the MWT im¬
proves with CPAP therapy by a magnitude (8 min) that is smaller
than the decrease seen in normal subjects after induced visible
EEG arousals (10 min) (7) but greater than the decrease seen af¬
ter nonvisible arousals (4 min) in the present study. Our subjects
appeared to be sleepier after the undisturbed night than those
in our previous study (7). We therefore looked closeiy at our sub¬
jects' working habits, and found that three of our student sub¬
jects had evening jobs on weekends which ran into the early morn¬
ing. Each was studied at the same time of the week in both limbs
of the study, and always after at least 2 nights of normal sleep
at home plus the acclimatization night before the study night.
These three subjects may have increased the overall sleepiness
of our study sample.
We monitored BP for the first sleep cycle only, because dur¬
ing pilot studies we showed that normal subjects were not sleepy
enough to tolerate BP monitoring for the whole night without
sleep disruption. The plethysmography device used in our study
may have increased arousal frequency on study nights, since the
arousal frequency on the undisturbed night in the study was 22
per hour, as compared with 15 per hour on the undisturbed night
in our previous fragmentation study (7). Mood, cognitive func¬
tion, and daytime sleepiness in normal subjects are impaired
by sleep disruption (5, 6), and we therefore felt that monitoring
BP over the whole night would have compromised the present
study.
We found no significant difference in arousal frequencies mea¬
sured centrally or frontally (either 3-s or 1.5-s duration) on differ¬
ent study nights. There was no significant difference between cor¬
tical areas in the number of tones that caused arousals. We decided
to monitor frontal EEG channels because O'Malley and cowork-































Figure 4. Paired point values for (a) hedonic tone and (b) tense arousal mood dimensions at 7:00 a.m.
ers (31), in a provisional study with topographic brain mapping,
found that in patients with mild sleep apnea, frontal arousals
were seen at the termination of 95% of respiratory events, whereas
only 73% of such arousals were detected at occipital sites. In
contrast. We did not find that visual scoring of frontal EEG sig¬
nals increased the detection of visible EEG arousals in response
to tones in normal subjects. The maximum volume and dura¬
tion of tones required to produce a nonvisible arousal response
was 65 db for less than 4 s, which is much smaller than that re¬
quired to induce visible cortical arousal in our previous fragmen¬
tation study (100 db for up to 12 s).
We performed fast Fourier transformation on the frontal elec¬
troencephalogram from Stage 2 sleep. We found significant in¬
creases in EEG frequency in response to tones that did not cause
visible EEG arousals. Davies and colleagues (18) tracked EEG
changes in normal subjects in response to auditory stimuli, using
a computerized artificial neural network without seeing visible
cortical arousals. These changes were always accompanied by
transient increases in arterial BP (18). Rees and coworkers (14)
used fast Fourier transformations of the electroencephalograms
of SAHS patients and found increases in EEG frequency coinci¬
dent with increases in BP at the end of respiratory events whether
or not they terminated in cortical arousals. This evidence, taken
together with the induced decreases in daytime sleepiness that
we have demonstrated in the present study, suggests that perhaps
a more sophisticated analysis of the electroencephalogram or a
nonvisible marker of arousal (32) should be included in routine
sleep studies to assess the true extent of sleep fragmentation
suffered by patients being assessed for sleep disorders.
We found a decrease in hedonic tone and a trend toward an
increase in tense arousal on awakening after nonvisible sleep frag¬
mentation. This is consistent with findings in studies using acute
hypoglycemia as a physiologic stressor. Normal subjects had de¬
creased hedonic tone and increased tense arousal, which was max¬
imal with the onset of autonomic reactions to acute hypoglyce¬
mia (33), whereas adrenalectomized subjects, who do not have
the normal Adrenaline response to hypoglycemia, did not show
these changes (34). Together, these results suggest that changes
in hedonic tone and tense arousal could be autonomically medi¬
ated, whereas changes in energetic arousal are due to cortical
stimulation. This hypothesis is supported by our findings in the
present study of transient changes in mood due to repetitive non-
visible arousal from sleep, and in our previous study (7) of longer
lasting impairment of energetic arousal due to cortical sleep frag¬
mentation.
In this study, we have shown that one night of induced non-
visible sleep fragmentation causes increased daytime sleepiness
and impaired mood upon awakening. The importance of sleep
fragmentation with nonvisible EEG arousals in patients with sleep
disorders needs to be assessed.
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